date generated: 2021-05-25
Mitch performs unidimensional and multidimensional gene set enrichment analysis. The concept behind this dates to work by Cox and Mann (https://doi.org/10.1186/1471-2105-13-S16-S12). This implementation is suited to R based workflows of multi-omics datasets. This software was developed by Antony Kaspi and Mark Ziemann. Learn more about Mitch at the website: https://github.com/markziemann/Mitch
Here is the first few lines of the input profile.
## t
## A1BG 0.0412627
## AAAS 0.2317684
## AACS 0.4461738
## AAGAB -0.8398882
## AAK1 1.5132512
## AAMP -0.6831837
Here are some metrics about the input data profile:
| Profile metrics | |
|---|---|
| num_genesets | 2484 |
| num_genes_in_profile | 9869 |
| duplicated_genes_present | 0 |
| num_profile_genes_in_sets | 5319 |
| num_profile_genes_not_in_sets | 4550 |
Here is a plot of the input profiles. Note the dynamic ranges.
Here is the contour plot of the profile including all detected genes.
| Gene sets metrics | |
|---|---|
| num_genesets | 2484 |
| num_genesets_excluded | 1343 |
| num_genesets_included | 1141 |
Significance is calculated by -log10(p-value). All points shown are FDR<0.05.
Significance is calculated by -log10(p-value). Top N sets shown irrespective of FDR.
| set | setSize | pANOVA | s.dist | p.adjustANOVA |
|---|---|---|---|---|
| Metabolism of RNA | 498 | 1.38e-06 | 0.128 | 0.00158 |
| Mitotic Metaphase and Anaphase | 186 | 8.41e-05 | 0.168 | 0.03800 |
| Mitotic Anaphase | 185 | 1.13e-04 | 0.165 | 0.03800 |
| Translation | 225 | 1.33e-04 | 0.149 | 0.03800 |
| NOTCH3 Activation and Transmission of Signal to the Nucleus | 15 | 2.42e-04 | 0.547 | 0.04490 |
| PLC beta mediated events | 29 | 2.92e-04 | -0.389 | 0.04490 |
| DAG and IP3 signaling | 26 | 3.63e-04 | -0.404 | 0.04490 |
| Regulation of expression of SLITs and ROBOs | 117 | 4.73e-04 | 0.188 | 0.04490 |
| Selenocysteine synthesis | 65 | 4.77e-04 | 0.251 | 0.04490 |
| Signaling by GPCR | 195 | 5.88e-04 | -0.144 | 0.04490 |
| Mitochondrial translation elongation | 81 | 6.64e-04 | 0.219 | 0.04490 |
| Integrin cell surface interactions | 23 | 7.16e-04 | -0.408 | 0.04490 |
| Peptide chain elongation | 64 | 7.50e-04 | 0.244 | 0.04490 |
| rRNA processing | 149 | 7.96e-04 | 0.160 | 0.04490 |
| L13a-mediated translational silencing of Ceruloplasmin expression | 82 | 8.39e-04 | 0.214 | 0.04490 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | 83 | 9.39e-04 | 0.211 | 0.04490 |
| NOTCH2 Activation and Transmission of Signal to the Nucleus | 12 | 9.67e-04 | 0.550 | 0.04490 |
| Signaling by ROBO receptors | 146 | 9.79e-04 | 0.159 | 0.04490 |
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | 69 | 9.92e-04 | 0.230 | 0.04490 |
| rRNA processing in the nucleus and cytosol | 145 | 9.99e-04 | 0.159 | 0.04490 |
| set | setSize | pANOVA | s.dist | p.adjustANOVA |
|---|---|---|---|---|
| Metabolism of RNA | 498 | 1.38e-06 | 1.28e-01 | 0.00158 |
| Mitotic Metaphase and Anaphase | 186 | 8.41e-05 | 1.68e-01 | 0.03800 |
| Mitotic Anaphase | 185 | 1.13e-04 | 1.65e-01 | 0.03800 |
| Translation | 225 | 1.33e-04 | 1.49e-01 | 0.03800 |
| NOTCH3 Activation and Transmission of Signal to the Nucleus | 15 | 2.42e-04 | 5.47e-01 | 0.04490 |
| PLC beta mediated events | 29 | 2.92e-04 | -3.89e-01 | 0.04490 |
| DAG and IP3 signaling | 26 | 3.63e-04 | -4.04e-01 | 0.04490 |
| Regulation of expression of SLITs and ROBOs | 117 | 4.73e-04 | 1.88e-01 | 0.04490 |
| Selenocysteine synthesis | 65 | 4.77e-04 | 2.51e-01 | 0.04490 |
| Signaling by GPCR | 195 | 5.88e-04 | -1.44e-01 | 0.04490 |
| Mitochondrial translation elongation | 81 | 6.64e-04 | 2.19e-01 | 0.04490 |
| Integrin cell surface interactions | 23 | 7.16e-04 | -4.08e-01 | 0.04490 |
| Peptide chain elongation | 64 | 7.50e-04 | 2.44e-01 | 0.04490 |
| rRNA processing | 149 | 7.96e-04 | 1.60e-01 | 0.04490 |
| L13a-mediated translational silencing of Ceruloplasmin expression | 82 | 8.39e-04 | 2.14e-01 | 0.04490 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | 83 | 9.39e-04 | 2.11e-01 | 0.04490 |
| NOTCH2 Activation and Transmission of Signal to the Nucleus | 12 | 9.67e-04 | 5.50e-01 | 0.04490 |
| Signaling by ROBO receptors | 146 | 9.79e-04 | 1.59e-01 | 0.04490 |
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | 69 | 9.92e-04 | 2.30e-01 | 0.04490 |
| rRNA processing in the nucleus and cytosol | 145 | 9.99e-04 | 1.59e-01 | 0.04490 |
| GPCR downstream signalling | 178 | 1.01e-03 | -1.44e-01 | 0.04490 |
| Activated NOTCH1 Transmits Signal to the Nucleus | 19 | 1.01e-03 | 4.36e-01 | 0.04490 |
| Separation of Sister Chromatids | 141 | 1.01e-03 | 1.61e-01 | 0.04490 |
| Mitochondrial translation | 86 | 1.04e-03 | 2.05e-01 | 0.04490 |
| Inositol phosphate metabolism | 29 | 1.09e-03 | -3.51e-01 | 0.04490 |
| Translesion Synthesis by POLH | 16 | 1.09e-03 | 4.72e-01 | 0.04490 |
| SRP-dependent cotranslational protein targeting to membrane | 81 | 1.13e-03 | 2.10e-01 | 0.04490 |
| DNA Repair | 232 | 1.18e-03 | 1.24e-01 | 0.04490 |
| Mitochondrial translation termination | 80 | 1.20e-03 | 2.10e-01 | 0.04490 |
| Major pathway of rRNA processing in the nucleolus and cytosol | 140 | 1.27e-03 | 1.58e-01 | 0.04490 |
| Selenoamino acid metabolism | 73 | 1.38e-03 | 2.17e-01 | 0.04490 |
| Eukaryotic Translation Elongation | 67 | 1.46e-03 | 2.25e-01 | 0.04490 |
| CaM pathway | 20 | 1.49e-03 | -4.10e-01 | 0.04490 |
| Calmodulin induced events | 20 | 1.49e-03 | -4.10e-01 | 0.04490 |
| APC/C-mediated degradation of cell cycle proteins | 73 | 1.55e-03 | 2.15e-01 | 0.04490 |
| Regulation of mitotic cell cycle | 73 | 1.55e-03 | 2.15e-01 | 0.04490 |
| Mitochondrial translation initiation | 81 | 1.57e-03 | 2.04e-01 | 0.04490 |
| Signal Transduction | 1263 | 1.58e-03 | -5.50e-02 | 0.04490 |
| PI3K/AKT Signaling in Cancer | 50 | 1.58e-03 | -2.59e-01 | 0.04490 |
| Metabolism of proteins | 1217 | 1.64e-03 | 5.57e-02 | 0.04490 |
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | 81 | 1.70e-03 | 2.02e-01 | 0.04490 |
| Nonsense-Mediated Decay (NMD) | 81 | 1.70e-03 | 2.02e-01 | 0.04490 |
| Eukaryotic Translation Termination | 66 | 1.79e-03 | 2.23e-01 | 0.04490 |
| Ca-dependent events | 21 | 1.80e-03 | -3.94e-01 | 0.04490 |
| Anti-inflammatory response favouring Leishmania parasite infection | 51 | 1.85e-03 | -2.52e-01 | 0.04490 |
| Leishmania parasite growth and survival | 51 | 1.85e-03 | -2.52e-01 | 0.04490 |
| APC-Cdc20 mediated degradation of Nek2A | 21 | 1.86e-03 | 3.92e-01 | 0.04490 |
| Extracellular matrix organization | 75 | 1.90e-03 | -2.08e-01 | 0.04490 |
| APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint | 59 | 1.96e-03 | 2.33e-01 | 0.04490 |
| G-protein mediated events | 32 | 2.02e-03 | -3.16e-01 | 0.04490 |
| Cdc20:Phospho-APC/C mediated degradation of Cyclin A | 58 | 2.03e-03 | 2.35e-01 | 0.04490 |
| Muscle contraction | 64 | 2.05e-03 | -2.23e-01 | 0.04490 |
| Signaling by NOTCH2 | 18 | 2.08e-03 | 4.19e-01 | 0.04490 |
| APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | 60 | 2.15e-03 | 2.29e-01 | 0.04540 |
| Formation of a pool of free 40S subunits | 73 | 2.21e-03 | 2.08e-01 | 0.04590 |
| DNA Damage Recognition in GG-NER | 35 | 2.38e-03 | 2.97e-01 | 0.04860 |
| N-glycan trimming in the ER and Calnexin/Calreticulin cycle | 32 | 2.45e-03 | 3.10e-01 | 0.04900 |
| Intracellular signaling by second messengers | 197 | 2.55e-03 | -1.25e-01 | 0.04910 |
| APC/C:Cdc20 mediated degradation of Securin | 54 | 2.58e-03 | 2.37e-01 | 0.04910 |
| APC/C:Cdc20 mediated degradation of mitotic proteins | 61 | 2.58e-03 | 2.23e-01 | 0.04910 |
| M Phase | 272 | 2.64e-03 | 1.07e-01 | 0.04930 |
| Viral mRNA Translation | 65 | 2.70e-03 | 2.16e-01 | 0.04970 |
| Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | 62 | 3.07e-03 | 2.18e-01 | 0.05550 |
| Defective CFTR causes cystic fibrosis | 51 | 3.16e-03 | 2.39e-01 | 0.05630 |
| CDT1 association with the CDC6:ORC:origin complex | 44 | 3.27e-03 | 2.57e-01 | 0.05740 |
| DNA Replication Pre-Initiation | 66 | 3.35e-03 | 2.09e-01 | 0.05790 |
| TICAM1-dependent activation of IRF3/IRF7 | 12 | 3.51e-03 | 4.87e-01 | 0.05890 |
| SUMOylation of DNA methylation proteins | 14 | 3.56e-03 | -4.50e-01 | 0.05890 |
| G alpha (i) signalling events | 85 | 3.58e-03 | -1.83e-01 | 0.05890 |
| FCGR3A-mediated IL10 synthesis | 22 | 3.61e-03 | -3.59e-01 | 0.05890 |
| Cell Cycle, Mitotic | 390 | 3.71e-03 | 8.65e-02 | 0.05890 |
| Regulation of APC/C activators between G1/S and early anaphase | 66 | 3.72e-03 | 2.07e-01 | 0.05890 |
| Assembly of the pre-replicative complex | 53 | 3.90e-03 | 2.29e-01 | 0.06050 |
| Hh mutants are degraded by ERAD | 46 | 3.97e-03 | 2.46e-01 | 0.06050 |
| Prefoldin mediated transfer of substrate to CCT/TriC | 16 | 4.16e-03 | 4.14e-01 | 0.06050 |
| Late Phase of HIV Life Cycle | 105 | 4.16e-03 | 1.62e-01 | 0.06050 |
| Platelet calcium homeostasis | 17 | 4.18e-03 | -4.01e-01 | 0.06050 |
| Ubiquitin Mediated Degradation of Phosphorylated Cdc25A | 43 | 4.29e-03 | 2.52e-01 | 0.06050 |
| p53-Independent DNA Damage Response | 43 | 4.29e-03 | 2.52e-01 | 0.06050 |
| p53-Independent G1/S DNA damage checkpoint | 43 | 4.29e-03 | 2.52e-01 | 0.06050 |
| Diseases associated with glycosaminoglycan metabolism | 15 | 4.35e-03 | -4.25e-01 | 0.06050 |
| Cap-dependent Translation Initiation | 90 | 4.40e-03 | 1.74e-01 | 0.06050 |
| Eukaryotic Translation Initiation | 90 | 4.40e-03 | 1.74e-01 | 0.06050 |
| Hemostasis | 292 | 4.57e-03 | -9.73e-02 | 0.06210 |
| Processing of Capped Intron-Containing Pre-mRNA | 175 | 4.92e-03 | 1.24e-01 | 0.06540 |
| Orc1 removal from chromatin | 55 | 4.93e-03 | 2.19e-01 | 0.06540 |
| Regulation of TP53 Activity through Methylation | 16 | 5.13e-03 | 4.04e-01 | 0.06730 |
| Response of EIF2AK4 (GCN2) to amino acid deficiency | 72 | 5.25e-03 | 1.91e-01 | 0.06740 |
| Influenza Viral RNA Transcription and Replication | 106 | 5.26e-03 | 1.57e-01 | 0.06740 |
| UCH proteinases | 69 | 5.49e-03 | 1.94e-01 | 0.06970 |
| NRIF signals cell death from the nucleus | 13 | 6.04e-03 | 4.40e-01 | 0.07570 |
| HIV Life Cycle | 117 | 6.17e-03 | 1.47e-01 | 0.07660 |
| Cellular responses to stress | 425 | 6.31e-03 | 7.82e-02 | 0.07740 |
| Elevation of cytosolic Ca2+ levels | 10 | 6.63e-03 | -4.96e-01 | 0.07940 |
| Branched-chain amino acid catabolism | 19 | 6.67e-03 | 3.60e-01 | 0.07940 |
| Autodegradation of Cdh1 by Cdh1:APC/C | 52 | 6.68e-03 | 2.18e-01 | 0.07940 |
| Influenza Infection | 123 | 6.79e-03 | 1.42e-01 | 0.07990 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | 47 | 6.99e-03 | 2.28e-01 | 0.08130 |
| mRNA Splicing - Major Pathway | 129 | 7.05e-03 | 1.38e-01 | 0.08130 |
| Switching of origins to a post-replicative state | 70 | 7.23e-03 | 1.86e-01 | 0.08250 |
| mRNA Splicing | 137 | 7.35e-03 | 1.33e-01 | 0.08300 |
| Neurotransmitter receptors and postsynaptic signal transmission | 73 | 7.49e-03 | -1.81e-01 | 0.08330 |
| Cardiac conduction | 40 | 7.58e-03 | -2.44e-01 | 0.08330 |
| Metabolism of amino acids and derivatives | 210 | 7.68e-03 | 1.07e-01 | 0.08330 |
| Cell Cycle Checkpoints | 212 | 7.72e-03 | 1.07e-01 | 0.08330 |
| Cytosolic sensors of pathogen-associated DNA | 48 | 7.85e-03 | 2.22e-01 | 0.08330 |
| Metabolism of non-coding RNA | 43 | 7.88e-03 | 2.34e-01 | 0.08330 |
| snRNP Assembly | 43 | 7.88e-03 | 2.34e-01 | 0.08330 |
| Calnexin/calreticulin cycle | 23 | 8.25e-03 | 3.18e-01 | 0.08630 |
| Cellular response to starvation | 107 | 8.44e-03 | 1.48e-01 | 0.08750 |
| Translation initiation complex formation | 46 | 9.37e-03 | 2.22e-01 | 0.09630 |
| Cellular responses to external stimuli | 430 | 9.65e-03 | 7.37e-02 | 0.09790 |
| Activation of NMDA receptors and postsynaptic events | 43 | 9.70e-03 | -2.28e-01 | 0.09790 |
| HIV Infection | 177 | 1.01e-02 | 1.13e-01 | 0.10100 |
| Opioid Signalling | 52 | 1.04e-02 | -2.06e-01 | 0.10300 |
| Netrin-1 signaling | 24 | 1.05e-02 | -3.02e-01 | 0.10300 |
| RUNX1 regulates transcription of genes involved in differentiation of HSCs | 55 | 1.10e-02 | 1.98e-01 | 0.10700 |
| Regulation of PTEN gene transcription | 43 | 1.12e-02 | -2.24e-01 | 0.10700 |
| Integrin signaling | 16 | 1.13e-02 | -3.66e-01 | 0.10700 |
| Platelet Aggregation (Plug Formation) | 16 | 1.13e-02 | -3.66e-01 | 0.10700 |
| ADORA2B mediated anti-inflammatory cytokines production | 30 | 1.14e-02 | -2.67e-01 | 0.10800 |
| Cytokine Signaling in Immune system | 411 | 1.21e-02 | -7.30e-02 | 0.11200 |
| ER Quality Control Compartment (ERQC) | 18 | 1.21e-02 | 3.42e-01 | 0.11200 |
| Autodegradation of the E3 ubiquitin ligase COP1 | 43 | 1.27e-02 | 2.20e-01 | 0.11700 |
| CDK-mediated phosphorylation and removal of Cdc6 | 58 | 1.28e-02 | 1.89e-01 | 0.11700 |
| PKA-mediated phosphorylation of CREB | 11 | 1.38e-02 | -4.29e-01 | 0.12500 |
| Post NMDA receptor activation events | 37 | 1.39e-02 | -2.34e-01 | 0.12500 |
| Ribosomal scanning and start codon recognition | 46 | 1.41e-02 | 2.09e-01 | 0.12600 |
| Constitutive Signaling by AKT1 E17K in Cancer | 23 | 1.42e-02 | -2.95e-01 | 0.12600 |
| Asymmetric localization of PCP proteins | 51 | 1.43e-02 | 1.99e-01 | 0.12600 |
| Hh mutants abrogate ligand secretion | 48 | 1.45e-02 | 2.04e-01 | 0.12600 |
| Regulation of lipid metabolism by PPARalpha | 83 | 1.52e-02 | 1.54e-01 | 0.13200 |
| Interferon gamma signaling | 53 | 1.56e-02 | -1.92e-01 | 0.13400 |
| Signaling by NOTCH3 | 30 | 1.58e-02 | 2.55e-01 | 0.13500 |
| Regulation of activated PAK-2p34 by proteasome mediated degradation | 41 | 1.61e-02 | 2.17e-01 | 0.13500 |
| Cellular response to chemical stress | 111 | 1.61e-02 | 1.33e-01 | 0.13500 |
| Formation of the ternary complex, and subsequently, the 43S complex | 39 | 1.62e-02 | 2.23e-01 | 0.13500 |
| RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | 22 | 1.65e-02 | 2.95e-01 | 0.13600 |
| Glycosaminoglycan metabolism | 59 | 1.65e-02 | -1.81e-01 | 0.13600 |
| Degradation of AXIN | 46 | 1.69e-02 | 2.04e-01 | 0.13800 |
| DCC mediated attractive signaling | 11 | 1.70e-02 | -4.16e-01 | 0.13800 |
| SCF-beta-TrCP mediated degradation of Emi1 | 46 | 1.73e-02 | 2.03e-01 | 0.13900 |
| Signaling by NOTCH4 | 67 | 1.75e-02 | 1.68e-01 | 0.13900 |
| Hedgehog ligand biogenesis | 51 | 1.76e-02 | 1.92e-01 | 0.13900 |
| Mitotic G2-G2/M phases | 145 | 1.79e-02 | 1.14e-01 | 0.14100 |
| Inactivation of APC/C via direct inhibition of the APC/C complex | 16 | 1.82e-02 | 3.41e-01 | 0.14100 |
| Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components | 16 | 1.82e-02 | 3.41e-01 | 0.14100 |
| Interleukin-4 and Interleukin-13 signaling | 47 | 1.82e-02 | -1.99e-01 | 0.14100 |
| RHO GTPases activate PKNs | 26 | 1.85e-02 | -2.67e-01 | 0.14100 |
| Costimulation by the CD28 family | 44 | 1.86e-02 | -2.05e-01 | 0.14100 |
| Cellular response to hypoxia | 58 | 1.88e-02 | 1.79e-01 | 0.14200 |
| The role of GTSE1 in G2/M progression after G2 checkpoint | 51 | 1.91e-02 | 1.90e-01 | 0.14300 |
| Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding | 18 | 1.94e-02 | 3.19e-01 | 0.14400 |
| Regulation of RUNX3 expression and activity | 48 | 1.95e-02 | 1.95e-01 | 0.14500 |
| G2/M Transition | 143 | 1.97e-02 | 1.13e-01 | 0.14500 |
| RAS processing | 13 | 2.00e-02 | -3.73e-01 | 0.14700 |
| HDACs deacetylate histones | 26 | 2.13e-02 | -2.61e-01 | 0.15400 |
| G2/M Checkpoints | 108 | 2.13e-02 | 1.29e-01 | 0.15400 |
| Heparan sulfate/heparin (HS-GAG) metabolism | 19 | 2.25e-02 | -3.02e-01 | 0.16200 |
| DNA Replication | 101 | 2.28e-02 | 1.32e-01 | 0.16200 |
| Ubiquitin-dependent degradation of Cyclin D | 43 | 2.29e-02 | 2.01e-01 | 0.16200 |
| SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion | 10 | 2.32e-02 | -4.15e-01 | 0.16400 |
| PPARA activates gene expression | 81 | 2.37e-02 | 1.46e-01 | 0.16600 |
| Interferon alpha/beta signaling | 50 | 2.41e-02 | -1.85e-01 | 0.16600 |
| ECM proteoglycans | 10 | 2.42e-02 | -4.12e-01 | 0.16600 |
| Deactivation of the beta-catenin transactivating complex | 27 | 2.42e-02 | 2.51e-01 | 0.16600 |
| Mitotic Spindle Checkpoint | 93 | 2.42e-02 | 1.36e-01 | 0.16600 |
| Nuclear Envelope (NE) Reassembly | 56 | 2.48e-02 | 1.74e-01 | 0.16800 |
| PKMTs methylate histone lysines | 24 | 2.53e-02 | 2.64e-01 | 0.17100 |
| Regulation of Apoptosis | 44 | 2.66e-02 | 1.93e-01 | 0.17800 |
| Synthesis of IP3 and IP4 in the cytosol | 16 | 2.68e-02 | -3.20e-01 | 0.17900 |
| Neuronal System | 127 | 2.83e-02 | -1.13e-01 | 0.18700 |
| Transport of small molecules | 322 | 2.85e-02 | 7.17e-02 | 0.18700 |
| Membrane binding and targetting of GAG proteins | 11 | 2.90e-02 | 3.80e-01 | 0.18700 |
| Synthesis And Processing Of GAG, GAGPOL Polyproteins | 11 | 2.90e-02 | 3.80e-01 | 0.18700 |
| Vpu mediated degradation of CD4 | 43 | 2.90e-02 | 1.93e-01 | 0.18700 |
| Stabilization of p53 | 48 | 2.90e-02 | 1.82e-01 | 0.18700 |
| Purine catabolism | 10 | 2.95e-02 | -3.98e-01 | 0.18900 |
| PKA activation | 10 | 3.04e-02 | -3.95e-01 | 0.19400 |
| Synthesis of DNA | 94 | 3.08e-02 | 1.29e-01 | 0.19600 |
| ABC transporter disorders | 56 | 3.15e-02 | 1.66e-01 | 0.19800 |
| rRNA modification in the nucleus and cytosol | 42 | 3.19e-02 | 1.92e-01 | 0.19800 |
| Nucleotide Excision Repair | 98 | 3.20e-02 | 1.26e-01 | 0.19800 |
| Formation of TC-NER Pre-Incision Complex | 45 | 3.20e-02 | 1.85e-01 | 0.19800 |
| Signaling by FLT3 ITD and TKD mutants | 12 | 3.21e-02 | -3.57e-01 | 0.19800 |
| Cytoprotection by HMOX1 | 90 | 3.24e-02 | 1.31e-01 | 0.19900 |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | 30 | 3.30e-02 | -2.25e-01 | 0.20100 |
| G alpha (s) signalling events | 35 | 3.32e-02 | -2.08e-01 | 0.20200 |
| Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha | 51 | 3.43e-02 | 1.72e-01 | 0.20700 |
| G1/S Transition | 106 | 3.45e-02 | 1.19e-01 | 0.20700 |
| Fanconi Anemia Pathway | 29 | 3.52e-02 | 2.26e-01 | 0.20900 |
| Ion homeostasis | 25 | 3.52e-02 | -2.43e-01 | 0.20900 |
| Negative regulation of NOTCH4 signaling | 47 | 3.54e-02 | 1.78e-01 | 0.20900 |
| CD28 dependent PI3K/Akt signaling | 18 | 3.55e-02 | -2.86e-01 | 0.20900 |
| Activation of BAD and translocation to mitochondria | 14 | 3.82e-02 | -3.20e-01 | 0.22300 |
| AUF1 (hnRNP D0) binds and destabilizes mRNA | 45 | 3.86e-02 | 1.78e-01 | 0.22300 |
| Disorders of transmembrane transporters | 102 | 3.88e-02 | 1.19e-01 | 0.22300 |
| Asparagine N-linked glycosylation | 214 | 3.88e-02 | 8.24e-02 | 0.22300 |
| Dectin-1 mediated noncanonical NF-kB signaling | 50 | 3.89e-02 | 1.69e-01 | 0.22300 |
| SCF(Skp2)-mediated degradation of p27/p21 | 51 | 3.96e-02 | 1.67e-01 | 0.22600 |
| Constitutive Signaling by Aberrant PI3K in Cancer | 26 | 4.07e-02 | -2.32e-01 | 0.23100 |
| Cell Cycle | 482 | 4.09e-02 | 5.51e-02 | 0.23100 |
| Mitotic G1 phase and G1/S transition | 121 | 4.14e-02 | 1.08e-01 | 0.23300 |
| Signaling by VEGF | 71 | 4.17e-02 | -1.40e-01 | 0.23300 |
| MET promotes cell motility | 12 | 4.20e-02 | -3.39e-01 | 0.23300 |
| G1/S DNA Damage Checkpoints | 57 | 4.20e-02 | 1.56e-01 | 0.23300 |
| Negative regulation of the PI3K/AKT network | 53 | 4.26e-02 | -1.61e-01 | 0.23500 |
| Regulation of innate immune responses to cytosolic DNA | 11 | 4.29e-02 | 3.53e-01 | 0.23500 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | 48 | 4.48e-02 | -1.68e-01 | 0.24400 |
| Global Genome Nucleotide Excision Repair (GG-NER) | 76 | 4.57e-02 | 1.33e-01 | 0.24800 |
| Deadenylation-dependent mRNA decay | 49 | 4.61e-02 | 1.65e-01 | 0.24800 |
| Transport of Mature mRNA derived from an Intron-Containing Transcript | 45 | 4.61e-02 | 1.72e-01 | 0.24800 |
| GAB1 signalosome | 10 | 4.64e-02 | -3.64e-01 | 0.24800 |
| SARS-CoV-2 Infection | 54 | 4.65e-02 | 1.57e-01 | 0.24800 |
| Inflammasomes | 16 | 4.83e-02 | 2.85e-01 | 0.25700 |
| Formation of Incision Complex in GG-NER | 36 | 4.86e-02 | 1.90e-01 | 0.25700 |
| EML4 and NUDC in mitotic spindle formation | 85 | 4.91e-02 | 1.24e-01 | 0.25800 |
| APC/C:Cdc20 mediated degradation of Cyclin B | 19 | 4.94e-02 | 2.61e-01 | 0.25800 |
| ABC-family proteins mediated transport | 71 | 4.99e-02 | 1.35e-01 | 0.26000 |
| The NLRP3 inflammasome | 12 | 5.02e-02 | 3.27e-01 | 0.26000 |
| DNA Damage Bypass | 40 | 5.06e-02 | 1.79e-01 | 0.26100 |
| Integration of energy metabolism | 56 | 5.14e-02 | -1.51e-01 | 0.26400 |
| JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 | 10 | 5.19e-02 | -3.55e-01 | 0.26600 |
| VEGFA-VEGFR2 Pathway | 69 | 5.23e-02 | -1.35e-01 | 0.26600 |
| Chaperonin-mediated protein folding | 52 | 5.28e-02 | 1.55e-01 | 0.26700 |
| S Phase | 128 | 5.30e-02 | 9.94e-02 | 0.26700 |
| SUMOylation of DNA replication proteins | 41 | 5.31e-02 | 1.75e-01 | 0.26700 |
| Vif-mediated degradation of APOBEC3G | 42 | 5.34e-02 | 1.72e-01 | 0.26700 |
| PIP3 activates AKT signaling | 172 | 5.36e-02 | -8.57e-02 | 0.26700 |
| Transmission across Chemical Synapses | 93 | 5.38e-02 | -1.16e-01 | 0.26700 |
| Late endosomal microautophagy | 21 | 5.42e-02 | 2.43e-01 | 0.26800 |
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | 34 | 5.46e-02 | -1.91e-01 | 0.26800 |
| Activation of ATR in response to replication stress | 29 | 5.48e-02 | 2.06e-01 | 0.26800 |
| Semaphorin interactions | 36 | 5.68e-02 | -1.84e-01 | 0.27600 |
| Transcriptional regulation of white adipocyte differentiation | 55 | 5.68e-02 | 1.49e-01 | 0.27600 |
| Cyclin E associated events during G1/S transition | 70 | 5.74e-02 | 1.32e-01 | 0.27700 |
| Regulation of PTEN stability and activity | 55 | 5.76e-02 | 1.48e-01 | 0.27700 |
| MHC class II antigen presentation | 64 | 5.79e-02 | 1.37e-01 | 0.27800 |
| Neurexins and neuroligins | 20 | 5.86e-02 | -2.44e-01 | 0.28000 |
| Activation of BH3-only proteins | 25 | 5.91e-02 | -2.18e-01 | 0.28000 |
| Budding and maturation of HIV virion | 21 | 5.91e-02 | 2.38e-01 | 0.28000 |
| Interleukin-37 signaling | 16 | 5.93e-02 | -2.72e-01 | 0.28000 |
| Metalloprotease DUBs | 16 | 5.97e-02 | 2.72e-01 | 0.28100 |
| Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | 81 | 6.14e-02 | 1.20e-01 | 0.28600 |
| Amplification of signal from the kinetochores | 81 | 6.14e-02 | 1.20e-01 | 0.28600 |
| NIK–>noncanonical NF-kB signaling | 49 | 6.20e-02 | 1.54e-01 | 0.28600 |
| Metal ion SLC transporters | 13 | 6.20e-02 | 2.99e-01 | 0.28600 |
| Degradation of beta-catenin by the destruction complex | 67 | 6.32e-02 | 1.31e-01 | 0.29000 |
| DAP12 interactions | 21 | 6.34e-02 | -2.34e-01 | 0.29000 |
| Post-translational protein phosphorylation | 33 | 6.35e-02 | -1.87e-01 | 0.29000 |
| Translesion synthesis by POLI | 15 | 6.45e-02 | 2.76e-01 | 0.29300 |
| alpha-linolenic (omega3) and linoleic (omega6) acid metabolism | 10 | 6.55e-02 | -3.37e-01 | 0.29300 |
| alpha-linolenic acid (ALA) metabolism | 10 | 6.55e-02 | -3.37e-01 | 0.29300 |
| Transcription-Coupled Nucleotide Excision Repair (TC-NER) | 68 | 6.58e-02 | 1.29e-01 | 0.29300 |
| ROS and RNS production in phagocytes | 22 | 6.59e-02 | 2.27e-01 | 0.29300 |
| Iron uptake and transport | 37 | 6.60e-02 | 1.75e-01 | 0.29300 |
| Cell surface interactions at the vascular wall | 56 | 6.61e-02 | -1.42e-01 | 0.29300 |
| Assembly Of The HIV Virion | 13 | 6.69e-02 | 2.94e-01 | 0.29600 |
| Leishmania infection | 107 | 6.74e-02 | -1.03e-01 | 0.29700 |
| CD28 co-stimulation | 27 | 6.77e-02 | -2.03e-01 | 0.29700 |
| Smooth Muscle Contraction | 19 | 6.79e-02 | -2.42e-01 | 0.29700 |
| FBXL7 down-regulates AURKA during mitotic entry and in early mitosis | 45 | 6.91e-02 | 1.57e-01 | 0.30100 |
| Non-integrin membrane-ECM interactions | 12 | 7.04e-02 | -3.02e-01 | 0.30500 |
| TNF signaling | 35 | 7.06e-02 | 1.77e-01 | 0.30500 |
| Cell recruitment (pro-inflammatory response) | 15 | 7.12e-02 | 2.69e-01 | 0.30500 |
| Purinergic signaling in leishmaniasis infection | 15 | 7.12e-02 | 2.69e-01 | 0.30500 |
| SHC1 events in ERBB2 signaling | 10 | 7.14e-02 | -3.29e-01 | 0.30500 |
| Post-translational protein modification | 860 | 7.16e-02 | 3.71e-02 | 0.30500 |
| Regulation of RUNX2 expression and activity | 56 | 7.28e-02 | 1.39e-01 | 0.30800 |
| Formation of tubulin folding intermediates by CCT/TriC | 13 | 7.29e-02 | 2.87e-01 | 0.30800 |
| VEGFR2 mediated cell proliferation | 16 | 7.36e-02 | -2.58e-01 | 0.31000 |
| Citric acid cycle (TCA cycle) | 19 | 7.41e-02 | -2.37e-01 | 0.31100 |
| Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon | 13 | 7.47e-02 | 2.86e-01 | 0.31200 |
| Activation of the pre-replicative complex | 23 | 7.51e-02 | 2.15e-01 | 0.31300 |
| Sialic acid metabolism | 22 | 7.64e-02 | 2.18e-01 | 0.31600 |
| Protein-protein interactions at synapses | 31 | 7.66e-02 | -1.84e-01 | 0.31600 |
| Transcriptional regulation by RUNX1 | 122 | 7.69e-02 | 9.31e-02 | 0.31600 |
| Resolution of Sister Chromatid Cohesion | 90 | 7.77e-02 | 1.08e-01 | 0.31600 |
| Senescence-Associated Secretory Phenotype (SASP) | 39 | 7.78e-02 | 1.63e-01 | 0.31600 |
| Pyruvate metabolism and Citric Acid (TCA) cycle | 40 | 7.79e-02 | -1.61e-01 | 0.31600 |
| Pyroptosis | 17 | 7.79e-02 | 2.47e-01 | 0.31600 |
| Signaling by Interleukins | 256 | 7.87e-02 | -6.43e-02 | 0.31700 |
| Regulation of insulin secretion | 36 | 7.87e-02 | -1.70e-01 | 0.31700 |
| Signaling by ERBB4 | 28 | 7.92e-02 | 1.92e-01 | 0.31800 |
| Regulation of IFNA signaling | 12 | 7.98e-02 | -2.92e-01 | 0.31900 |
| Signaling by FLT3 fusion proteins | 16 | 8.03e-02 | -2.53e-01 | 0.31900 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | 21 | 8.04e-02 | -2.21e-01 | 0.31900 |
| Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template | 34 | 8.05e-02 | 1.73e-01 | 0.31900 |
| Signaling by NTRK2 (TRKB) | 15 | 8.09e-02 | -2.60e-01 | 0.31900 |
| Regulation of TNFR1 signaling | 30 | 8.13e-02 | 1.84e-01 | 0.32000 |
| Deadenylation of mRNA | 22 | 8.21e-02 | 2.14e-01 | 0.32200 |
| Ub-specific processing proteases | 130 | 8.23e-02 | 8.86e-02 | 0.32200 |
| Stimuli-sensing channels | 35 | 8.32e-02 | 1.69e-01 | 0.32400 |
| SUMO E3 ligases SUMOylate target proteins | 130 | 8.45e-02 | 8.79e-02 | 0.32700 |
| Basigin interactions | 14 | 8.46e-02 | -2.66e-01 | 0.32700 |
| Activation of NF-kappaB in B cells | 54 | 8.62e-02 | 1.35e-01 | 0.33200 |
| Cargo concentration in the ER | 19 | 8.66e-02 | 2.27e-01 | 0.33300 |
| ROS sensing by NFE2L2 | 47 | 8.72e-02 | 1.44e-01 | 0.33400 |
| Translesion synthesis by REV1 | 14 | 8.80e-02 | 2.63e-01 | 0.33600 |
| Degradation of GLI1 by the proteasome | 50 | 8.89e-02 | 1.39e-01 | 0.33800 |
| Degradation of GLI2 by the proteasome | 49 | 8.98e-02 | 1.40e-01 | 0.33900 |
| GLI3 is processed to GLI3R by the proteasome | 49 | 8.98e-02 | 1.40e-01 | 0.33900 |
| SUMOylation | 135 | 8.99e-02 | 8.49e-02 | 0.33900 |
| Transcriptional regulation by RUNX3 | 73 | 9.05e-02 | 1.15e-01 | 0.34000 |
| Sulfur amino acid metabolism | 15 | 9.16e-02 | -2.52e-01 | 0.34100 |
| Chondroitin sulfate/dermatan sulfate metabolism | 26 | 9.16e-02 | -1.91e-01 | 0.34100 |
| Immune System | 1091 | 9.20e-02 | -3.12e-02 | 0.34100 |
| Molecules associated with elastic fibres | 10 | 9.24e-02 | -3.07e-01 | 0.34100 |
| G alpha (q) signalling events | 70 | 9.25e-02 | -1.17e-01 | 0.34100 |
| Degradation of DVL | 47 | 9.31e-02 | 1.42e-01 | 0.34300 |
| Endosomal Sorting Complex Required For Transport (ESCRT) | 24 | 9.40e-02 | 1.98e-01 | 0.34500 |
| Signaling by EGFR | 35 | 9.45e-02 | -1.63e-01 | 0.34600 |
| InlB-mediated entry of Listeria monocytogenes into host cell | 11 | 9.56e-02 | 2.90e-01 | 0.34800 |
| p53-Dependent G1 DNA Damage Response | 55 | 9.64e-02 | 1.30e-01 | 0.34900 |
| p53-Dependent G1/S DNA damage checkpoint | 55 | 9.64e-02 | 1.30e-01 | 0.34900 |
| Regulated Necrosis | 41 | 9.67e-02 | 1.50e-01 | 0.34900 |
| DAP12 signaling | 19 | 9.77e-02 | -2.20e-01 | 0.35200 |
| Ephrin signaling | 12 | 9.86e-02 | -2.75e-01 | 0.35200 |
| mRNA Splicing - Minor Pathway | 42 | 9.93e-02 | 1.47e-01 | 0.35200 |
| RHOG GTPase cycle | 45 | 9.93e-02 | 1.42e-01 | 0.35200 |
| Protein folding | 58 | 9.94e-02 | 1.25e-01 | 0.35200 |
| RNA polymerase II transcribes snRNA genes | 62 | 9.95e-02 | 1.21e-01 | 0.35200 |
| Polo-like kinase mediated events | 16 | 1.01e-01 | 2.37e-01 | 0.35800 |
| RHOB GTPase cycle | 40 | 1.03e-01 | -1.49e-01 | 0.36100 |
| Synthesis of PIPs at the early endosome membrane | 11 | 1.03e-01 | 2.84e-01 | 0.36100 |
| RMTs methylate histone arginines | 23 | 1.03e-01 | 1.96e-01 | 0.36100 |
| Platelet activation, signaling and aggregation | 125 | 1.03e-01 | -8.46e-02 | 0.36100 |
| TP53 Regulates Transcription of DNA Repair Genes | 45 | 1.04e-01 | 1.40e-01 | 0.36300 |
| Regulation of HMOX1 expression and activity | 54 | 1.05e-01 | 1.28e-01 | 0.36300 |
| SARS-CoV-1 Infection | 41 | 1.07e-01 | 1.46e-01 | 0.37100 |
| Mitotic Prometaphase | 146 | 1.08e-01 | 7.74e-02 | 0.37300 |
| Signaling by Receptor Tyrosine Kinases | 273 | 1.09e-01 | -5.69e-02 | 0.37300 |
| Regulation of TP53 Activity through Acetylation | 27 | 1.09e-01 | -1.78e-01 | 0.37400 |
| Nicotinamide salvaging | 10 | 1.10e-01 | -2.92e-01 | 0.37500 |
| NCAM signaling for neurite out-growth | 23 | 1.10e-01 | -1.92e-01 | 0.37500 |
| Cyclin A:Cdk2-associated events at S phase entry | 72 | 1.10e-01 | 1.09e-01 | 0.37500 |
| Regulation of TP53 Activity through Phosphorylation | 74 | 1.15e-01 | 1.06e-01 | 0.39000 |
| Rev-mediated nuclear export of HIV RNA | 31 | 1.16e-01 | 1.63e-01 | 0.39200 |
| Insulin receptor recycling | 16 | 1.16e-01 | 2.27e-01 | 0.39200 |
| Carboxyterminal post-translational modifications of tubulin | 19 | 1.17e-01 | 2.08e-01 | 0.39300 |
| Nucleobase catabolism | 20 | 1.17e-01 | -2.02e-01 | 0.39300 |
| Generation of second messenger molecules | 16 | 1.18e-01 | -2.26e-01 | 0.39300 |
| Cross-presentation of soluble exogenous antigens (endosomes) | 37 | 1.19e-01 | 1.48e-01 | 0.39600 |
| Potential therapeutics for SARS | 56 | 1.19e-01 | -1.21e-01 | 0.39600 |
| Mitochondrial calcium ion transport | 13 | 1.20e-01 | 2.49e-01 | 0.39600 |
| MAPK6/MAPK4 signaling | 64 | 1.20e-01 | 1.12e-01 | 0.39600 |
| EPHB-mediated forward signaling | 25 | 1.20e-01 | -1.80e-01 | 0.39600 |
| RHOH GTPase cycle | 27 | 1.21e-01 | 1.72e-01 | 0.39800 |
| Postmitotic nuclear pore complex (NPC) reformation | 25 | 1.22e-01 | 1.79e-01 | 0.39800 |
| mRNA decay by 5’ to 3’ exoribonuclease | 14 | 1.22e-01 | 2.39e-01 | 0.39800 |
| ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | 15 | 1.22e-01 | -2.30e-01 | 0.39800 |
| RHO GTPases activate PAKs | 13 | 1.23e-01 | -2.47e-01 | 0.40000 |
| Zinc transporters | 10 | 1.25e-01 | 2.81e-01 | 0.40300 |
| CLEC7A (Dectin-1) induces NFAT activation | 11 | 1.25e-01 | -2.67e-01 | 0.40400 |
| Phase II - Conjugation of compounds | 42 | 1.27e-01 | 1.36e-01 | 0.40900 |
| Translesion synthesis by POLK | 15 | 1.30e-01 | 2.26e-01 | 0.41600 |
| Antigen processing-Cross presentation | 71 | 1.31e-01 | 1.04e-01 | 0.41600 |
| Peroxisomal lipid metabolism | 20 | 1.31e-01 | -1.95e-01 | 0.41600 |
| Sealing of the nuclear envelope (NE) by ESCRT-III | 16 | 1.31e-01 | 2.18e-01 | 0.41600 |
| Metabolism of nitric oxide: NOS3 activation and regulation | 12 | 1.33e-01 | -2.51e-01 | 0.42000 |
| Transport of the SLBP Dependant Mature mRNA | 31 | 1.33e-01 | 1.56e-01 | 0.42000 |
| Cytochrome P450 - arranged by substrate type | 14 | 1.33e-01 | -2.32e-01 | 0.42000 |
| Cellular response to heat stress | 75 | 1.34e-01 | 1.00e-01 | 0.42000 |
| Deubiquitination | 188 | 1.34e-01 | 6.37e-02 | 0.42100 |
| PCP/CE pathway | 70 | 1.35e-01 | 1.04e-01 | 0.42200 |
| Transport of bile salts and organic acids, metal ions and amine compounds | 29 | 1.37e-01 | 1.60e-01 | 0.42700 |
| Elastic fibre formation | 15 | 1.38e-01 | -2.21e-01 | 0.43000 |
| DNA Double-Strand Break Repair | 106 | 1.40e-01 | 8.33e-02 | 0.43300 |
| Transcriptional Regulation by VENTX | 25 | 1.40e-01 | 1.71e-01 | 0.43300 |
| Mitochondrial biogenesis | 50 | 1.44e-01 | -1.19e-01 | 0.44400 |
| TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway | 10 | 1.45e-01 | -2.66e-01 | 0.44400 |
| Phase I - Functionalization of compounds | 29 | 1.45e-01 | -1.56e-01 | 0.44400 |
| Synthesis of Leukotrienes (LT) and Eoxins (EX) | 10 | 1.45e-01 | -2.66e-01 | 0.44400 |
| BBSome-mediated cargo-targeting to cilium | 18 | 1.47e-01 | 1.97e-01 | 0.45000 |
| Glycogen synthesis | 11 | 1.49e-01 | 2.51e-01 | 0.45400 |
| Other interleukin signaling | 16 | 1.49e-01 | -2.08e-01 | 0.45400 |
| Effects of PIP2 hydrolysis | 18 | 1.51e-01 | -1.95e-01 | 0.45800 |
| p75NTR signals via NF-kB | 11 | 1.52e-01 | 2.50e-01 | 0.45800 |
| HDR through Homologous Recombination (HRR) | 54 | 1.52e-01 | 1.13e-01 | 0.45800 |
| NGF-stimulated transcription | 25 | 1.53e-01 | -1.65e-01 | 0.45900 |
| Condensation of Prophase Chromosomes | 12 | 1.53e-01 | -2.38e-01 | 0.45900 |
| Host Interactions of HIV factors | 103 | 1.55e-01 | 8.14e-02 | 0.46100 |
| TCF dependent signaling in response to WNT | 117 | 1.55e-01 | 7.64e-02 | 0.46100 |
| Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein | 56 | 1.57e-01 | 1.10e-01 | 0.46600 |
| TICAM1, RIP1-mediated IKK complex recruitment | 17 | 1.57e-01 | 1.98e-01 | 0.46600 |
| Regulation of BACH1 activity | 11 | 1.58e-01 | 2.46e-01 | 0.46600 |
| TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest | 15 | 1.58e-01 | 2.11e-01 | 0.46600 |
| Pexophagy | 11 | 1.59e-01 | 2.46e-01 | 0.46700 |
| DDX58/IFIH1-mediated induction of interferon-alpha/beta | 56 | 1.61e-01 | 1.08e-01 | 0.47300 |
| Aberrant regulation of mitotic exit in cancer due to RB1 defects | 15 | 1.66e-01 | 2.07e-01 | 0.48500 |
| Metabolism of polyamines | 46 | 1.68e-01 | 1.18e-01 | 0.48900 |
| Platelet homeostasis | 45 | 1.68e-01 | -1.19e-01 | 0.49000 |
| SUMOylation of immune response proteins | 10 | 1.69e-01 | 2.51e-01 | 0.49200 |
| Chaperone Mediated Autophagy | 12 | 1.70e-01 | 2.29e-01 | 0.49300 |
| Cytochrome c-mediated apoptotic response | 10 | 1.71e-01 | 2.50e-01 | 0.49500 |
| Cyclin A/B1/B2 associated events during G2/M transition | 22 | 1.76e-01 | 1.67e-01 | 0.50300 |
| Regulation of KIT signaling | 10 | 1.76e-01 | -2.47e-01 | 0.50300 |
| Interactions of Rev with host cellular proteins | 32 | 1.76e-01 | 1.38e-01 | 0.50300 |
| Cleavage of the damaged purine | 10 | 1.77e-01 | -2.47e-01 | 0.50300 |
| Depurination | 10 | 1.77e-01 | -2.47e-01 | 0.50300 |
| Recognition and association of DNA glycosylase with site containing an affected purine | 10 | 1.77e-01 | -2.47e-01 | 0.50300 |
| Suppression of phagosomal maturation | 12 | 1.78e-01 | 2.25e-01 | 0.50300 |
| RHOV GTPase cycle | 22 | 1.78e-01 | -1.66e-01 | 0.50300 |
| RHO GTPases Activate Formins | 100 | 1.78e-01 | 7.82e-02 | 0.50300 |
| Recognition of DNA damage by PCNA-containing replication complex | 25 | 1.79e-01 | 1.55e-01 | 0.50500 |
| CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | 15 | 1.81e-01 | -1.99e-01 | 0.50900 |
| Listeria monocytogenes entry into host cells | 14 | 1.82e-01 | 2.06e-01 | 0.50900 |
| activated TAK1 mediates p38 MAPK activation | 12 | 1.82e-01 | -2.23e-01 | 0.50900 |
| Association of TriC/CCT with target proteins during biosynthesis | 28 | 1.83e-01 | 1.45e-01 | 0.51100 |
| Homology Directed Repair | 84 | 1.84e-01 | 8.40e-02 | 0.51200 |
| Transport of the SLBP independent Mature mRNA | 30 | 1.84e-01 | 1.40e-01 | 0.51200 |
| Nuclear signaling by ERBB4 | 14 | 1.86e-01 | 2.04e-01 | 0.51600 |
| Resolution of D-loop Structures through Holliday Junction Intermediates | 23 | 1.87e-01 | 1.59e-01 | 0.51800 |
| Retrograde transport at the Trans-Golgi-Network | 42 | 1.88e-01 | 1.18e-01 | 0.51800 |
| TRAF6 mediated IRF7 activation | 15 | 1.88e-01 | 1.96e-01 | 0.51800 |
| Cholesterol biosynthesis | 17 | 1.89e-01 | 1.84e-01 | 0.51900 |
| Response of Mtb to phagocytosis | 20 | 1.90e-01 | 1.69e-01 | 0.52100 |
| RNA Polymerase II Transcription Termination | 35 | 1.91e-01 | 1.28e-01 | 0.52100 |
| Erythropoietin activates RAS | 10 | 1.92e-01 | 2.38e-01 | 0.52100 |
| Inhibition of DNA recombination at telomere | 17 | 1.92e-01 | -1.83e-01 | 0.52100 |
| TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) | 13 | 1.92e-01 | 2.09e-01 | 0.52100 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | 10 | 1.93e-01 | 2.38e-01 | 0.52100 |
| Dual Incision in GG-NER | 35 | 1.94e-01 | 1.27e-01 | 0.52300 |
| ER-Phagosome pathway | 66 | 1.94e-01 | 9.25e-02 | 0.52300 |
| FOXO-mediated transcription of cell cycle genes | 12 | 1.95e-01 | -2.16e-01 | 0.52300 |
| Hyaluronan metabolism | 10 | 1.96e-01 | -2.36e-01 | 0.52400 |
| Signaling by PDGF | 24 | 1.97e-01 | -1.52e-01 | 0.52600 |
| Triglyceride metabolism | 16 | 1.97e-01 | -1.86e-01 | 0.52600 |
| FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes | 14 | 1.98e-01 | -1.99e-01 | 0.52700 |
| GPCR ligand binding | 71 | 2.00e-01 | -8.82e-02 | 0.52800 |
| TNFR2 non-canonical NF-kB pathway | 65 | 2.00e-01 | 9.21e-02 | 0.52800 |
| Regulation of IFNG signaling | 13 | 2.00e-01 | -2.05e-01 | 0.52800 |
| FCERI mediated Ca+2 mobilization | 23 | 2.02e-01 | -1.54e-01 | 0.53300 |
| Dual incision in TC-NER | 55 | 2.05e-01 | 9.90e-02 | 0.53600 |
| Fatty acid metabolism | 96 | 2.05e-01 | -7.50e-02 | 0.53600 |
| Glucagon signaling in metabolic regulation | 16 | 2.05e-01 | -1.83e-01 | 0.53600 |
| Role of phospholipids in phagocytosis | 16 | 2.05e-01 | -1.83e-01 | 0.53600 |
| Glyoxylate metabolism and glycine degradation | 19 | 2.06e-01 | 1.68e-01 | 0.53700 |
| Role of LAT2/NTAL/LAB on calcium mobilization | 10 | 2.07e-01 | -2.31e-01 | 0.53700 |
| IRS-related events triggered by IGF1R | 21 | 2.07e-01 | -1.59e-01 | 0.53700 |
| Neddylation | 172 | 2.08e-01 | 5.60e-02 | 0.53700 |
| Signaling by MET | 39 | 2.08e-01 | -1.17e-01 | 0.53800 |
| Signaling by SCF-KIT | 32 | 2.09e-01 | -1.28e-01 | 0.53800 |
| Defective pyroptosis | 10 | 2.11e-01 | -2.28e-01 | 0.54300 |
| Plasma lipoprotein clearance | 19 | 2.12e-01 | 1.65e-01 | 0.54400 |
| Regulation of RAS by GAPs | 55 | 2.14e-01 | 9.71e-02 | 0.54600 |
| Regulation of HSF1-mediated heat shock response | 62 | 2.14e-01 | 9.14e-02 | 0.54600 |
| Regulation of ornithine decarboxylase (ODC) | 42 | 2.15e-01 | 1.11e-01 | 0.54900 |
| G-protein beta:gamma signalling | 18 | 2.16e-01 | -1.68e-01 | 0.54900 |
| Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding | 20 | 2.17e-01 | 1.60e-01 | 0.55000 |
| Glutathione conjugation | 20 | 2.18e-01 | 1.59e-01 | 0.55100 |
| Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA | 14 | 2.20e-01 | -1.89e-01 | 0.55500 |
| Diseases associated with glycosylation precursor biosynthesis | 18 | 2.21e-01 | 1.67e-01 | 0.55600 |
| Synthesis of glycosylphosphatidylinositol (GPI) | 14 | 2.22e-01 | -1.89e-01 | 0.55600 |
| Termination of translesion DNA synthesis | 28 | 2.22e-01 | 1.33e-01 | 0.55600 |
| HSF1 activation | 21 | 2.23e-01 | 1.54e-01 | 0.55600 |
| Infectious disease | 507 | 2.23e-01 | 3.21e-02 | 0.55600 |
| Ion channel transport | 74 | 2.24e-01 | 8.19e-02 | 0.55800 |
| Transcription of the HIV genome | 50 | 2.25e-01 | 9.92e-02 | 0.56000 |
| Factors involved in megakaryocyte development and platelet production | 83 | 2.26e-01 | -7.71e-02 | 0.56000 |
| Pre-NOTCH Transcription and Translation | 26 | 2.27e-01 | 1.37e-01 | 0.56100 |
| Innate Immune System | 582 | 2.29e-01 | -2.97e-02 | 0.56600 |
| NEP/NS2 Interacts with the Cellular Export Machinery | 28 | 2.31e-01 | 1.31e-01 | 0.57000 |
| Glycogen storage diseases | 10 | 2.33e-01 | 2.18e-01 | 0.57200 |
| Signaling by NTRK1 (TRKA) | 79 | 2.33e-01 | -7.78e-02 | 0.57200 |
| ZBP1(DAI) mediated induction of type I IFNs | 15 | 2.35e-01 | 1.77e-01 | 0.57400 |
| RHOBTB1 GTPase cycle | 18 | 2.36e-01 | 1.61e-01 | 0.57600 |
| LDL clearance | 12 | 2.37e-01 | 1.97e-01 | 0.57600 |
| Collagen formation | 19 | 2.37e-01 | -1.57e-01 | 0.57600 |
| Arachidonic acid metabolism | 21 | 2.38e-01 | -1.49e-01 | 0.57700 |
| DARPP-32 events | 18 | 2.39e-01 | -1.61e-01 | 0.57800 |
| RNA Polymerase II Pre-transcription Events | 60 | 2.41e-01 | 8.76e-02 | 0.58300 |
| Degradation of the extracellular matrix | 26 | 2.43e-01 | -1.32e-01 | 0.58500 |
| Export of Viral Ribonucleoproteins from Nucleus | 29 | 2.45e-01 | 1.25e-01 | 0.59100 |
| Metabolism of carbohydrates | 172 | 2.47e-01 | -5.14e-02 | 0.59300 |
| Hedgehog ‘on’ state | 61 | 2.47e-01 | 8.58e-02 | 0.59300 |
| TRAF3-dependent IRF activation pathway | 13 | 2.48e-01 | 1.85e-01 | 0.59300 |
| ERKs are inactivated | 11 | 2.49e-01 | 2.01e-01 | 0.59400 |
| Signaling by NOTCH | 128 | 2.50e-01 | 5.92e-02 | 0.59400 |
| IGF1R signaling cascade | 22 | 2.53e-01 | -1.41e-01 | 0.59800 |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | 22 | 2.53e-01 | -1.41e-01 | 0.59800 |
| HDMs demethylate histones | 15 | 2.53e-01 | -1.71e-01 | 0.59800 |
| Rap1 signalling | 11 | 2.53e-01 | -1.99e-01 | 0.59800 |
| Nephrin family interactions | 14 | 2.54e-01 | -1.76e-01 | 0.59900 |
| Energy dependent regulation of mTOR by LKB1-AMPK | 21 | 2.56e-01 | -1.43e-01 | 0.60200 |
| FLT3 Signaling | 32 | 2.56e-01 | -1.16e-01 | 0.60200 |
| Signalling to RAS | 12 | 2.59e-01 | -1.88e-01 | 0.60800 |
| RHOD GTPase cycle | 33 | 2.62e-01 | 1.13e-01 | 0.61100 |
| Termination of O-glycan biosynthesis | 10 | 2.62e-01 | 2.05e-01 | 0.61100 |
| HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | 78 | 2.65e-01 | 7.32e-02 | 0.61600 |
| Resolution of D-Loop Structures | 24 | 2.69e-01 | 1.30e-01 | 0.62500 |
| Class A/1 (Rhodopsin-like receptors) | 44 | 2.70e-01 | -9.63e-02 | 0.62500 |
| Diseases of programmed cell death | 36 | 2.70e-01 | -1.06e-01 | 0.62500 |
| Depolymerisation of the Nuclear Lamina | 11 | 2.72e-01 | -1.91e-01 | 0.62900 |
| Nuclear Envelope Breakdown | 45 | 2.73e-01 | 9.45e-02 | 0.62900 |
| Neutrophil degranulation | 288 | 2.74e-01 | -3.78e-02 | 0.62900 |
| Mitochondrial iron-sulfur cluster biogenesis | 10 | 2.76e-01 | 1.99e-01 | 0.63400 |
| Signaling by ERBB2 in Cancer | 11 | 2.78e-01 | -1.89e-01 | 0.63800 |
| Signaling by NTRKs | 86 | 2.79e-01 | -6.77e-02 | 0.63800 |
| Synthesis of very long-chain fatty acyl-CoAs | 12 | 2.80e-01 | -1.80e-01 | 0.64000 |
| Hedgehog ‘off’ state | 74 | 2.82e-01 | 7.25e-02 | 0.64200 |
| RHOC GTPase cycle | 45 | 2.83e-01 | -9.25e-02 | 0.64400 |
| Beta-catenin independent WNT signaling | 99 | 2.84e-01 | 6.25e-02 | 0.64400 |
| Regulation of cholesterol biosynthesis by SREBP (SREBF) | 45 | 2.86e-01 | 9.20e-02 | 0.64800 |
| HCMV Late Events | 47 | 2.88e-01 | 8.97e-02 | 0.64800 |
| RUNX3 regulates NOTCH signaling | 11 | 2.89e-01 | 1.85e-01 | 0.64800 |
| Interferon Signaling | 136 | 2.90e-01 | -5.27e-02 | 0.64800 |
| SLC-mediated transmembrane transport | 90 | 2.90e-01 | 6.46e-02 | 0.64800 |
| Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects | 15 | 2.91e-01 | -1.58e-01 | 0.64800 |
| Defective binding of RB1 mutants to E2F1,(E2F2, E2F3) | 15 | 2.91e-01 | -1.58e-01 | 0.64800 |
| G alpha (z) signalling events | 22 | 2.91e-01 | -1.30e-01 | 0.64800 |
| Transport of Mature Transcript to Cytoplasm | 54 | 2.92e-01 | 8.31e-02 | 0.64800 |
| COPII-mediated vesicle transport | 47 | 2.92e-01 | 8.90e-02 | 0.64800 |
| MicroRNA (miRNA) biogenesis | 17 | 2.92e-01 | -1.48e-01 | 0.64800 |
| Cobalamin (Cbl, vitamin B12) transport and metabolism | 10 | 2.94e-01 | 1.92e-01 | 0.64900 |
| Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | 41 | 2.96e-01 | 9.45e-02 | 0.64900 |
| Constitutive Signaling by NOTCH1 PEST Domain Mutants | 41 | 2.96e-01 | 9.45e-02 | 0.64900 |
| Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | 41 | 2.96e-01 | 9.45e-02 | 0.64900 |
| Signaling by NOTCH1 PEST Domain Mutants in Cancer | 41 | 2.96e-01 | 9.45e-02 | 0.64900 |
| Signaling by NOTCH1 in Cancer | 41 | 2.96e-01 | 9.45e-02 | 0.64900 |
| Gap junction trafficking and regulation | 10 | 2.96e-01 | -1.91e-01 | 0.64900 |
| Regulation of PLK1 Activity at G2/M Transition | 63 | 2.98e-01 | 7.59e-02 | 0.65200 |
| Diseases associated with O-glycosylation of proteins | 20 | 2.99e-01 | 1.34e-01 | 0.65200 |
| Collagen biosynthesis and modifying enzymes | 13 | 3.00e-01 | -1.66e-01 | 0.65200 |
| Synthesis of substrates in N-glycan biosythesis | 43 | 3.00e-01 | 9.14e-02 | 0.65200 |
| FCERI mediated NF-kB activation | 61 | 3.00e-01 | 7.68e-02 | 0.65200 |
| Signaling by NOTCH1 | 51 | 3.03e-01 | 8.34e-02 | 0.65400 |
| Sphingolipid de novo biosynthesis | 18 | 3.04e-01 | 1.40e-01 | 0.65400 |
| Interconversion of nucleotide di- and triphosphates | 21 | 3.04e-01 | 1.30e-01 | 0.65400 |
| Translation of structural proteins | 26 | 3.04e-01 | 1.17e-01 | 0.65400 |
| FLT3 signaling in disease | 24 | 3.05e-01 | -1.21e-01 | 0.65400 |
| Sema3A PAK dependent Axon repulsion | 11 | 3.08e-01 | -1.77e-01 | 0.66100 |
| KSRP (KHSRP) binds and destabilizes mRNA | 14 | 3.09e-01 | -1.57e-01 | 0.66100 |
| The role of Nef in HIV-1 replication and disease pathogenesis | 19 | 3.09e-01 | -1.35e-01 | 0.66100 |
| Detoxification of Reactive Oxygen Species | 22 | 3.10e-01 | 1.25e-01 | 0.66100 |
| Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta) | 12 | 3.12e-01 | 1.69e-01 | 0.66300 |
| MTOR signalling | 32 | 3.12e-01 | -1.03e-01 | 0.66300 |
| Ion transport by P-type ATPases | 26 | 3.13e-01 | -1.14e-01 | 0.66400 |
| BMAL1:CLOCK,NPAS2 activates circadian gene expression | 14 | 3.14e-01 | -1.55e-01 | 0.66500 |
| Cilium Assembly | 134 | 3.15e-01 | 5.05e-02 | 0.66500 |
| Nuclear import of Rev protein | 29 | 3.15e-01 | 1.08e-01 | 0.66500 |
| Negative regulation of NMDA receptor-mediated neuronal transmission | 11 | 3.17e-01 | -1.74e-01 | 0.66800 |
| Processing of Capped Intronless Pre-mRNA | 21 | 3.18e-01 | 1.26e-01 | 0.66800 |
| Fcgamma receptor (FCGR) dependent phagocytosis | 61 | 3.19e-01 | -7.39e-02 | 0.66800 |
| Aquaporin-mediated transport | 19 | 3.19e-01 | -1.32e-01 | 0.66800 |
| RHO GTPases Activate WASPs and WAVEs | 28 | 3.21e-01 | -1.09e-01 | 0.66900 |
| Estrogen-dependent nuclear events downstream of ESR-membrane signaling | 16 | 3.21e-01 | -1.43e-01 | 0.66900 |
| Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters | 14 | 3.22e-01 | -1.53e-01 | 0.66900 |
| Extra-nuclear estrogen signaling | 46 | 3.22e-01 | -8.44e-02 | 0.66900 |
| IRS-mediated signalling | 20 | 3.23e-01 | -1.28e-01 | 0.66900 |
| SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | 23 | 3.23e-01 | -1.19e-01 | 0.66900 |
| RAC3 GTPase cycle | 55 | 3.26e-01 | 7.66e-02 | 0.67100 |
| Interleukin-6 family signaling | 13 | 3.27e-01 | -1.57e-01 | 0.67100 |
| Gene expression (Transcription) | 958 | 3.27e-01 | 1.92e-02 | 0.67100 |
| Vpr-mediated nuclear import of PICs | 30 | 3.28e-01 | 1.03e-01 | 0.67100 |
| Signaling by WNT | 168 | 3.29e-01 | 4.39e-02 | 0.67100 |
| VxPx cargo-targeting to cilium | 15 | 3.29e-01 | 1.46e-01 | 0.67100 |
| Oncogene Induced Senescence | 27 | 3.29e-01 | 1.09e-01 | 0.67100 |
| Negative regulators of DDX58/IFIH1 signaling | 33 | 3.29e-01 | 9.83e-02 | 0.67100 |
| Disassembly of the destruction complex and recruitment of AXIN to the membrane | 26 | 3.29e-01 | -1.11e-01 | 0.67100 |
| Cargo recognition for clathrin-mediated endocytosis | 64 | 3.31e-01 | 7.04e-02 | 0.67200 |
| tRNA processing in the nucleus | 50 | 3.31e-01 | 7.96e-02 | 0.67200 |
| Glycerophospholipid biosynthesis | 69 | 3.37e-01 | -6.69e-02 | 0.68300 |
| Axon guidance | 283 | 3.37e-01 | 3.34e-02 | 0.68300 |
| Cell-Cell communication | 44 | 3.39e-01 | -8.34e-02 | 0.68500 |
| Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA | 14 | 3.40e-01 | -1.47e-01 | 0.68500 |
| GPVI-mediated activation cascade | 23 | 3.41e-01 | -1.15e-01 | 0.68700 |
| Sema4D in semaphorin signaling | 13 | 3.43e-01 | -1.52e-01 | 0.68700 |
| NOD1/2 Signaling Pathway | 22 | 3.43e-01 | -1.17e-01 | 0.68700 |
| Activation of gene expression by SREBF (SREBP) | 33 | 3.45e-01 | 9.51e-02 | 0.69000 |
| Diseases of signal transduction by growth factor receptors and second messengers | 261 | 3.46e-01 | -3.41e-02 | 0.69000 |
| Toll Like Receptor 3 (TLR3) Cascade | 70 | 3.46e-01 | 6.53e-02 | 0.69000 |
| EGR2 and SOX10-mediated initiation of Schwann cell myelination | 12 | 3.47e-01 | -1.57e-01 | 0.69000 |
| SUMOylation of SUMOylation proteins | 30 | 3.51e-01 | 9.85e-02 | 0.69500 |
| Vitamin B5 (pantothenate) metabolism | 11 | 3.51e-01 | -1.62e-01 | 0.69500 |
| Glycolysis | 54 | 3.53e-01 | 7.32e-02 | 0.69500 |
| Death Receptor Signalling | 88 | 3.53e-01 | 5.74e-02 | 0.69500 |
| Apoptotic cleavage of cellular proteins | 24 | 3.54e-01 | -1.09e-01 | 0.69500 |
| MyD88:MAL(TIRAP) cascade initiated on plasma membrane | 65 | 3.55e-01 | -6.65e-02 | 0.69500 |
| Toll Like Receptor 2 (TLR2) Cascade | 65 | 3.55e-01 | -6.65e-02 | 0.69500 |
| Toll Like Receptor TLR1:TLR2 Cascade | 65 | 3.55e-01 | -6.65e-02 | 0.69500 |
| Toll Like Receptor TLR6:TLR2 Cascade | 65 | 3.55e-01 | -6.65e-02 | 0.69500 |
| Nuclear Pore Complex (NPC) Disassembly | 32 | 3.56e-01 | 9.45e-02 | 0.69500 |
| Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC) | 26 | 3.56e-01 | 1.05e-01 | 0.69500 |
| Regulation of Glucokinase by Glucokinase Regulatory Protein | 26 | 3.56e-01 | 1.05e-01 | 0.69500 |
| Signaling by TGFB family members | 71 | 3.60e-01 | -6.29e-02 | 0.70100 |
| RND2 GTPase cycle | 32 | 3.61e-01 | -9.34e-02 | 0.70200 |
| Sema4D induced cell migration and growth-cone collapse | 11 | 3.64e-01 | -1.58e-01 | 0.70600 |
| Cell death signalling via NRAGE, NRIF and NADE | 40 | 3.64e-01 | 8.30e-02 | 0.70600 |
| Processing of DNA double-strand break ends | 52 | 3.66e-01 | 7.25e-02 | 0.70700 |
| Signaling by Erythropoietin | 19 | 3.66e-01 | 1.20e-01 | 0.70700 |
| Downstream signaling events of B Cell Receptor (BCR) | 67 | 3.68e-01 | 6.37e-02 | 0.71000 |
| Infection with Mycobacterium tuberculosis | 22 | 3.71e-01 | 1.10e-01 | 0.71200 |
| RAB geranylgeranylation | 39 | 3.71e-01 | 8.29e-02 | 0.71200 |
| Polymerase switching on the C-strand of the telomere | 20 | 3.72e-01 | -1.15e-01 | 0.71200 |
| Plasma lipoprotein assembly, remodeling, and clearance | 33 | 3.73e-01 | 8.98e-02 | 0.71200 |
| RIP-mediated NFkB activation via ZBP1 | 12 | 3.73e-01 | 1.49e-01 | 0.71200 |
| Gastrin-CREB signalling pathway via PKC and MAPK | 11 | 3.75e-01 | -1.54e-01 | 0.71500 |
| L1CAM interactions | 39 | 3.75e-01 | -8.21e-02 | 0.71500 |
| Nuclear Events (kinase and transcription factor activation) | 42 | 3.77e-01 | -7.89e-02 | 0.71600 |
| MAP3K8 (TPL2)-dependent MAPK1/3 activation | 13 | 3.78e-01 | 1.41e-01 | 0.71600 |
| Spry regulation of FGF signaling | 15 | 3.78e-01 | 1.31e-01 | 0.71600 |
| Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase | 15 | 3.80e-01 | 1.31e-01 | 0.71600 |
| Disorders of Developmental Biology | 10 | 3.81e-01 | -1.60e-01 | 0.71600 |
| Disorders of Nervous System Development | 10 | 3.81e-01 | -1.60e-01 | 0.71600 |
| Loss of function of MECP2 in Rett syndrome | 10 | 3.81e-01 | -1.60e-01 | 0.71600 |
| Pervasive developmental disorders | 10 | 3.81e-01 | -1.60e-01 | 0.71600 |
| p75 NTR receptor-mediated signalling | 54 | 3.83e-01 | 6.88e-02 | 0.71700 |
| Interleukin-1 signaling | 74 | 3.83e-01 | 5.88e-02 | 0.71700 |
| SUMOylation of chromatin organization proteins | 47 | 3.84e-01 | -7.35e-02 | 0.71800 |
| Mitochondrial protein import | 42 | 3.87e-01 | -7.73e-02 | 0.72200 |
| Signaling by KIT in disease | 16 | 3.88e-01 | -1.25e-01 | 0.72200 |
| Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants | 16 | 3.88e-01 | -1.25e-01 | 0.72200 |
| Developmental Biology | 438 | 3.89e-01 | 2.43e-02 | 0.72300 |
| Regulation of mRNA stability by proteins that bind AU-rich elements | 73 | 3.91e-01 | 5.82e-02 | 0.72300 |
| Negative regulation of FLT3 | 13 | 3.92e-01 | 1.37e-01 | 0.72300 |
| Interactions of Vpr with host cellular proteins | 31 | 3.92e-01 | 8.90e-02 | 0.72300 |
| Metabolism of steroid hormones | 13 | 3.92e-01 | -1.37e-01 | 0.72300 |
| Unwinding of DNA | 10 | 3.95e-01 | 1.55e-01 | 0.72800 |
| Selective autophagy | 50 | 3.96e-01 | -6.94e-02 | 0.72900 |
| Glycogen metabolism | 17 | 3.97e-01 | 1.19e-01 | 0.73000 |
| CTLA4 inhibitory signaling | 15 | 3.99e-01 | -1.26e-01 | 0.73100 |
| RNA Polymerase I Transcription Initiation | 38 | 3.99e-01 | -7.92e-02 | 0.73100 |
| COPI-independent Golgi-to-ER retrograde traffic | 28 | 4.00e-01 | -9.19e-02 | 0.73200 |
| Apoptotic factor-mediated response | 15 | 4.02e-01 | 1.25e-01 | 0.73300 |
| RNA Polymerase I Promoter Escape | 25 | 4.02e-01 | 9.69e-02 | 0.73300 |
| Nonhomologous End-Joining (NHEJ) | 27 | 4.03e-01 | 9.30e-02 | 0.73300 |
| Gluconeogenesis | 24 | 4.04e-01 | -9.86e-02 | 0.73300 |
| Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex | 13 | 4.05e-01 | -1.34e-01 | 0.73400 |
| IKK complex recruitment mediated by RIP1 | 17 | 4.06e-01 | 1.16e-01 | 0.73500 |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | 13 | 4.10e-01 | 1.32e-01 | 0.73700 |
| Signaling by Ligand-Responsive EGFR Variants in Cancer | 13 | 4.10e-01 | 1.32e-01 | 0.73700 |
| Transcriptional regulation of granulopoiesis | 24 | 4.10e-01 | -9.71e-02 | 0.73700 |
| Removal of the Flap Intermediate | 12 | 4.11e-01 | 1.37e-01 | 0.73700 |
| Signaling by Hedgehog | 97 | 4.14e-01 | 4.82e-02 | 0.73700 |
| Protein localization | 113 | 4.14e-01 | -4.46e-02 | 0.73700 |
| Nicotinate metabolism | 16 | 4.15e-01 | -1.18e-01 | 0.73700 |
| Downstream signaling of activated FGFR1 | 11 | 4.16e-01 | -1.42e-01 | 0.73700 |
| Downstream signaling of activated FGFR2 | 11 | 4.16e-01 | -1.42e-01 | 0.73700 |
| Downstream signaling of activated FGFR3 | 11 | 4.16e-01 | -1.42e-01 | 0.73700 |
| Downstream signaling of activated FGFR4 | 11 | 4.16e-01 | -1.42e-01 | 0.73700 |
| FCGR3A-mediated phagocytosis | 41 | 4.16e-01 | -7.35e-02 | 0.73700 |
| Leishmania phagocytosis | 41 | 4.16e-01 | -7.35e-02 | 0.73700 |
| Parasite infection | 41 | 4.16e-01 | -7.35e-02 | 0.73700 |
| Telomere C-strand (Lagging Strand) Synthesis | 27 | 4.17e-01 | -9.03e-02 | 0.73800 |
| Mitotic Prophase | 69 | 4.18e-01 | 5.65e-02 | 0.73800 |
| Formation of the beta-catenin:TCF transactivating complex | 24 | 4.20e-01 | 9.52e-02 | 0.73800 |
| N-glycan antennae elongation in the medial/trans-Golgi | 18 | 4.20e-01 | -1.10e-01 | 0.73800 |
| Apoptotic execution phase | 32 | 4.21e-01 | -8.22e-02 | 0.73800 |
| AKT phosphorylates targets in the cytosol | 13 | 4.23e-01 | -1.28e-01 | 0.73800 |
| Response to elevated platelet cytosolic Ca2+ | 50 | 4.23e-01 | -6.56e-02 | 0.73800 |
| Class B/2 (Secretin family receptors) | 25 | 4.24e-01 | -9.25e-02 | 0.73800 |
| Nervous system development | 294 | 4.25e-01 | 2.73e-02 | 0.73800 |
| Mismatch Repair | 13 | 4.25e-01 | 1.28e-01 | 0.73800 |
| Downstream signal transduction | 20 | 4.26e-01 | -1.03e-01 | 0.73800 |
| Rab regulation of trafficking | 85 | 4.26e-01 | -5.01e-02 | 0.73800 |
| MAPK family signaling cascades | 176 | 4.26e-01 | -3.49e-02 | 0.73800 |
| tRNA processing | 82 | 4.26e-01 | 5.09e-02 | 0.73800 |
| E2F mediated regulation of DNA replication | 12 | 4.26e-01 | -1.33e-01 | 0.73800 |
| Interleukin-7 signaling | 14 | 4.31e-01 | -1.22e-01 | 0.74500 |
| EPH-ephrin mediated repulsion of cells | 24 | 4.34e-01 | 9.24e-02 | 0.74900 |
| Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha) | 12 | 4.35e-01 | 1.30e-01 | 0.75000 |
| RHOQ GTPase cycle | 36 | 4.36e-01 | 7.50e-02 | 0.75100 |
| RHOU GTPase cycle | 24 | 4.37e-01 | -9.17e-02 | 0.75100 |
| TP53 Regulates Transcription of Genes Involved in Cytochrome C Release | 13 | 4.40e-01 | 1.24e-01 | 0.75400 |
| Resolution of Abasic Sites (AP sites) | 31 | 4.41e-01 | 8.01e-02 | 0.75400 |
| RND3 GTPase cycle | 28 | 4.41e-01 | -8.42e-02 | 0.75400 |
| Metabolism of water-soluble vitamins and cofactors | 76 | 4.42e-01 | -5.11e-02 | 0.75400 |
| Cargo trafficking to the periciliary membrane | 38 | 4.42e-01 | 7.21e-02 | 0.75400 |
| Josephin domain DUBs | 11 | 4.43e-01 | 1.34e-01 | 0.75500 |
| Antiviral mechanism by IFN-stimulated genes | 73 | 4.44e-01 | 5.19e-02 | 0.75500 |
| Assembly and cell surface presentation of NMDA receptors | 12 | 4.45e-01 | -1.27e-01 | 0.75500 |
| Signaling by BMP | 13 | 4.48e-01 | -1.22e-01 | 0.75900 |
| Attenuation phase | 19 | 4.48e-01 | 1.01e-01 | 0.75900 |
| RHOA GTPase cycle | 86 | 4.49e-01 | -4.73e-02 | 0.75900 |
| ADP signalling through P2Y purinoceptor 12 | 10 | 4.50e-01 | 1.38e-01 | 0.75900 |
| Striated Muscle Contraction | 10 | 4.52e-01 | -1.37e-01 | 0.76100 |
| Glucagon-like Peptide-1 (GLP1) regulates insulin secretion | 19 | 4.52e-01 | -9.96e-02 | 0.76100 |
| Signaling by NTRK3 (TRKC) | 10 | 4.54e-01 | -1.37e-01 | 0.76200 |
| Gamma carboxylation, hypusine formation and arylsulfatase activation | 21 | 4.57e-01 | 9.39e-02 | 0.76600 |
| COPI-dependent Golgi-to-ER retrograde traffic | 63 | 4.58e-01 | 5.42e-02 | 0.76700 |
| PRC2 methylates histones and DNA | 11 | 4.58e-01 | -1.29e-01 | 0.76700 |
| Initiation of Nuclear Envelope (NE) Reformation | 17 | 4.59e-01 | 1.04e-01 | 0.76700 |
| Vasopressin regulates renal water homeostasis via Aquaporins | 18 | 4.60e-01 | -1.01e-01 | 0.76700 |
| Signaling by FGFR1 in disease | 23 | 4.62e-01 | -8.86e-02 | 0.77000 |
| G beta:gamma signalling through PLC beta | 10 | 4.64e-01 | -1.34e-01 | 0.77100 |
| Presynaptic function of Kainate receptors | 10 | 4.64e-01 | -1.34e-01 | 0.77100 |
| Signaling by ERBB2 KD Mutants | 10 | 4.69e-01 | -1.32e-01 | 0.77700 |
| AURKA Activation by TPX2 | 51 | 4.70e-01 | 5.86e-02 | 0.77800 |
| Triglyceride catabolism | 11 | 4.70e-01 | -1.26e-01 | 0.77800 |
| VEGFR2 mediated vascular permeability | 21 | 4.72e-01 | -9.07e-02 | 0.77900 |
| RHO GTPases activate CIT | 14 | 4.73e-01 | -1.11e-01 | 0.77900 |
| Metabolism of folate and pterines | 11 | 4.73e-01 | -1.25e-01 | 0.77900 |
| Condensation of Prometaphase Chromosomes | 10 | 4.74e-01 | -1.31e-01 | 0.77900 |
| Adaptive Immune System | 451 | 4.74e-01 | -1.99e-02 | 0.77900 |
| Long-term potentiation | 10 | 4.75e-01 | -1.30e-01 | 0.77900 |
| Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1 | 15 | 4.76e-01 | -1.06e-01 | 0.77900 |
| TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest | 12 | 4.77e-01 | -1.19e-01 | 0.77900 |
| Signalling to ERKs | 25 | 4.77e-01 | -8.22e-02 | 0.77900 |
| ER to Golgi Anterograde Transport | 101 | 4.78e-01 | 4.10e-02 | 0.77900 |
| Antigen processing: Ubiquitination & Proteasome degradation | 226 | 4.80e-01 | 2.74e-02 | 0.78200 |
| FOXO-mediated transcription | 45 | 4.84e-01 | -6.04e-02 | 0.78600 |
| Phosphorylation of the APC/C | 15 | 4.84e-01 | 1.04e-01 | 0.78600 |
| Nucleobase biosynthesis | 12 | 4.85e-01 | 1.16e-01 | 0.78600 |
| SLC transporter disorders | 46 | 4.87e-01 | 5.94e-02 | 0.78700 |
| HIV Transcription Initiation | 37 | 4.90e-01 | 6.56e-02 | 0.78700 |
| RNA Polymerase II HIV Promoter Escape | 37 | 4.90e-01 | 6.56e-02 | 0.78700 |
| RNA Polymerase II Promoter Escape | 37 | 4.90e-01 | 6.56e-02 | 0.78700 |
| RNA Polymerase II Transcription Initiation | 37 | 4.90e-01 | 6.56e-02 | 0.78700 |
| RNA Polymerase II Transcription Initiation And Promoter Clearance | 37 | 4.90e-01 | 6.56e-02 | 0.78700 |
| RNA Polymerase II Transcription Pre-Initiation And Promoter Opening | 37 | 4.90e-01 | 6.56e-02 | 0.78700 |
| MAPK1/MAPK3 signaling | 153 | 4.93e-01 | -3.23e-02 | 0.78800 |
| RIPK1-mediated regulated necrosis | 24 | 4.93e-01 | 8.09e-02 | 0.78800 |
| Regulation of necroptotic cell death | 24 | 4.93e-01 | 8.09e-02 | 0.78800 |
| Signaling by Nuclear Receptors | 142 | 4.95e-01 | -3.33e-02 | 0.78800 |
| Downregulation of SMAD2/3:SMAD4 transcriptional activity | 21 | 4.95e-01 | 8.60e-02 | 0.78800 |
| Transcription of E2F targets under negative control by DREAM complex | 17 | 4.96e-01 | 9.54e-02 | 0.78800 |
| Deposition of new CENPA-containing nucleosomes at the centromere | 20 | 4.96e-01 | 8.79e-02 | 0.78800 |
| Nucleosome assembly | 20 | 4.96e-01 | 8.79e-02 | 0.78800 |
| HDR through Single Strand Annealing (SSA) | 32 | 5.00e-01 | 6.90e-02 | 0.78900 |
| NRAGE signals death through JNK | 25 | 5.01e-01 | -7.79e-02 | 0.78900 |
| Homologous DNA Pairing and Strand Exchange | 34 | 5.01e-01 | 6.67e-02 | 0.78900 |
| Formation of RNA Pol II elongation complex | 43 | 5.01e-01 | 5.93e-02 | 0.78900 |
| RNA Polymerase II Transcription Elongation | 43 | 5.01e-01 | 5.93e-02 | 0.78900 |
| HSF1-dependent transactivation | 25 | 5.02e-01 | 7.77e-02 | 0.78900 |
| Meiotic recombination | 19 | 5.04e-01 | 8.87e-02 | 0.78900 |
| tRNA Aminoacylation | 21 | 5.04e-01 | -8.42e-02 | 0.78900 |
| Transcriptional regulation by RUNX2 | 82 | 5.05e-01 | 4.27e-02 | 0.78900 |
| Intrinsic Pathway for Apoptosis | 44 | 5.08e-01 | -5.78e-02 | 0.78900 |
| MyD88-independent TLR4 cascade | 70 | 5.09e-01 | 4.57e-02 | 0.78900 |
| TRIF(TICAM1)-mediated TLR4 signaling | 70 | 5.09e-01 | 4.57e-02 | 0.78900 |
| Heme biosynthesis | 10 | 5.14e-01 | 1.19e-01 | 0.78900 |
| Telomere Maintenance | 53 | 5.15e-01 | -5.18e-02 | 0.78900 |
| ISG15 antiviral mechanism | 67 | 5.16e-01 | 4.60e-02 | 0.78900 |
| RET signaling | 22 | 5.17e-01 | -7.99e-02 | 0.78900 |
| Negative regulation of FGFR1 signaling | 17 | 5.17e-01 | 9.09e-02 | 0.78900 |
| Negative regulation of FGFR2 signaling | 17 | 5.17e-01 | 9.09e-02 | 0.78900 |
| Negative regulation of FGFR3 signaling | 17 | 5.17e-01 | 9.09e-02 | 0.78900 |
| Negative regulation of FGFR4 signaling | 17 | 5.17e-01 | 9.09e-02 | 0.78900 |
| Gap-filling DNA repair synthesis and ligation in TC-NER | 54 | 5.17e-01 | 5.10e-02 | 0.78900 |
| Complex I biogenesis | 38 | 5.18e-01 | 6.06e-02 | 0.78900 |
| Signaling by Insulin receptor | 40 | 5.20e-01 | 5.89e-02 | 0.78900 |
| Class I MHC mediated antigen processing & presentation | 267 | 5.20e-01 | 2.30e-02 | 0.78900 |
| S33 mutants of beta-catenin aren’t phosphorylated | 13 | 5.21e-01 | 1.03e-01 | 0.78900 |
| S37 mutants of beta-catenin aren’t phosphorylated | 13 | 5.21e-01 | 1.03e-01 | 0.78900 |
| S45 mutants of beta-catenin aren’t phosphorylated | 13 | 5.21e-01 | 1.03e-01 | 0.78900 |
| Signaling by CTNNB1 phospho-site mutants | 13 | 5.21e-01 | 1.03e-01 | 0.78900 |
| Signaling by GSK3beta mutants | 13 | 5.21e-01 | 1.03e-01 | 0.78900 |
| T41 mutants of beta-catenin aren’t phosphorylated | 13 | 5.21e-01 | 1.03e-01 | 0.78900 |
| RHOF GTPase cycle | 23 | 5.21e-01 | 7.73e-02 | 0.78900 |
| Signaling by RAF1 mutants | 25 | 5.21e-01 | -7.41e-02 | 0.78900 |
| Signaling by CSF3 (G-CSF) | 25 | 5.22e-01 | -7.40e-02 | 0.78900 |
| Pyruvate metabolism | 19 | 5.22e-01 | -8.49e-02 | 0.78900 |
| Signaling by Retinoic Acid | 17 | 5.23e-01 | 8.95e-02 | 0.78900 |
| Diseases of DNA repair | 10 | 5.24e-01 | 1.16e-01 | 0.78900 |
| Signaling by Non-Receptor Tyrosine Kinases | 33 | 5.24e-01 | 6.42e-02 | 0.78900 |
| Signaling by PTK6 | 33 | 5.24e-01 | 6.42e-02 | 0.78900 |
| Intraflagellar transport | 30 | 5.25e-01 | 6.72e-02 | 0.78900 |
| Caspase activation via Death Receptors in the presence of ligand | 10 | 5.26e-01 | 1.16e-01 | 0.78900 |
| Autophagy | 95 | 5.27e-01 | 3.77e-02 | 0.78900 |
| Metabolic disorders of biological oxidation enzymes | 14 | 5.27e-01 | 9.76e-02 | 0.78900 |
| Presynaptic phase of homologous DNA pairing and strand exchange | 31 | 5.27e-01 | 6.57e-02 | 0.78900 |
| Maturation of nucleoprotein | 10 | 5.28e-01 | -1.15e-01 | 0.78900 |
| SUMOylation of DNA damage response and repair proteins | 65 | 5.28e-01 | 4.53e-02 | 0.78900 |
| DNA Double Strand Break Response | 33 | 5.29e-01 | 6.34e-02 | 0.78900 |
| Fatty acyl-CoA biosynthesis | 22 | 5.29e-01 | -7.75e-02 | 0.78900 |
| mRNA Capping | 25 | 5.33e-01 | 7.20e-02 | 0.79300 |
| Mitochondrial Fatty Acid Beta-Oxidation | 24 | 5.35e-01 | 7.31e-02 | 0.79300 |
| Formation of HIV elongation complex in the absence of HIV Tat | 31 | 5.37e-01 | 6.42e-02 | 0.79300 |
| Formation of HIV-1 elongation complex containing HIV-1 Tat | 31 | 5.37e-01 | 6.42e-02 | 0.79300 |
| HIV Transcription Elongation | 31 | 5.37e-01 | 6.42e-02 | 0.79300 |
| Tat-mediated elongation of the HIV-1 transcript | 31 | 5.37e-01 | 6.42e-02 | 0.79300 |
| Anchoring of the basal body to the plasma membrane | 70 | 5.37e-01 | 4.27e-02 | 0.79300 |
| Dopamine Neurotransmitter Release Cycle | 10 | 5.39e-01 | -1.12e-01 | 0.79400 |
| Pre-NOTCH Processing in Golgi | 15 | 5.40e-01 | -9.15e-02 | 0.79400 |
| Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | 32 | 5.40e-01 | 6.27e-02 | 0.79400 |
| Class I peroxisomal membrane protein import | 18 | 5.40e-01 | -8.34e-02 | 0.79400 |
| Transport of vitamins, nucleosides, and related molecules | 21 | 5.42e-01 | 7.68e-02 | 0.79600 |
| Clathrin-mediated endocytosis | 89 | 5.44e-01 | 3.73e-02 | 0.79600 |
| Platelet degranulation | 46 | 5.45e-01 | -5.17e-02 | 0.79600 |
| ESR-mediated signaling | 106 | 5.45e-01 | -3.42e-02 | 0.79600 |
| RNA Polymerase II Transcription | 856 | 5.45e-01 | 1.25e-02 | 0.79600 |
| TBC/RABGAPs | 39 | 5.47e-01 | -5.59e-02 | 0.79700 |
| Regulation of actin dynamics for phagocytic cup formation | 43 | 5.48e-01 | -5.30e-02 | 0.79800 |
| Membrane Trafficking | 419 | 5.50e-01 | 1.73e-02 | 0.79900 |
| Sensory Perception | 63 | 5.51e-01 | -4.35e-02 | 0.79900 |
| RUNX2 regulates bone development | 17 | 5.51e-01 | -8.36e-02 | 0.79900 |
| Processive synthesis on the C-strand of the telomere | 17 | 5.52e-01 | -8.34e-02 | 0.79900 |
| Amino acids regulate mTORC1 | 35 | 5.53e-01 | 5.80e-02 | 0.80000 |
| SUMOylation of ubiquitinylation proteins | 35 | 5.56e-01 | 5.76e-02 | 0.80200 |
| Transferrin endocytosis and recycling | 18 | 5.56e-01 | 8.01e-02 | 0.80300 |
| Golgi Cisternae Pericentriolar Stack Reorganization | 13 | 5.59e-01 | 9.37e-02 | 0.80300 |
| Loss of Nlp from mitotic centrosomes | 48 | 5.60e-01 | 4.87e-02 | 0.80300 |
| Loss of proteins required for interphase microtubule organization from the centrosome | 48 | 5.60e-01 | 4.87e-02 | 0.80300 |
| PI3K Cascade | 18 | 5.60e-01 | -7.95e-02 | 0.80300 |
| O-linked glycosylation of mucins | 26 | 5.63e-01 | -6.57e-02 | 0.80600 |
| Transcriptional regulation by small RNAs | 40 | 5.64e-01 | 5.28e-02 | 0.80700 |
| G1/S-Specific Transcription | 24 | 5.64e-01 | 6.80e-02 | 0.80700 |
| MAP2K and MAPK activation | 22 | 5.66e-01 | -7.07e-02 | 0.80700 |
| Signaling by high-kinase activity BRAF mutants | 22 | 5.66e-01 | -7.07e-02 | 0.80700 |
| The citric acid (TCA) cycle and respiratory electron transport | 109 | 5.66e-01 | -3.19e-02 | 0.80700 |
| Glycosphingolipid metabolism | 25 | 5.69e-01 | -6.59e-02 | 0.80900 |
| Miscellaneous transport and binding events | 14 | 5.70e-01 | -8.78e-02 | 0.80900 |
| COPI-mediated anterograde transport | 67 | 5.76e-01 | 3.96e-02 | 0.81800 |
| Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA) | 20 | 5.78e-01 | 7.20e-02 | 0.81900 |
| ATF4 activates genes in response to endoplasmic reticulum stress | 22 | 5.80e-01 | -6.83e-02 | 0.82100 |
| RHO GTPases Activate NADPH Oxidases | 14 | 5.82e-01 | -8.51e-02 | 0.82200 |
| Heme signaling | 25 | 5.83e-01 | -6.35e-02 | 0.82300 |
| Regulation of TP53 Degradation | 33 | 5.84e-01 | 5.51e-02 | 0.82400 |
| TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain | 16 | 5.85e-01 | 7.89e-02 | 0.82400 |
| SUMOylation of transcription factors | 13 | 5.86e-01 | 8.73e-02 | 0.82400 |
| Gene Silencing by RNA | 54 | 5.90e-01 | 4.25e-02 | 0.82800 |
| NoRC negatively regulates rRNA expression | 39 | 5.90e-01 | 4.99e-02 | 0.82800 |
| Amino acid transport across the plasma membrane | 16 | 5.94e-01 | -7.70e-02 | 0.83300 |
| Unfolded Protein Response (UPR) | 67 | 5.96e-01 | 3.75e-02 | 0.83500 |
| Growth hormone receptor signaling | 17 | 5.97e-01 | -7.40e-02 | 0.83500 |
| Metabolism of vitamins and cofactors | 105 | 6.01e-01 | -2.97e-02 | 0.83900 |
| HCMV Early Events | 48 | 6.02e-01 | -4.36e-02 | 0.83900 |
| Glutamate Neurotransmitter Release Cycle | 11 | 6.03e-01 | 9.07e-02 | 0.83900 |
| Meiotic synapsis | 22 | 6.04e-01 | -6.38e-02 | 0.84000 |
| Toll Like Receptor 4 (TLR4) Cascade | 87 | 6.05e-01 | -3.22e-02 | 0.84000 |
| Interleukin-2 family signaling | 28 | 6.06e-01 | -5.64e-02 | 0.84000 |
| TNFR1-induced proapoptotic signaling | 12 | 6.06e-01 | 8.60e-02 | 0.84000 |
| Toll-like Receptor Cascades | 97 | 6.07e-01 | -3.03e-02 | 0.84000 |
| Transport of Ribonucleoproteins into the Host Nucleus | 28 | 6.11e-01 | 5.56e-02 | 0.84500 |
| DNA strand elongation | 27 | 6.12e-01 | 5.64e-02 | 0.84600 |
| Synthesis of PC | 21 | 6.13e-01 | 6.37e-02 | 0.84600 |
| Phospholipid metabolism | 127 | 6.14e-01 | -2.60e-02 | 0.84600 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | 151 | 6.16e-01 | 2.38e-02 | 0.84600 |
| Signaling by WNT in cancer | 23 | 6.17e-01 | -6.03e-02 | 0.84600 |
| Transport of Mature mRNAs Derived from Intronless Transcripts | 38 | 6.18e-01 | 4.69e-02 | 0.84600 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | 29 | 6.19e-01 | -5.34e-02 | 0.84600 |
| Signaling by RAS mutants | 29 | 6.19e-01 | -5.34e-02 | 0.84600 |
| Signaling by moderate kinase activity BRAF mutants | 29 | 6.19e-01 | -5.34e-02 | 0.84600 |
| Signaling downstream of RAS mutants | 29 | 6.19e-01 | -5.34e-02 | 0.84600 |
| RHO GTPases Activate ROCKs | 13 | 6.21e-01 | -7.92e-02 | 0.84800 |
| Vesicle-mediated transport | 426 | 6.22e-01 | 1.41e-02 | 0.84800 |
| Cleavage of the damaged pyrimidine | 13 | 6.24e-01 | -7.85e-02 | 0.84800 |
| Depyrimidination | 13 | 6.24e-01 | -7.85e-02 | 0.84800 |
| Recognition and association of DNA glycosylase with site containing an affected pyrimidine | 13 | 6.24e-01 | -7.85e-02 | 0.84800 |
| Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells | 11 | 6.28e-01 | 8.44e-02 | 0.85200 |
| Removal of the Flap Intermediate from the C-strand | 15 | 6.29e-01 | -7.22e-02 | 0.85200 |
| Metabolism | 1168 | 6.33e-01 | 8.58e-03 | 0.85600 |
| NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 | 10 | 6.34e-01 | 8.70e-02 | 0.85600 |
| Oxidative Stress Induced Senescence | 51 | 6.34e-01 | -3.86e-02 | 0.85600 |
| Viral Messenger RNA Synthesis | 38 | 6.40e-01 | 4.39e-02 | 0.86300 |
| ADP signalling through P2Y purinoceptor 1 | 13 | 6.41e-01 | -7.47e-02 | 0.86400 |
| Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | 37 | 6.44e-01 | 4.39e-02 | 0.86500 |
| Myogenesis | 13 | 6.44e-01 | -7.40e-02 | 0.86500 |
| Peptide ligand-binding receptors | 19 | 6.45e-01 | -6.10e-02 | 0.86500 |
| Regulation of TP53 Expression and Degradation | 34 | 6.46e-01 | 4.56e-02 | 0.86500 |
| EPH-Ephrin signaling | 54 | 6.46e-01 | -3.62e-02 | 0.86500 |
| Signaling by BRAF and RAF fusions | 42 | 6.52e-01 | -4.02e-02 | 0.87100 |
| Activation of HOX genes during differentiation | 36 | 6.53e-01 | 4.34e-02 | 0.87100 |
| Activation of anterior HOX genes in hindbrain development during early embryogenesis | 36 | 6.53e-01 | 4.34e-02 | 0.87100 |
| NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux | 20 | 6.54e-01 | -5.79e-02 | 0.87200 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | 29 | 6.57e-01 | -4.77e-02 | 0.87400 |
| RAF activation | 27 | 6.60e-01 | -4.90e-02 | 0.87700 |
| Regulation of pyruvate dehydrogenase (PDH) complex | 11 | 6.62e-01 | -7.62e-02 | 0.87800 |
| ERK/MAPK targets | 16 | 6.62e-01 | 6.31e-02 | 0.87800 |
| Protein ubiquitination | 55 | 6.62e-01 | -3.41e-02 | 0.87800 |
| TP53 Regulates Metabolic Genes | 60 | 6.64e-01 | 3.25e-02 | 0.87900 |
| Regulation of RUNX1 Expression and Activity | 12 | 6.65e-01 | -7.22e-02 | 0.87900 |
| FCERI mediated MAPK activation | 22 | 6.69e-01 | -5.26e-02 | 0.88300 |
| B-WICH complex positively regulates rRNA expression | 25 | 6.70e-01 | 4.93e-02 | 0.88300 |
| Metabolism of lipids | 411 | 6.71e-01 | 1.24e-02 | 0.88400 |
| Thrombin signalling through proteinase activated receptors (PARs) | 17 | 6.74e-01 | 5.90e-02 | 0.88500 |
| Programmed Cell Death | 148 | 6.74e-01 | 2.01e-02 | 0.88500 |
| Purine salvage | 11 | 6.74e-01 | -7.32e-02 | 0.88500 |
| Transcriptional activation of mitochondrial biogenesis | 36 | 6.76e-01 | -4.03e-02 | 0.88500 |
| Downregulation of ERBB2 signaling | 15 | 6.77e-01 | 6.21e-02 | 0.88500 |
| Respiratory electron transport | 71 | 6.78e-01 | 2.86e-02 | 0.88500 |
| RAF/MAP kinase cascade | 148 | 6.79e-01 | -1.98e-02 | 0.88500 |
| NS1 Mediated Effects on Host Pathways | 36 | 6.80e-01 | 3.97e-02 | 0.88500 |
| Metabolism of fat-soluble vitamins | 13 | 6.83e-01 | 6.55e-02 | 0.88500 |
| Formation of the Early Elongation Complex | 25 | 6.83e-01 | 4.72e-02 | 0.88500 |
| Formation of the HIV-1 Early Elongation Complex | 25 | 6.83e-01 | 4.72e-02 | 0.88500 |
| Signaling by FGFR4 | 24 | 6.83e-01 | 4.82e-02 | 0.88500 |
| Signaling by FGFR in disease | 37 | 6.84e-01 | -3.88e-02 | 0.88500 |
| TNFR1-induced NFkappaB signaling pathway | 19 | 6.86e-01 | 5.37e-02 | 0.88500 |
| Negative epigenetic regulation of rRNA expression | 40 | 6.87e-01 | 3.68e-02 | 0.88500 |
| Extension of Telomeres | 41 | 6.87e-01 | -3.64e-02 | 0.88500 |
| Negative regulation of MAPK pathway | 35 | 6.89e-01 | 3.91e-02 | 0.88500 |
| APC truncation mutants have impaired AXIN binding | 12 | 6.90e-01 | 6.66e-02 | 0.88500 |
| AXIN missense mutants destabilize the destruction complex | 12 | 6.90e-01 | 6.66e-02 | 0.88500 |
| Signaling by AMER1 mutants | 12 | 6.90e-01 | 6.66e-02 | 0.88500 |
| Signaling by APC mutants | 12 | 6.90e-01 | 6.66e-02 | 0.88500 |
| Signaling by AXIN mutants | 12 | 6.90e-01 | 6.66e-02 | 0.88500 |
| Truncations of AMER1 destabilize the destruction complex | 12 | 6.90e-01 | 6.66e-02 | 0.88500 |
| Mitophagy | 25 | 6.92e-01 | -4.58e-02 | 0.88700 |
| HATs acetylate histones | 53 | 6.93e-01 | -3.14e-02 | 0.88700 |
| Cell-cell junction organization | 12 | 6.93e-01 | 6.58e-02 | 0.88700 |
| Biological oxidations | 74 | 7.00e-01 | 2.60e-02 | 0.89400 |
| Transcriptional Regulation by TP53 | 273 | 7.01e-01 | 1.36e-02 | 0.89500 |
| Mitochondrial tRNA aminoacylation | 16 | 7.10e-01 | -5.37e-02 | 0.90100 |
| Positive epigenetic regulation of rRNA expression | 38 | 7.11e-01 | -3.48e-02 | 0.90100 |
| RNA Polymerase I Transcription Termination | 23 | 7.11e-01 | 4.47e-02 | 0.90100 |
| Processing of Intronless Pre-mRNAs | 14 | 7.13e-01 | -5.68e-02 | 0.90100 |
| Retinoid metabolism and transport | 11 | 7.13e-01 | 6.41e-02 | 0.90100 |
| MyD88 cascade initiated on plasma membrane | 60 | 7.13e-01 | -2.75e-02 | 0.90100 |
| Toll Like Receptor 10 (TLR10) Cascade | 60 | 7.13e-01 | -2.75e-02 | 0.90100 |
| Toll Like Receptor 5 (TLR5) Cascade | 60 | 7.13e-01 | -2.75e-02 | 0.90100 |
| Gap-filling DNA repair synthesis and ligation in GG-NER | 23 | 7.13e-01 | 4.43e-02 | 0.90100 |
| Regulation of beta-cell development | 15 | 7.14e-01 | 5.47e-02 | 0.90100 |
| Signaling by ERBB2 | 31 | 7.16e-01 | -3.78e-02 | 0.90100 |
| Response of EIF2AK1 (HRI) to heme deficiency | 13 | 7.16e-01 | -5.83e-02 | 0.90100 |
| Processive synthesis on the lagging strand | 13 | 7.17e-01 | 5.81e-02 | 0.90100 |
| Telomere Extension By Telomerase | 19 | 7.18e-01 | -4.80e-02 | 0.90100 |
| Signaling by FGFR2 | 46 | 7.18e-01 | 3.09e-02 | 0.90100 |
| Base-Excision Repair, AP Site Formation | 15 | 7.21e-01 | -5.34e-02 | 0.90400 |
| Signaling by Leptin | 10 | 7.25e-01 | 6.42e-02 | 0.90600 |
| RHO GTPase cycle | 271 | 7.26e-01 | -1.25e-02 | 0.90600 |
| G0 and Early G1 | 24 | 7.26e-01 | 4.13e-02 | 0.90600 |
| Signaling by EGFR in Cancer | 15 | 7.26e-01 | 5.22e-02 | 0.90600 |
| TGF-beta receptor signaling activates SMADs | 30 | 7.28e-01 | 3.68e-02 | 0.90600 |
| GABA receptor activation | 16 | 7.28e-01 | -5.03e-02 | 0.90600 |
| Notch-HLH transcription pathway | 21 | 7.30e-01 | -4.35e-02 | 0.90900 |
| Kinesins | 30 | 7.32e-01 | -3.61e-02 | 0.90900 |
| Sensory processing of sound by outer hair cells of the cochlea | 15 | 7.33e-01 | -5.09e-02 | 0.90900 |
| Signaling by FGFR2 in disease | 22 | 7.33e-01 | -4.20e-02 | 0.90900 |
| RHOBTB GTPase Cycle | 28 | 7.37e-01 | 3.67e-02 | 0.91200 |
| mRNA 3’-end processing | 28 | 7.37e-01 | 3.67e-02 | 0.91200 |
| Lysosome Vesicle Biogenesis | 24 | 7.42e-01 | 3.89e-02 | 0.91500 |
| Golgi Associated Vesicle Biogenesis | 37 | 7.42e-01 | 3.13e-02 | 0.91500 |
| Metabolism of nucleotides | 68 | 7.42e-01 | -2.31e-02 | 0.91500 |
| Synthesis of bile acids and bile salts | 13 | 7.43e-01 | -5.26e-02 | 0.91500 |
| Transport of Mature mRNA Derived from an Intronless Transcript | 37 | 7.45e-01 | 3.10e-02 | 0.91500 |
| G beta:gamma signalling through CDC42 | 10 | 7.45e-01 | -5.95e-02 | 0.91500 |
| PI Metabolism | 59 | 7.45e-01 | 2.45e-02 | 0.91500 |
| Metabolism of steroids | 80 | 7.47e-01 | 2.09e-02 | 0.91500 |
| Antigen Presentation: Folding, assembly and peptide loading of class I MHC | 23 | 7.48e-01 | -3.88e-02 | 0.91500 |
| Glutamate binding, activation of AMPA receptors and synaptic plasticity | 12 | 7.50e-01 | 5.31e-02 | 0.91500 |
| Trafficking of AMPA receptors | 12 | 7.50e-01 | 5.31e-02 | 0.91500 |
| Diseases associated with the TLR signaling cascade | 16 | 7.51e-01 | -4.59e-02 | 0.91500 |
| Diseases of Immune System | 16 | 7.51e-01 | -4.59e-02 | 0.91500 |
| Synthesis of PIPs at the Golgi membrane | 11 | 7.51e-01 | 5.53e-02 | 0.91500 |
| Amyloid fiber formation | 27 | 7.54e-01 | 3.49e-02 | 0.91700 |
| Apoptosis | 128 | 7.55e-01 | 1.60e-02 | 0.91700 |
| Macroautophagy | 87 | 7.55e-01 | 1.94e-02 | 0.91700 |
| Regulation of FZD by ubiquitination | 12 | 7.56e-01 | -5.19e-02 | 0.91700 |
| RAF-independent MAPK1/3 activation | 19 | 7.56e-01 | -4.12e-02 | 0.91700 |
| Nucleotide salvage | 18 | 7.57e-01 | -4.22e-02 | 0.91700 |
| Cell junction organization | 22 | 7.59e-01 | 3.78e-02 | 0.91800 |
| NR1H2 and NR1H3-mediated signaling | 24 | 7.60e-01 | -3.61e-02 | 0.91800 |
| Uptake and actions of bacterial toxins | 18 | 7.60e-01 | 4.16e-02 | 0.91800 |
| Insulin receptor signalling cascade | 25 | 7.65e-01 | -3.45e-02 | 0.92300 |
| Toll Like Receptor 9 (TLR9) Cascade | 64 | 7.70e-01 | 2.12e-02 | 0.92800 |
| Glucose metabolism | 69 | 7.71e-01 | 2.03e-02 | 0.92800 |
| Downstream TCR signaling | 69 | 7.72e-01 | 2.02e-02 | 0.92800 |
| PCNA-Dependent Long Patch Base Excision Repair | 18 | 7.73e-01 | -3.94e-02 | 0.92800 |
| Signaling by FGFR3 | 25 | 7.74e-01 | 3.31e-02 | 0.92800 |
| Oncogenic MAPK signaling | 54 | 7.75e-01 | -2.25e-02 | 0.92800 |
| Ovarian tumor domain proteases | 28 | 7.75e-01 | 3.12e-02 | 0.92800 |
| Synaptic adhesion-like molecules | 10 | 7.76e-01 | -5.21e-02 | 0.92800 |
| TAK1 activates NFkB by phosphorylation and activation of IKKs complex | 16 | 7.77e-01 | -4.10e-02 | 0.92800 |
| Signaling by FGFR2 IIIa TM | 14 | 7.80e-01 | 4.32e-02 | 0.93100 |
| Peptide hormone metabolism | 23 | 7.82e-01 | -3.34e-02 | 0.93100 |
| Diseases of mitotic cell cycle | 30 | 7.82e-01 | 2.92e-02 | 0.93100 |
| Regulation of TP53 Activity | 130 | 7.83e-01 | 1.40e-02 | 0.93200 |
| NOTCH1 Intracellular Domain Regulates Transcription | 37 | 7.84e-01 | -2.61e-02 | 0.93200 |
| SUMOylation of intracellular receptors | 19 | 7.85e-01 | 3.62e-02 | 0.93200 |
| Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | 21 | 7.87e-01 | 3.41e-02 | 0.93200 |
| Defects in vitamin and cofactor metabolism | 16 | 7.87e-01 | 3.91e-02 | 0.93200 |
| RUNX2 regulates osteoblast differentiation | 13 | 7.89e-01 | 4.30e-02 | 0.93300 |
| Early Phase of HIV Life Cycle | 13 | 7.89e-01 | -4.29e-02 | 0.93300 |
| RNA Polymerase III Transcription Initiation From Type 3 Promoter | 25 | 7.91e-01 | 3.06e-02 | 0.93500 |
| Peroxisomal protein import | 45 | 7.93e-01 | 2.26e-02 | 0.93500 |
| G2/M DNA damage checkpoint | 51 | 7.94e-01 | -2.11e-02 | 0.93500 |
| RHOBTB2 GTPase cycle | 19 | 7.95e-01 | -3.45e-02 | 0.93500 |
| RAC1 GTPase cycle | 102 | 7.95e-01 | 1.49e-02 | 0.93500 |
| NOTCH3 Intracellular Domain Regulates Transcription | 15 | 7.95e-01 | -3.87e-02 | 0.93500 |
| FOXO-mediated transcription of cell death genes | 14 | 7.97e-01 | 3.97e-02 | 0.93600 |
| Diseases of metabolism | 119 | 8.05e-01 | 1.32e-02 | 0.94200 |
| RNA Polymerase III Transcription Initiation | 32 | 8.05e-01 | 2.52e-02 | 0.94200 |
| Epigenetic regulation of gene expression | 70 | 8.08e-01 | 1.68e-02 | 0.94200 |
| RNA Polymerase I Promoter Clearance | 42 | 8.09e-01 | -2.16e-02 | 0.94200 |
| RNA Polymerase I Transcription | 42 | 8.09e-01 | -2.16e-02 | 0.94200 |
| TP53 Regulates Transcription of Cell Cycle Genes | 40 | 8.10e-01 | 2.20e-02 | 0.94200 |
| Interleukin receptor SHC signaling | 15 | 8.11e-01 | -3.58e-02 | 0.94200 |
| Regulation of signaling by CBL | 14 | 8.11e-01 | 3.69e-02 | 0.94200 |
| IRE1alpha activates chaperones | 37 | 8.11e-01 | 2.27e-02 | 0.94200 |
| Negative regulation of MET activity | 16 | 8.11e-01 | 3.45e-02 | 0.94200 |
| Recycling pathway of L1 | 15 | 8.12e-01 | -3.56e-02 | 0.94200 |
| mTORC1-mediated signalling | 17 | 8.13e-01 | -3.31e-02 | 0.94300 |
| Circadian Clock | 50 | 8.15e-01 | -1.91e-02 | 0.94300 |
| Sphingolipid metabolism | 43 | 8.17e-01 | 2.04e-02 | 0.94300 |
| SARS-CoV Infections | 109 | 8.18e-01 | 1.28e-02 | 0.94300 |
| Transcriptional Regulation by E2F6 | 28 | 8.18e-01 | -2.52e-02 | 0.94300 |
| FGFR2 alternative splicing | 21 | 8.18e-01 | 2.90e-02 | 0.94300 |
| Inactivation, recovery and regulation of the phototransduction cascade | 16 | 8.20e-01 | -3.28e-02 | 0.94300 |
| The phototransduction cascade | 16 | 8.20e-01 | -3.28e-02 | 0.94300 |
| Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins. | 72 | 8.21e-01 | 1.54e-02 | 0.94300 |
| FGFR2 mutant receptor activation | 15 | 8.22e-01 | 3.36e-02 | 0.94300 |
| Pre-NOTCH Expression and Processing | 40 | 8.23e-01 | 2.05e-02 | 0.94300 |
| Post-chaperonin tubulin folding pathway | 12 | 8.23e-01 | 3.74e-02 | 0.94300 |
| Transcriptional Regulation by MECP2 | 28 | 8.25e-01 | -2.42e-02 | 0.94400 |
| TP53 Regulates Transcription of Cell Death Genes | 29 | 8.25e-01 | -2.38e-02 | 0.94400 |
| Signaling by cytosolic FGFR1 fusion mutants | 16 | 8.26e-01 | -3.18e-02 | 0.94400 |
| Aggrephagy | 19 | 8.27e-01 | 2.90e-02 | 0.94400 |
| RORA activates gene expression | 10 | 8.29e-01 | 3.95e-02 | 0.94600 |
| RNA Polymerase III Abortive And Retractive Initiation | 36 | 8.32e-01 | 2.05e-02 | 0.94700 |
| RNA Polymerase III Transcription | 36 | 8.32e-01 | 2.05e-02 | 0.94700 |
| Insulin processing | 14 | 8.35e-01 | -3.21e-02 | 0.94900 |
| O-linked glycosylation | 39 | 8.35e-01 | 1.93e-02 | 0.94900 |
| Chromosome Maintenance | 71 | 8.36e-01 | -1.42e-02 | 0.94900 |
| Transport of inorganic cations/anions and amino acids/oligopeptides | 37 | 8.37e-01 | -1.96e-02 | 0.94900 |
| Beta-catenin phosphorylation cascade | 15 | 8.37e-01 | 3.06e-02 | 0.94900 |
| Platelet sensitization by LDL | 13 | 8.40e-01 | 3.24e-02 | 0.95100 |
| CLEC7A (Dectin-1) signaling | 81 | 8.42e-01 | -1.28e-02 | 0.95300 |
| TCR signaling | 84 | 8.43e-01 | -1.25e-02 | 0.95300 |
| Aberrant regulation of mitotic cell cycle due to RB1 defects | 29 | 8.46e-01 | 2.09e-02 | 0.95400 |
| RAC2 GTPase cycle | 52 | 8.46e-01 | 1.56e-02 | 0.95400 |
| Fc epsilon receptor (FCERI) signaling | 103 | 8.50e-01 | -1.08e-02 | 0.95700 |
| Interleukin-6 signaling | 10 | 8.51e-01 | -3.43e-02 | 0.95800 |
| Regulation of MECP2 expression and activity | 20 | 8.53e-01 | -2.40e-02 | 0.95900 |
| C-type lectin receptors (CLRs) | 97 | 8.54e-01 | -1.08e-02 | 0.95900 |
| NOTCH4 Intracellular Domain Regulates Transcription | 14 | 8.55e-01 | -2.82e-02 | 0.95900 |
| Cellular Senescence | 99 | 8.60e-01 | -1.03e-02 | 0.96100 |
| Caspase activation via extrinsic apoptotic signalling pathway | 15 | 8.61e-01 | -2.62e-02 | 0.96100 |
| HIV elongation arrest and recovery | 21 | 8.63e-01 | -2.18e-02 | 0.96100 |
| Pausing and recovery of HIV elongation | 21 | 8.63e-01 | -2.18e-02 | 0.96100 |
| Pausing and recovery of Tat-mediated HIV elongation | 21 | 8.63e-01 | -2.18e-02 | 0.96100 |
| Tat-mediated HIV elongation arrest and recovery | 21 | 8.63e-01 | -2.18e-02 | 0.96100 |
| Signaling by Rho GTPases | 413 | 8.64e-01 | 4.99e-03 | 0.96100 |
| SUMOylation of RNA binding proteins | 40 | 8.64e-01 | -1.57e-02 | 0.96100 |
| EGFR downregulation | 20 | 8.65e-01 | -2.20e-02 | 0.96200 |
| Disease | 900 | 8.68e-01 | -3.35e-03 | 0.96200 |
| SUMOylation of transcription cofactors | 35 | 8.69e-01 | -1.61e-02 | 0.96200 |
| Abortive elongation of HIV-1 transcript in the absence of Tat | 17 | 8.69e-01 | 2.31e-02 | 0.96200 |
| Cyclin D associated events in G1 | 40 | 8.70e-01 | 1.50e-02 | 0.96200 |
| G1 Phase | 40 | 8.70e-01 | 1.50e-02 | 0.96200 |
| Estrogen-dependent gene expression | 64 | 8.70e-01 | 1.18e-02 | 0.96200 |
| RNA Polymerase III Transcription Initiation From Type 2 Promoter | 23 | 8.71e-01 | 1.95e-02 | 0.96300 |
| Leading Strand Synthesis | 12 | 8.74e-01 | -2.65e-02 | 0.96300 |
| Polymerase switching | 12 | 8.74e-01 | -2.65e-02 | 0.96300 |
| Assembly of collagen fibrils and other multimeric structures | 10 | 8.76e-01 | -2.86e-02 | 0.96400 |
| tRNA modification in the nucleus and cytosol | 28 | 8.78e-01 | -1.68e-02 | 0.96600 |
| TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | 61 | 8.79e-01 | -1.13e-02 | 0.96700 |
| Golgi-to-ER retrograde transport | 91 | 8.81e-01 | 9.14e-03 | 0.96700 |
| Nuclear Receptor transcription pathway | 26 | 8.82e-01 | 1.69e-02 | 0.96700 |
| Resolution of AP sites via the multiple-nucleotide patch replacement pathway | 20 | 8.83e-01 | 1.91e-02 | 0.96800 |
| Inwardly rectifying K+ channels | 10 | 8.84e-01 | -2.67e-02 | 0.96800 |
| PINK1-PRKN Mediated Mitophagy | 20 | 8.86e-01 | -1.85e-02 | 0.96900 |
| Interleukin-15 signaling | 11 | 8.87e-01 | -2.49e-02 | 0.96900 |
| Interleukin-10 signaling | 13 | 8.89e-01 | -2.24e-02 | 0.96900 |
| Interleukin-20 family signaling | 13 | 8.89e-01 | -2.24e-02 | 0.96900 |
| PIWI-interacting RNA (piRNA) biogenesis | 14 | 8.89e-01 | -2.15e-02 | 0.96900 |
| Diseases of carbohydrate metabolism | 22 | 8.94e-01 | 1.64e-02 | 0.97300 |
| Metabolism of porphyrins | 15 | 8.96e-01 | -1.96e-02 | 0.97300 |
| RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known | 32 | 8.96e-01 | 1.34e-02 | 0.97300 |
| Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | 28 | 9.00e-01 | 1.38e-02 | 0.97600 |
| Synthesis of active ubiquitin: roles of E1 and E2 enzymes | 25 | 9.00e-01 | 1.45e-02 | 0.97600 |
| Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | 34 | 9.00e-01 | -1.24e-02 | 0.97600 |
| G-protein activation | 10 | 9.02e-01 | 2.25e-02 | 0.97600 |
| Signaling by PDGFR in disease | 15 | 9.02e-01 | -1.83e-02 | 0.97600 |
| Generic Transcription Pathway | 771 | 9.04e-01 | -2.62e-03 | 0.97600 |
| Sensory processing of sound | 24 | 9.06e-01 | 1.40e-02 | 0.97700 |
| Sensory processing of sound by inner hair cells of the cochlea | 24 | 9.06e-01 | 1.40e-02 | 0.97700 |
| Diseases associated with N-glycosylation of proteins | 15 | 9.07e-01 | -1.73e-02 | 0.97700 |
| Insertion of tail-anchored proteins into the endoplasmic reticulum membrane | 13 | 9.08e-01 | 1.85e-02 | 0.97700 |
| Potassium Channels | 23 | 9.09e-01 | -1.38e-02 | 0.97700 |
| RHOJ GTPase cycle | 34 | 9.13e-01 | -1.09e-02 | 0.97900 |
| Recruitment of NuMA to mitotic centrosomes | 55 | 9.13e-01 | 8.57e-03 | 0.97900 |
| PERK regulates gene expression | 25 | 9.13e-01 | -1.26e-02 | 0.97900 |
| Frs2-mediated activation | 11 | 9.19e-01 | -1.78e-02 | 0.98200 |
| TRAF6 mediated NF-kB activation | 17 | 9.19e-01 | 1.42e-02 | 0.98200 |
| Glucagon-type ligand receptors | 11 | 9.19e-01 | -1.76e-02 | 0.98200 |
| Chromatin modifying enzymes | 137 | 9.20e-01 | -4.96e-03 | 0.98200 |
| Chromatin organization | 137 | 9.20e-01 | -4.96e-03 | 0.98200 |
| E3 ubiquitin ligases ubiquitinate target proteins | 39 | 9.21e-01 | -9.19e-03 | 0.98200 |
| DNA Damage/Telomere Stress Induced Senescence | 24 | 9.25e-01 | -1.11e-02 | 0.98400 |
| Signal amplification | 17 | 9.25e-01 | -1.32e-02 | 0.98400 |
| Organelle biogenesis and maintenance | 184 | 9.25e-01 | 4.03e-03 | 0.98400 |
| Prolonged ERK activation events | 13 | 9.27e-01 | 1.47e-02 | 0.98500 |
| MAP kinase activation | 46 | 9.30e-01 | -7.46e-03 | 0.98700 |
| Ca2+ pathway | 34 | 9.31e-01 | -8.64e-03 | 0.98700 |
| RUNX3 regulates p14-ARF | 10 | 9.32e-01 | 1.57e-02 | 0.98700 |
| Inactivation of CSF3 (G-CSF) signaling | 20 | 9.33e-01 | -1.09e-02 | 0.98700 |
| Transport to the Golgi and subsequent modification | 124 | 9.34e-01 | 4.30e-03 | 0.98800 |
| Interleukin-12 signaling | 35 | 9.36e-01 | -7.87e-03 | 0.98800 |
| Downregulation of TGF-beta receptor signaling | 25 | 9.38e-01 | 9.05e-03 | 0.98800 |
| Signaling by FGFR1 | 27 | 9.41e-01 | -8.23e-03 | 0.98800 |
| HSP90 chaperone cycle for steroid hormone receptors (SHR) | 32 | 9.41e-01 | 7.54e-03 | 0.98800 |
| G beta:gamma signalling through PI3Kgamma | 14 | 9.42e-01 | -1.13e-02 | 0.98800 |
| Metabolism of cofactors | 17 | 9.42e-01 | -1.01e-02 | 0.98800 |
| PTEN Regulation | 105 | 9.43e-01 | 4.06e-03 | 0.98800 |
| Signaling by FGFR | 50 | 9.43e-01 | -5.81e-03 | 0.98800 |
| RHO GTPase Effectors | 184 | 9.44e-01 | 3.02e-03 | 0.98800 |
| Adrenaline,noradrenaline inhibits insulin secretion | 11 | 9.44e-01 | 1.21e-02 | 0.98800 |
| Bile acid and bile salt metabolism | 14 | 9.44e-01 | 1.08e-02 | 0.98800 |
| RNA Polymerase III Transcription Termination | 20 | 9.46e-01 | -8.76e-03 | 0.98800 |
| Post-translational modification: synthesis of GPI-anchored proteins | 30 | 9.46e-01 | 7.16e-03 | 0.98800 |
| Interleukin-17 signaling | 49 | 9.46e-01 | 5.60e-03 | 0.98800 |
| Interleukin-1 family signaling | 92 | 9.49e-01 | -3.90e-03 | 0.98900 |
| Meiosis | 39 | 9.50e-01 | -5.80e-03 | 0.98900 |
| CDC42 GTPase cycle | 91 | 9.52e-01 | 3.64e-03 | 0.98900 |
| Intra-Golgi traffic | 38 | 9.53e-01 | -5.51e-03 | 0.98900 |
| Activation of kainate receptors upon glutamate binding | 14 | 9.59e-01 | -8.03e-03 | 0.98900 |
| RNA Pol II CTD phosphorylation and interaction with CE | 23 | 9.60e-01 | 6.12e-03 | 0.98900 |
| RNA Pol II CTD phosphorylation and interaction with CE during HIV infection | 23 | 9.60e-01 | 6.12e-03 | 0.98900 |
| Signal transduction by L1 | 11 | 9.60e-01 | -8.65e-03 | 0.98900 |
| Visual phototransduction | 32 | 9.61e-01 | -5.01e-03 | 0.98900 |
| RNA Polymerase III Chain Elongation | 16 | 9.64e-01 | -6.60e-03 | 0.98900 |
| Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer’s disease models | 20 | 9.65e-01 | -5.73e-03 | 0.98900 |
| Neurodegenerative Diseases | 20 | 9.65e-01 | -5.73e-03 | 0.98900 |
| Signaling by TGF-beta Receptor Complex | 59 | 9.66e-01 | -3.23e-03 | 0.98900 |
| Purine ribonucleoside monophosphate biosynthesis | 10 | 9.67e-01 | -7.61e-03 | 0.98900 |
| trans-Golgi Network Vesicle Budding | 50 | 9.67e-01 | -3.38e-03 | 0.98900 |
| N-Glycan antennae elongation | 11 | 9.67e-01 | 7.12e-03 | 0.98900 |
| MyD88 dependent cascade initiated on endosome | 62 | 9.68e-01 | 2.99e-03 | 0.98900 |
| Toll Like Receptor 7/8 (TLR7/8) Cascade | 62 | 9.68e-01 | 2.99e-03 | 0.98900 |
| Signaling by Rho GTPases, Miro GTPases and RHOBTB3 | 425 | 9.68e-01 | 1.16e-03 | 0.98900 |
| Translocation of SLC2A4 (GLUT4) to the plasma membrane | 43 | 9.68e-01 | -3.56e-03 | 0.98900 |
| Synthesis of PA | 17 | 9.68e-01 | 5.56e-03 | 0.98900 |
| Activation of GABAB receptors | 15 | 9.68e-01 | -5.91e-03 | 0.98900 |
| GABA B receptor activation | 15 | 9.68e-01 | -5.91e-03 | 0.98900 |
| Diseases of glycosylation | 67 | 9.69e-01 | -2.79e-03 | 0.98900 |
| Reproduction | 43 | 9.69e-01 | -3.45e-03 | 0.98900 |
| Signaling by the B Cell Receptor (BCR) | 87 | 9.71e-01 | -2.26e-03 | 0.99000 |
| MAPK targets/ Nuclear events mediated by MAP kinases | 22 | 9.72e-01 | 4.34e-03 | 0.99000 |
| RAB GEFs exchange GTP for GDP on RABs | 56 | 9.75e-01 | -2.39e-03 | 0.99200 |
| Thromboxane signalling through TP receptor | 12 | 9.76e-01 | 5.07e-03 | 0.99200 |
| CD209 (DC-SIGN) signaling | 15 | 9.77e-01 | 4.21e-03 | 0.99300 |
| Centrosome maturation | 56 | 9.80e-01 | 1.89e-03 | 0.99400 |
| Recruitment of mitotic centrosome proteins and complexes | 56 | 9.80e-01 | 1.89e-03 | 0.99400 |
| Keratan sulfate biosynthesis | 14 | 9.81e-01 | 3.71e-03 | 0.99400 |
| G alpha (12/13) signalling events | 33 | 9.82e-01 | -2.26e-03 | 0.99400 |
| FGFR1 mutant receptor activation | 19 | 9.85e-01 | -2.54e-03 | 0.99400 |
| Interleukin-35 Signalling | 11 | 9.86e-01 | 3.04e-03 | 0.99400 |
| Synthesis of PIPs at the plasma membrane | 36 | 9.87e-01 | 1.55e-03 | 0.99400 |
| Signaling by Hippo | 11 | 9.87e-01 | -2.77e-03 | 0.99400 |
| Lagging Strand Synthesis | 17 | 9.89e-01 | -2.02e-03 | 0.99400 |
| Keratan sulfate/keratin metabolism | 18 | 9.89e-01 | -1.92e-03 | 0.99400 |
| XBP1(S) activates chaperone genes | 36 | 9.89e-01 | 1.32e-03 | 0.99400 |
| RNA Polymerase III Transcription Initiation From Type 1 Promoter | 24 | 9.89e-01 | -1.62e-03 | 0.99400 |
| Neurotransmitter release cycle | 18 | 9.89e-01 | 1.83e-03 | 0.99400 |
| Interleukin-12 family signaling | 41 | 9.93e-01 | 8.49e-04 | 0.99600 |
| HCMV Infection | 67 | 9.96e-01 | -3.35e-04 | 0.99900 |
| Base Excision Repair | 38 | 9.98e-01 | 2.62e-04 | 1.00000 |
| RND1 GTPase cycle | 29 | 9.99e-01 | -1.40e-04 | 1.00000 |
| mRNA decay by 3’ to 5’ exoribonuclease | 13 | 1.00e+00 | -9.37e-05 | 1.00000 |
Metabolism of RNA
| 504 | |
|---|---|
| set | Metabolism of RNA |
| setSize | 498 |
| pANOVA | 1.38e-06 |
| s.dist | 0.128 |
| p.adjustANOVA | 0.00158 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| NCBP1 | 8402 |
| SNRPC | 8378 |
| PES1 | 8341 |
| RNU12 | 8329 |
| SNRPN | 8320 |
| GLE1 | 8318 |
| RPS25 | 8288 |
| DDX47 | 8287 |
| CWC22 | 8283 |
| TSEN54 | 8251 |
| RPS27A | 8228 |
| RCL1 | 8222 |
| SNRPD3 | 8221 |
| CNOT7 | 8204 |
| CDK7 | 8195 |
| PSMA3 | 8188 |
| RPS3 | 8185 |
| RPS6 | 8168 |
| RPS28 | 8167 |
| RNU11 | 8142 |
| GeneID | Gene Rank |
|---|---|
| NCBP1 | 8402 |
| SNRPC | 8378 |
| PES1 | 8341 |
| RNU12 | 8329 |
| SNRPN | 8320 |
| GLE1 | 8318 |
| RPS25 | 8288 |
| DDX47 | 8287 |
| CWC22 | 8283 |
| TSEN54 | 8251 |
| RPS27A | 8228 |
| RCL1 | 8222 |
| SNRPD3 | 8221 |
| CNOT7 | 8204 |
| CDK7 | 8195 |
| PSMA3 | 8188 |
| RPS3 | 8185 |
| RPS6 | 8168 |
| RPS28 | 8167 |
| RNU11 | 8142 |
| PUS3 | 8141 |
| NUP35 | 8140 |
| RPL4 | 8137 |
| PRPF3 | 8106 |
| RPSA | 8071 |
| NUP107 | 8020 |
| EIF4A2 | 8016 |
| RPS24 | 7985 |
| CSNK1E | 7983 |
| SNRPD2 | 7972 |
| GEMIN7 | 7971 |
| RPL34 | 7954 |
| GEMIN6 | 7934 |
| DNAJC8 | 7931 |
| RPL3 | 7916 |
| CDKAL1 | 7908 |
| NSUN6 | 7900 |
| WBSCR22 | 7872 |
| SF3A2 | 7866 |
| SNRNP40 | 7841 |
| EDC4 | 7800 |
| PAN2 | 7799 |
| FBL | 7793 |
| HNRNPC | 7786 |
| RPL15 | 7772 |
| NUP98 | 7764 |
| RIOK2 | 7755 |
| MNAT1 | 7743 |
| UTP20 | 7701 |
| LSM10 | 7694 |
| GAR1 | 7687 |
| TFIP11 | 7655 |
| PARN | 7647 |
| PPIL6 | 7640 |
| RPL28 | 7634 |
| RPP30 | 7603 |
| PSMB5 | 7598 |
| CHERP | 7588 |
| PRPF31 | 7586 |
| C1D | 7585 |
| BYSL | 7563 |
| WDR75 | 7541 |
| RPS20 | 7538 |
| POLR2K | 7535 |
| ELAC2 | 7506 |
| RPL38 | 7481 |
| DDX42 | 7469 |
| WDR18 | 7463 |
| RPL9 | 7462 |
| ZBTB8OS | 7434 |
| UBB | 7418 |
| UTP6 | 7403 |
| DDX52 | 7367 |
| HBS1L | 7361 |
| RAN | 7323 |
| ERCC2 | 7313 |
| SMG5 | 7295 |
| RPL41 | 7287 |
| SRRM1 | 7240 |
| CDC40 | 7236 |
| PSMC1 | 7227 |
| RPL26 | 7225 |
| SNW1 | 7224 |
| THUMPD1 | 7215 |
| POLDIP3 | 7198 |
| RPL26L1 | 7153 |
| EXOSC10 | 7129 |
| HNRNPH1 | 7063 |
| PAIP1 | 7052 |
| PSMA5 | 7049 |
| TRMU | 7048 |
| PRCC | 7046 |
| NUP62 | 7023 |
| DCP1B | 7016 |
| PSMD12 | 7015 |
| RPP14 | 7012 |
| SET | 7004 |
| SMG1 | 6991 |
| PPIL3 | 6931 |
| PCBP1 | 6928 |
| TPR | 6893 |
| RPL32 | 6861 |
| SYF2 | 6860 |
| PSME2 | 6844 |
| PSMB10 | 6829 |
| U2AF1L4 | 6821 |
| LSM6 | 6797 |
| NCBP2 | 6756 |
| PHAX | 6753 |
| NUP133 | 6710 |
| POLR2G | 6708 |
| NXF1 | 6707 |
| PABPN1 | 6672 |
| PSMB7 | 6667 |
| PAN3 | 6662 |
| SLBP | 6615 |
| DCAF13 | 6595 |
| RPL37A | 6591 |
| PSMB6 | 6558 |
| TRIT1 | 6557 |
| RPS23 | 6550 |
| PSMD11 | 6544 |
| RPL23 | 6505 |
| LSM7 | 6494 |
| FCF1 | 6479 |
| TP53RK | 6464 |
| EDC3 | 6434 |
| ZCCHC6 | 6428 |
| SF3B4 | 6419 |
| RPL37 | 6405 |
| LTV1 | 6380 |
| RPS16 | 6351 |
| WBP11 | 6347 |
| SNRPA | 6333 |
| C2orf49 | 6328 |
| SNRPA1 | 6325 |
| WDR77 | 6314 |
| DDX23 | 6302 |
| SNRPE | 6300 |
| TPRKB | 6271 |
| NUP205 | 6267 |
| THOC5 | 6249 |
| MPHOSPH6 | 6246 |
| PDCD7 | 6212 |
| SF3B5 | 6211 |
| LSM2 | 6198 |
| SMNDC1 | 6156 |
| SART1 | 6130 |
| PRMT5 | 6109 |
| EXOSC6 | 6042 |
| GTPBP3 | 6011 |
| PSMC6 | 5996 |
| RRP7A | 5962 |
| GTF2F2 | 5927 |
| EIF4A1 | 5915 |
| RPS10 | 5908 |
| IGF2BP1 | 5883 |
| POP4 | 5860 |
| YWHAZ | 5837 |
| IMP4 | 5827 |
| TBL3 | 5814 |
| UBC | 5810 |
| CNOT8 | 5785 |
| EIF4A3 | 5779 |
| NUP160 | 5658 |
| RPS18 | 5632 |
| RPL27A | 5614 |
| PABPC1 | 5582 |
| HNRNPUL1 | 5579 |
| ZFP36L1 | 5570 |
| CNOT6L | 5569 |
| RPS8 | 5562 |
| NOP10 | 5553 |
| PSMB3 | 5497 |
| QTRT1 | 5490 |
| PPP2R2A | 5472 |
| XPOT | 5466 |
| UBA52 | 5448 |
| WDR12 | 5442 |
| ALKBH8 | 5418 |
| PPIL1 | 5396 |
| PRPF19 | 5393 |
| HNRNPK | 5391 |
| ISY1 | 5327 |
| PSMD4 | 5325 |
| TNKS1BP1 | 5298 |
| POLR2B | 5291 |
| RPL29 | 5290 |
| CTNNBL1 | 5289 |
| DCPS | 5228 |
| THADA | 5184 |
| RPS29 | 5166 |
| SNRNP70 | 5116 |
| CWC15 | 5096 |
| PSMD7 | 5075 |
| POM121C | 5072 |
| PNO1 | 5053 |
| WDR43 | 5052 |
| RPL22 | 5041 |
| HNRNPU | 5008 |
| UTP15 | 4993 |
| PSMB1 | 4974 |
| ZFP36 | 4950 |
| PRPF6 | 4948 |
| POP7 | 4929 |
| ADAT1 | 4927 |
| THOC1 | 4926 |
| TRDMT1 | 4922 |
| RANBP2 | 4903 |
| CRNKL1 | 4891 |
| SNRNP27 | 4890 |
| SNRPB | 4874 |
| DCP1A | 4837 |
| NOL6 | 4802 |
| DDX20 | 4703 |
| SENP3 | 4693 |
| PSMF1 | 4670 |
| EXOSC7 | 4662 |
| PSMD1 | 4661 |
| RPS9 | 4648 |
| RPL6 | 4621 |
| RPL36 | 4617 |
| RNGTT | 4613 |
| PSMD9 | 4605 |
| SF3B2 | 4587 |
| LSM3 | 4544 |
| SYMPK | 4534 |
| USP39 | 4527 |
| RPS3A | 4514 |
| CLP1 | 4503 |
| TTC37 | 4449 |
| RPL17 | 4433 |
| SNRPG | 4428 |
| NOB1 | 4405 |
| IMP3 | 4395 |
| RPL11 | 4330 |
| XPO1 | 4303 |
| PELP1 | 4290 |
| PPIH | 4252 |
| SF3B3 | 4250 |
| PDCD11 | 4218 |
| UTP3 | 4201 |
| SUPT5H | 4179 |
| RPS27L | 4151 |
| FTSJ3 | 4146 |
| PUS7 | 4126 |
| PTBP1 | 4122 |
| PPIE | 4108 |
| XAB2 | 4099 |
| NOL12 | 4088 |
| POM121 | 4069 |
| CDC5L | 4035 |
| ERCC3 | 4023 |
| CPSF2 | 4004 |
| PSME3 | 3994 |
| THG1L | 3987 |
| CSTF1 | 3962 |
| HNRNPD | 3947 |
| HEATR1 | 3939 |
| LSM4 | 3901 |
| BMS1 | 3878 |
| EBNA1BP2 | 3873 |
| SKIV2L | 3863 |
| LSM5 | 3840 |
| POLR2C | 3775 |
| FAM98B | 3772 |
| NUP54 | 3754 |
| NSUN4 | 3736 |
| PCBP2 | 3727 |
| NUP188 | 3714 |
| TRNT1 | 3712 |
| PSMD14 | 3709 |
| RNMT | 3703 |
| SNRPB2 | 3677 |
| NUP85 | 3668 |
| NUDT21 | 3640 |
| PSMD2 | 3621 |
| SNRNP48 | 3610 |
| HNRNPM | 3606 |
| MRM1 | 3590 |
| CLNS1A | 3571 |
| POP5 | 3562 |
| RPL31 | 3555 |
| TRMT61B | 3550 |
| UPF1 | 3538 |
| EXOSC2 | 3525 |
| PRKCA | 3486 |
| SNRNP200 | 3481 |
| DDX21 | 3469 |
| EXOSC8 | 3443 |
| RPLP1 | 3408 |
| WTAP | 3380 |
| METTL1 | 3365 |
| RPS12 | 3328 |
| SF1 | 3310 |
| HSPA1A | 3274 |
| PSMA6 | 3273 |
| LSM11 | 3268 |
| SRRM2 | 3259 |
| PSMC3 | 3247 |
| NOL11 | 3213 |
| PSMB9 | 3199 |
| NUP93 | 3175 |
| ENPP2 | 3135 |
| CNOT1 | 3125 |
| NUP155 | 3101 |
| RPLP0 | 3049 |
| DDX6 | 3031 |
| RBM28 | 3026 |
| PSMD8 | 3011 |
| NXT1 | 2961 |
| CCAR1 | 2954 |
| U2AF2 | 2952 |
| TSEN15 | 2949 |
| DIS3 | 2928 |
| PSMA7 | 2927 |
| CTU1 | 2912 |
| XRN2 | 2897 |
| PPP2CA | 2847 |
| DHX9 | 2843 |
| TFB1M | 2841 |
| HNRNPL | 2831 |
| RPS26 | 2822 |
| IGF2BP3 | 2812 |
| PPIL4 | 2797 |
| SLU7 | 2793 |
| U2AF1 | 2776 |
| RNPC3 | 2772 |
| POLR2E | 2768 |
| CASC3 | 2750 |
| GEMIN5 | 2733 |
| GTF2H4 | 2685 |
| EIF4B | 2671 |
| RPS19 | 2666 |
| PSMD13 | 2662 |
| NOP14 | 2648 |
| TRMT11 | 2642 |
| WDR61 | 2635 |
| NUP43 | 2582 |
| MAPKAPK2 | 2575 |
| PRPF38A | 2573 |
| PSMD3 | 2545 |
| UPF2 | 2503 |
| PSMC5 | 2470 |
| TNPO1 | 2469 |
| AQR | 2428 |
| SNRNP25 | 2423 |
| PSMD6 | 2403 |
| RIOK1 | 2384 |
| LSM1 | 2373 |
| RPS7 | 2356 |
| HNRNPA2B1 | 2348 |
| DHX16 | 2330 |
| CD2BP2 | 2299 |
| RAE1 | 2287 |
| NUP214 | 2228 |
| RPL14 | 2209 |
| RPS11 | 2201 |
| RNPS1 | 2173 |
| UPF3A | 2172 |
| YBX1 | 2163 |
| RPL18 | 2150 |
| RPL7 | 2139 |
| PSMC4 | 2130 |
| WDR36 | 2073 |
| SF3A3 | 2044 |
| GSPT1 | 2009 |
| NUP210 | 2001 |
| ADAT2 | 1991 |
| CNOT3 | 1955 |
| NUP50 | 1921 |
| ADAT3 | 1906 |
| RPL35 | 1903 |
| EIF4G1 | 1882 |
| ZCCHC11 | 1872 |
| PSMA1 | 1855 |
| PRPF8 | 1852 |
| GTF2F1 | 1836 |
| AAAS | 1828 |
| RPP21 | 1823 |
| CNOT4 | 1813 |
| PLRG1 | 1766 |
| DDX1 | 1753 |
| NOP56 | 1724 |
| LCMT2 | 1719 |
| NUP153 | 1709 |
| TRMT1 | 1695 |
| MAPK14 | 1668 |
| PAPOLA | 1653 |
| DCP2 | 1533 |
| SMG7 | 1498 |
| WDR33 | 1490 |
| TRMT61A | 1453 |
| RPLP2 | 1447 |
| WDR3 | 1443 |
| NUP37 | 1438 |
| PSMA2 | 1432 |
| TSR1 | 1421 |
| URM1 | 1362 |
| SNRPD1 | 1350 |
| NOP58 | 1322 |
| EXOSC4 | 1277 |
| RRP1 | 1248 |
| RPS5 | 1210 |
| RIOK3 | 1192 |
| HNRNPF | 1175 |
| SNUPN | 1170 |
| ADAR | 1168 |
| TEX10 | 1160 |
| BUD31 | 1158 |
| RPS15 | 1135 |
| POLR2A | 1117 |
| CSNK1D | 1107 |
| RPL23A | 1098 |
| MPHOSPH10 | 1092 |
| CD44 | 1077 |
| HNRNPA0 | 1046 |
| RRP9 | 1022 |
| GTF2H3 | 1021 |
| POLR2H | 1005 |
| CNOT10 | 1000 |
| ISG20L2 | 997 |
| RPP25 | 991 |
| NOP2 | 904 |
| CCNH | 888 |
| NCL | 872 |
| SEH1L | 844 |
| RPP38 | 823 |
| NIP7 | 820 |
| DDX5 | 765 |
| PSMB8 | 756 |
| ADARB1 | 722 |
| POLR2I | 691 |
| DHX37 | 689 |
| NOC4L | 665 |
| ANP32A | 658 |
| FUS | 646 |
| CNOT6 | 634 |
| NSUN2 | 618 |
| PWP2 | 608 |
| PATL1 | 604 |
| FIP1L1 | 598 |
| MTO1 | 594 |
| KHSRP | 558 |
| TRMT12 | 551 |
| YWHAB | 506 |
| EXOSC3 | 501 |
| DDX46 | 489 |
| RPL39L | 485 |
| EFTUD2 | 371 |
| TNFSF13 | 367 |
| RPL13 | 339 |
| POLR2F | 337 |
| FYTTD1 | 314 |
| NHP2 | 301 |
| TYW1 | 284 |
| TYW3 | 244 |
| FAU | 233 |
| GNL3 | 216 |
| PSME1 | 209 |
| PSME4 | 207 |
| HSPB1 | 159 |
| PPWD1 | 143 |
| PNRC2 | 96 |
| RPS15A | 72 |
| CPSF4 | 65 |
| METTL14 | 62 |
| SNRNP35 | -6 |
| ETF1 | -25 |
| GTF2H5 | -35 |
| PUF60 | -56 |
| TXNL4A | -98 |
| SF3A1 | -202 |
| HNRNPR | -218 |
| POLR2D | -240 |
| POP1 | -251 |
| CPSF1 | -275 |
| RPL8 | -295 |
| ACTB | -298 |
| RBM17 | -372 |
| DDX49 | -412 |
| RPP40 | -457 |
| EXOSC5 | -485 |
| SEC13 | -516 |
| RPL10A | -562 |
| EIF4E | -590 |
| TSEN2 | -657 |
| WBP4 | -845 |
| ERI1 | -851 |
| PRKCD | -938 |
| CPSF3 | -995 |
| SRRT | -999 |
| AKT1 | -1052 |
| RPL36AL | -1188 |
| PUS1 | -1191 |
| THOC7 | -1303 |
| CTU2 | -1305 |
| ZMAT5 | -1367 |
Mitotic Metaphase and Anaphase
| 542 | |
|---|---|
| set | Mitotic Metaphase and Anaphase |
| setSize | 186 |
| pANOVA | 8.41e-05 |
| s.dist | 0.168 |
| p.adjustANOVA | 0.038 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| ZWILCH | 8324 |
| CDC23 | 8244 |
| RPS27A | 8228 |
| PSMA3 | 8188 |
| NUP35 | 8140 |
| SKA2 | 8095 |
| SPC25 | 8021 |
| NUP107 | 8020 |
| VRK2 | 8002 |
| TUBA1A | 7982 |
| ITGB3BP | 7906 |
| KIF2A | 7884 |
| PPP2R1B | 7877 |
| CCNB2 | 7856 |
| NUP98 | 7764 |
| CHMP6 | 7662 |
| PSMB5 | 7598 |
| TUBA4A | 7569 |
| BANF1 | 7554 |
| UBB | 7418 |
| GeneID | Gene Rank |
|---|---|
| ZWILCH | 8324 |
| CDC23 | 8244 |
| RPS27A | 8228 |
| PSMA3 | 8188 |
| NUP35 | 8140 |
| SKA2 | 8095 |
| SPC25 | 8021 |
| NUP107 | 8020 |
| VRK2 | 8002 |
| TUBA1A | 7982 |
| ITGB3BP | 7906 |
| KIF2A | 7884 |
| PPP2R1B | 7877 |
| CCNB2 | 7856 |
| NUP98 | 7764 |
| CHMP6 | 7662 |
| PSMB5 | 7598 |
| TUBA4A | 7569 |
| BANF1 | 7554 |
| UBB | 7418 |
| PTTG1 | 7353 |
| RAD21 | 7352 |
| RANGAP1 | 7332 |
| CENPK | 7331 |
| RAN | 7323 |
| ANAPC7 | 7272 |
| PSMC1 | 7227 |
| CDCA8 | 7190 |
| KNTC1 | 7127 |
| PSMA5 | 7049 |
| NUP62 | 7023 |
| PSMD12 | 7015 |
| CENPH | 7000 |
| NUF2 | 6976 |
| BUB1B | 6952 |
| PPP2R5E | 6882 |
| MAD2L1 | 6862 |
| PSME2 | 6844 |
| PSMB10 | 6829 |
| LEMD2 | 6806 |
| MAPRE1 | 6750 |
| NUP133 | 6710 |
| CHMP4B | 6687 |
| FBXO5 | 6669 |
| PSMB7 | 6667 |
| CDC20 | 6613 |
| BUB3 | 6580 |
| PSMB6 | 6558 |
| PSMD11 | 6544 |
| SMC3 | 6498 |
| CHMP2A | 6470 |
| ANAPC10 | 6447 |
| VRK1 | 6441 |
| CLASP2 | 6396 |
| PPP2R5D | 6390 |
| UBE2C | 6275 |
| NUP205 | 6267 |
| NSL1 | 6255 |
| CENPO | 6228 |
| SUMO1 | 6159 |
| ANAPC5 | 6000 |
| PSMC6 | 5996 |
| KIF2C | 5934 |
| ZWINT | 5868 |
| UBC | 5810 |
| CENPE | 5698 |
| NUP160 | 5658 |
| AHCTF1 | 5566 |
| PSMB3 | 5497 |
| PPP2R2A | 5472 |
| NDE1 | 5467 |
| ESPL1 | 5459 |
| UBA52 | 5448 |
| PSMD4 | 5325 |
| TUBA1C | 5273 |
| CLASP1 | 5253 |
| BIRC5 | 5224 |
| ANAPC1 | 5142 |
| STAG1 | 5087 |
| PSMD7 | 5075 |
| PSMB1 | 4974 |
| DYNLL2 | 4965 |
| RANBP2 | 4903 |
| AURKB | 4882 |
| CENPM | 4808 |
| RCC1 | 4803 |
| LMNA | 4679 |
| ZW10 | 4675 |
| PSMF1 | 4670 |
| PSMD1 | 4661 |
| CENPF | 4636 |
| VPS4A | 4622 |
| CENPQ | 4612 |
| PSMD9 | 4605 |
| ANAPC4 | 4531 |
| CHMP2B | 4483 |
| PPP2R5B | 4371 |
| XPO1 | 4303 |
| ANAPC11 | 4297 |
| SPC24 | 4230 |
| TMPO | 4115 |
| POM121 | 4069 |
| INCENP | 4041 |
| LMNB1 | 4000 |
| PSME3 | 3994 |
| NDC80 | 3903 |
| SIRT2 | 3829 |
| TUBB2A | 3793 |
| CENPL | 3755 |
| NUP54 | 3754 |
| LEMD3 | 3740 |
| NUP188 | 3714 |
| PSMD14 | 3709 |
| NUP85 | 3668 |
| PSMD2 | 3621 |
| PMF1 | 3508 |
| CDCA5 | 3307 |
| PSMA6 | 3273 |
| PSMC3 | 3247 |
| PSMB9 | 3199 |
| TUBA1B | 3184 |
| NUP93 | 3175 |
| BUB1 | 3149 |
| PPP1CC | 3143 |
| NUP155 | 3101 |
| PPP2R5A | 3085 |
| UBE2E1 | 3040 |
| PSMD8 | 3011 |
| PSMA7 | 2927 |
| CC2D1B | 2926 |
| PLK1 | 2868 |
| PPP2CA | 2847 |
| CDC16 | 2815 |
| CHMP4A | 2746 |
| PSMD13 | 2662 |
| CENPN | 2589 |
| NUP43 | 2582 |
| DSN1 | 2568 |
| CDK1 | 2546 |
| PSMD3 | 2545 |
| PSMC5 | 2470 |
| TNPO1 | 2469 |
| PSMD6 | 2403 |
| DYNC1I2 | 2184 |
| PSMC4 | 2130 |
| B9D2 | 2128 |
| PPP2R5C | 2104 |
| UBE2D1 | 1866 |
| PSMA1 | 1855 |
| TAOK1 | 1847 |
| CHMP7 | 1840 |
| LBR | 1829 |
| DYNC1LI1 | 1660 |
| SPAST | 1651 |
| NUDC | 1526 |
| NUP37 | 1438 |
| PSMA2 | 1432 |
| CKAP5 | 1363 |
| KIF18A | 1274 |
| MAD1L1 | 1233 |
| RCC2 | 1194 |
| DYNC1LI2 | 881 |
| SEH1L | 844 |
| PSMB8 | 756 |
| PAFAH1B1 | 687 |
| DYNLL1 | 677 |
| DYNC1H1 | 425 |
| KPNB1 | 363 |
| CENPT | 313 |
| PSME1 | 209 |
| PSME4 | 207 |
| PDS5A | 166 |
| MIS12 | 137 |
| UBE2I | -28 |
| NDEL1 | -63 |
| CENPA | -64 |
| ANAPC2 | -135 |
| CLIP1 | -399 |
| CENPP | -475 |
| SEC13 | -516 |
| TUBA4B | -578 |
| PDS5B | -583 |
| PPP2CB | -624 |
| ANKLE2 | -905 |
| CCNB1 | -1067 |
| APITD1 | -1142 |
Mitotic Anaphase
| 539 | |
|---|---|
| set | Mitotic Anaphase |
| setSize | 185 |
| pANOVA | 0.000113 |
| s.dist | 0.165 |
| p.adjustANOVA | 0.038 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| ZWILCH | 8324 |
| CDC23 | 8244 |
| RPS27A | 8228 |
| PSMA3 | 8188 |
| NUP35 | 8140 |
| SKA2 | 8095 |
| SPC25 | 8021 |
| NUP107 | 8020 |
| VRK2 | 8002 |
| TUBA1A | 7982 |
| ITGB3BP | 7906 |
| KIF2A | 7884 |
| PPP2R1B | 7877 |
| CCNB2 | 7856 |
| NUP98 | 7764 |
| CHMP6 | 7662 |
| PSMB5 | 7598 |
| TUBA4A | 7569 |
| BANF1 | 7554 |
| UBB | 7418 |
| GeneID | Gene Rank |
|---|---|
| ZWILCH | 8324 |
| CDC23 | 8244 |
| RPS27A | 8228 |
| PSMA3 | 8188 |
| NUP35 | 8140 |
| SKA2 | 8095 |
| SPC25 | 8021 |
| NUP107 | 8020 |
| VRK2 | 8002 |
| TUBA1A | 7982 |
| ITGB3BP | 7906 |
| KIF2A | 7884 |
| PPP2R1B | 7877 |
| CCNB2 | 7856 |
| NUP98 | 7764 |
| CHMP6 | 7662 |
| PSMB5 | 7598 |
| TUBA4A | 7569 |
| BANF1 | 7554 |
| UBB | 7418 |
| PTTG1 | 7353 |
| RAD21 | 7352 |
| RANGAP1 | 7332 |
| CENPK | 7331 |
| RAN | 7323 |
| ANAPC7 | 7272 |
| PSMC1 | 7227 |
| CDCA8 | 7190 |
| KNTC1 | 7127 |
| PSMA5 | 7049 |
| NUP62 | 7023 |
| PSMD12 | 7015 |
| CENPH | 7000 |
| NUF2 | 6976 |
| BUB1B | 6952 |
| PPP2R5E | 6882 |
| MAD2L1 | 6862 |
| PSME2 | 6844 |
| PSMB10 | 6829 |
| LEMD2 | 6806 |
| MAPRE1 | 6750 |
| NUP133 | 6710 |
| CHMP4B | 6687 |
| PSMB7 | 6667 |
| CDC20 | 6613 |
| BUB3 | 6580 |
| PSMB6 | 6558 |
| PSMD11 | 6544 |
| SMC3 | 6498 |
| CHMP2A | 6470 |
| ANAPC10 | 6447 |
| VRK1 | 6441 |
| CLASP2 | 6396 |
| PPP2R5D | 6390 |
| UBE2C | 6275 |
| NUP205 | 6267 |
| NSL1 | 6255 |
| CENPO | 6228 |
| SUMO1 | 6159 |
| ANAPC5 | 6000 |
| PSMC6 | 5996 |
| KIF2C | 5934 |
| ZWINT | 5868 |
| UBC | 5810 |
| CENPE | 5698 |
| NUP160 | 5658 |
| AHCTF1 | 5566 |
| PSMB3 | 5497 |
| PPP2R2A | 5472 |
| NDE1 | 5467 |
| ESPL1 | 5459 |
| UBA52 | 5448 |
| PSMD4 | 5325 |
| TUBA1C | 5273 |
| CLASP1 | 5253 |
| BIRC5 | 5224 |
| ANAPC1 | 5142 |
| STAG1 | 5087 |
| PSMD7 | 5075 |
| PSMB1 | 4974 |
| DYNLL2 | 4965 |
| RANBP2 | 4903 |
| AURKB | 4882 |
| CENPM | 4808 |
| RCC1 | 4803 |
| LMNA | 4679 |
| ZW10 | 4675 |
| PSMF1 | 4670 |
| PSMD1 | 4661 |
| CENPF | 4636 |
| VPS4A | 4622 |
| CENPQ | 4612 |
| PSMD9 | 4605 |
| ANAPC4 | 4531 |
| CHMP2B | 4483 |
| PPP2R5B | 4371 |
| XPO1 | 4303 |
| ANAPC11 | 4297 |
| SPC24 | 4230 |
| TMPO | 4115 |
| POM121 | 4069 |
| INCENP | 4041 |
| LMNB1 | 4000 |
| PSME3 | 3994 |
| NDC80 | 3903 |
| SIRT2 | 3829 |
| TUBB2A | 3793 |
| CENPL | 3755 |
| NUP54 | 3754 |
| LEMD3 | 3740 |
| NUP188 | 3714 |
| PSMD14 | 3709 |
| NUP85 | 3668 |
| PSMD2 | 3621 |
| PMF1 | 3508 |
| CDCA5 | 3307 |
| PSMA6 | 3273 |
| PSMC3 | 3247 |
| PSMB9 | 3199 |
| TUBA1B | 3184 |
| NUP93 | 3175 |
| BUB1 | 3149 |
| PPP1CC | 3143 |
| NUP155 | 3101 |
| PPP2R5A | 3085 |
| UBE2E1 | 3040 |
| PSMD8 | 3011 |
| PSMA7 | 2927 |
| CC2D1B | 2926 |
| PLK1 | 2868 |
| PPP2CA | 2847 |
| CDC16 | 2815 |
| CHMP4A | 2746 |
| PSMD13 | 2662 |
| CENPN | 2589 |
| NUP43 | 2582 |
| DSN1 | 2568 |
| CDK1 | 2546 |
| PSMD3 | 2545 |
| PSMC5 | 2470 |
| TNPO1 | 2469 |
| PSMD6 | 2403 |
| DYNC1I2 | 2184 |
| PSMC4 | 2130 |
| B9D2 | 2128 |
| PPP2R5C | 2104 |
| UBE2D1 | 1866 |
| PSMA1 | 1855 |
| TAOK1 | 1847 |
| CHMP7 | 1840 |
| LBR | 1829 |
| DYNC1LI1 | 1660 |
| SPAST | 1651 |
| NUDC | 1526 |
| NUP37 | 1438 |
| PSMA2 | 1432 |
| CKAP5 | 1363 |
| KIF18A | 1274 |
| MAD1L1 | 1233 |
| RCC2 | 1194 |
| DYNC1LI2 | 881 |
| SEH1L | 844 |
| PSMB8 | 756 |
| PAFAH1B1 | 687 |
| DYNLL1 | 677 |
| DYNC1H1 | 425 |
| KPNB1 | 363 |
| CENPT | 313 |
| PSME1 | 209 |
| PSME4 | 207 |
| PDS5A | 166 |
| MIS12 | 137 |
| UBE2I | -28 |
| NDEL1 | -63 |
| CENPA | -64 |
| ANAPC2 | -135 |
| CLIP1 | -399 |
| CENPP | -475 |
| SEC13 | -516 |
| TUBA4B | -578 |
| PDS5B | -583 |
| PPP2CB | -624 |
| ANKLE2 | -905 |
| CCNB1 | -1067 |
| APITD1 | -1142 |
Translation
| 1066 | |
|---|---|
| set | Translation |
| setSize | 225 |
| pANOVA | 0.000133 |
| s.dist | 0.149 |
| p.adjustANOVA | 0.038 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| EIF4H | 8386 |
| TARS2 | 8362 |
| RPS25 | 8288 |
| RPS27A | 8228 |
| MRPL47 | 8226 |
| AURKAIP1 | 8219 |
| SSR2 | 8207 |
| RPS3 | 8185 |
| RPS6 | 8168 |
| RPS28 | 8167 |
| RPL4 | 8137 |
| OXA1L | 8131 |
| MRPS21 | 8122 |
| PTCD3 | 8109 |
| RPSA | 8071 |
| MRPL30 | 8047 |
| MRPL19 | 8025 |
| EIF4A2 | 8016 |
| MRPS33 | 7992 |
| RPS24 | 7985 |
| GeneID | Gene Rank |
|---|---|
| EIF4H | 8386 |
| TARS2 | 8362 |
| RPS25 | 8288 |
| RPS27A | 8228 |
| MRPL47 | 8226 |
| AURKAIP1 | 8219 |
| SSR2 | 8207 |
| RPS3 | 8185 |
| RPS6 | 8168 |
| RPS28 | 8167 |
| RPL4 | 8137 |
| OXA1L | 8131 |
| MRPS21 | 8122 |
| PTCD3 | 8109 |
| RPSA | 8071 |
| MRPL30 | 8047 |
| MRPL19 | 8025 |
| EIF4A2 | 8016 |
| MRPS33 | 7992 |
| RPS24 | 7985 |
| MRPS31 | 7966 |
| EIF3K | 7962 |
| RPL34 | 7954 |
| RPL3 | 7916 |
| ERAL1 | 7911 |
| MRPS10 | 7836 |
| GADD45GIP1 | 7827 |
| MRPL42 | 7815 |
| RPL15 | 7772 |
| MRPL27 | 7736 |
| SRP14 | 7728 |
| MRPL10 | 7697 |
| MRPS11 | 7667 |
| RPL28 | 7634 |
| DAP3 | 7632 |
| RPS20 | 7538 |
| TUFM | 7516 |
| MRPL39 | 7494 |
| RPL38 | 7481 |
| RPL9 | 7462 |
| MRPS27 | 7438 |
| MRPL37 | 7358 |
| MRPL55 | 7303 |
| EARS2 | 7289 |
| RPL41 | 7287 |
| CHCHD1 | 7269 |
| RPL26 | 7225 |
| RPL26L1 | 7153 |
| MRPL13 | 7092 |
| MRPS16 | 7028 |
| MRPL1 | 7006 |
| EIF2S1 | 6910 |
| MRPL35 | 6889 |
| APEH | 6876 |
| RPL32 | 6861 |
| MTIF2 | 6816 |
| EEF1B2 | 6724 |
| MRPL2 | 6617 |
| RPL37A | 6591 |
| RPS23 | 6550 |
| RPL23 | 6505 |
| EIF3A | 6467 |
| MRPL46 | 6439 |
| TSFM | 6415 |
| RPL37 | 6405 |
| MRPS30 | 6402 |
| MRPL54 | 6395 |
| MRPS36 | 6353 |
| RPS16 | 6351 |
| EIF3E | 6310 |
| EIF3B | 6240 |
| MRPL20 | 6209 |
| MRPS26 | 6194 |
| SEC11A | 5992 |
| EIF5B | 5991 |
| EEF2 | 5988 |
| EIF4EBP1 | 5966 |
| EIF4A1 | 5915 |
| RPS10 | 5908 |
| MRPS23 | 5857 |
| SPCS3 | 5750 |
| SRP19 | 5734 |
| RPS18 | 5632 |
| SRP72 | 5621 |
| RPL27A | 5614 |
| MRPL12 | 5591 |
| PABPC1 | 5582 |
| RPS8 | 5562 |
| RPN2 | 5499 |
| UBA52 | 5448 |
| FARSB | 5363 |
| SRP54 | 5353 |
| RPL29 | 5290 |
| MRPS12 | 5286 |
| MRPL22 | 5218 |
| SEC61A2 | 5197 |
| MRPL24 | 5181 |
| MRPL52 | 5168 |
| RPS29 | 5166 |
| MRPS17 | 5154 |
| EIF3H | 5136 |
| YARS2 | 5089 |
| MRPL48 | 5073 |
| RPL22 | 5041 |
| EIF3F | 4913 |
| EEF1E1 | 4897 |
| PPA2 | 4858 |
| SPCS2 | 4754 |
| SEC61G | 4736 |
| MRPL45 | 4727 |
| MRPL44 | 4705 |
| RPS9 | 4648 |
| MRPS18B | 4629 |
| RPL6 | 4621 |
| RPL36 | 4617 |
| RPS3A | 4514 |
| RPL17 | 4433 |
| MRPS28 | 4382 |
| RPL11 | 4330 |
| EIF2S2 | 4264 |
| MTRF1L | 4244 |
| MARS2 | 4188 |
| NARS2 | 4161 |
| RPS27L | 4151 |
| MRPL32 | 4062 |
| MRPL49 | 4037 |
| MRPS18A | 3867 |
| MRPL34 | 3831 |
| MRPS18C | 3802 |
| EEF1A1 | 3605 |
| RPL31 | 3555 |
| MRPS9 | 3510 |
| VARS2 | 3461 |
| RPLP1 | 3408 |
| WARS2 | 3396 |
| RPS12 | 3328 |
| FARSA | 3204 |
| N6AMT1 | 3174 |
| GFM2 | 3148 |
| HARS2 | 3147 |
| PARS2 | 3144 |
| RPLP0 | 3049 |
| SRPRB | 3037 |
| RPS26 | 2822 |
| EIF5 | 2798 |
| MRPS2 | 2764 |
| EIF4B | 2671 |
| RPS19 | 2666 |
| MRPS5 | 2651 |
| MRPL33 | 2630 |
| MRPL18 | 2600 |
| MRPS15 | 2580 |
| SSR3 | 2528 |
| MRPL15 | 2411 |
| RPS7 | 2356 |
| RPL14 | 2209 |
| RPN1 | 2203 |
| RPS11 | 2201 |
| SEC11C | 2181 |
| RPL18 | 2150 |
| RPL7 | 2139 |
| MRPS22 | 2055 |
| GSPT1 | 2009 |
| EIF2B3 | 1983 |
| LARS2 | 1908 |
| RPL35 | 1903 |
| EIF4G1 | 1882 |
| MTIF3 | 1863 |
| MRPS34 | 1675 |
| GFM1 | 1669 |
| MRPL51 | 1507 |
| RPLP2 | 1447 |
| MRPL23 | 1446 |
| MRPS14 | 1431 |
| AARS2 | 1413 |
| SRP68 | 1381 |
| RARS2 | 1340 |
| EIF3J | 1279 |
| RPS5 | 1210 |
| RPS15 | 1135 |
| RPL23A | 1098 |
| MRPS25 | 1033 |
| MRPL14 | 990 |
| EEF1D | 959 |
| MRPS35 | 902 |
| EIF3L | 880 |
| MRPL4 | 787 |
| CARS2 | 782 |
| MRPS6 | 774 |
| EIF2B5 | 770 |
| EIF2B2 | 753 |
| PPA1 | 745 |
| MTFMT | 729 |
| MRPL53 | 726 |
| SEC61A1 | 663 |
| RPL39L | 485 |
| MRPS7 | 442 |
| EIF2B1 | 353 |
| RPL13 | 339 |
| FAU | 233 |
| EEF1G | 186 |
| EIF2B4 | 180 |
| MRPL11 | 147 |
| RPS15A | 72 |
| ETF1 | -25 |
| MRPL41 | -27 |
| MRPS24 | -87 |
| MRPL21 | -102 |
| EIF3M | -129 |
| MRPL38 | -142 |
| EIF3G | -171 |
| EIF3I | -201 |
| IARS2 | -241 |
| RPL8 | -295 |
| SSR1 | -313 |
| MRPL36 | -314 |
| RPL10A | -562 |
| EIF4E | -590 |
| SARS2 | -606 |
| MRPL50 | -611 |
| TRAM1 | -687 |
| MRPL43 | -1040 |
| RPL36AL | -1188 |
| AIMP2 | -1212 |
| MRPL16 | -1346 |
NOTCH3 Activation and Transmission of Signal to the Nucleus
| 564 | |
|---|---|
| set | NOTCH3 Activation and Transmission of Signal to the Nucleus |
| setSize | 15 |
| pANOVA | 0.000242 |
| s.dist | 0.547 |
| p.adjustANOVA | 0.0449 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| NCSTN | 8369 |
| TACC3 | 8325 |
| RPS27A | 8228 |
| WWP2 | 7914 |
| UBB | 7418 |
| APH1A | 6905 |
| PSEN1 | 6541 |
| APH1B | 6499 |
| PSENEN | 6061 |
| UBC | 5810 |
| MIB1 | 5480 |
| UBA52 | 5448 |
| ADAM10 | 5018 |
| PSEN2 | 2706 |
| YBX1 | 2163 |
| GeneID | Gene Rank |
|---|---|
| NCSTN | 8369 |
| TACC3 | 8325 |
| RPS27A | 8228 |
| WWP2 | 7914 |
| UBB | 7418 |
| APH1A | 6905 |
| PSEN1 | 6541 |
| APH1B | 6499 |
| PSENEN | 6061 |
| UBC | 5810 |
| MIB1 | 5480 |
| UBA52 | 5448 |
| ADAM10 | 5018 |
| PSEN2 | 2706 |
| YBX1 | 2163 |
PLC beta mediated events
| 641 | |
|---|---|
| set | PLC beta mediated events |
| setSize | 29 |
| pANOVA | 0.000292 |
| s.dist | -0.389 |
| p.adjustANOVA | 0.0449 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| GNA15 | -1343 |
| PLCB3 | -1010 |
| PRKCD | -938 |
| PLCB2 | -912 |
| CAMK2D | -628 |
| ADCY7 | -609 |
| CAMKK1 | -336 |
| PDE1B | -308 |
| CREB1 | -273 |
| PRKAR1A | -147 |
| ITPR2 | 190 |
| AHCYL1 | 266 |
| CAMKK2 | 293 |
| ADCY4 | 377 |
| PRKACA | 480 |
| PRKAR2A | 771 |
| NBEA | 1043 |
| PRKACB | 1167 |
| ITPR3 | 1758 |
| CAMK4 | 1835 |
| GeneID | Gene Rank |
|---|---|
| GNA15 | -1343 |
| PLCB3 | -1010 |
| PRKCD | -938 |
| PLCB2 | -912 |
| CAMK2D | -628 |
| ADCY7 | -609 |
| CAMKK1 | -336 |
| PDE1B | -308 |
| CREB1 | -273 |
| PRKAR1A | -147 |
| ITPR2 | 190 |
| AHCYL1 | 266 |
| CAMKK2 | 293 |
| ADCY4 | 377 |
| PRKACA | 480 |
| PRKAR2A | 771 |
| NBEA | 1043 |
| PRKACB | 1167 |
| ITPR3 | 1758 |
| CAMK4 | 1835 |
| CALM1 | 2569 |
| ADCY9 | 2727 |
| MAPK1 | 3217 |
| PRKCA | 3486 |
| KPNA2 | 3922 |
| CAMK2G | 6968 |
| PRKAR1B | 7076 |
| ITPR1 | 7110 |
| GNAQ | 7124 |
DAG and IP3 signaling
| 174 | |
|---|---|
| set | DAG and IP3 signaling |
| setSize | 26 |
| pANOVA | 0.000363 |
| s.dist | -0.404 |
| p.adjustANOVA | 0.0449 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| PRKCD | -938 |
| CAMK2D | -628 |
| ADCY7 | -609 |
| PRKCE | -493 |
| CAMKK1 | -336 |
| PDE1B | -308 |
| CREB1 | -273 |
| PRKAR1A | -147 |
| ITPR2 | 190 |
| AHCYL1 | 266 |
| CAMKK2 | 293 |
| ADCY4 | 377 |
| PRKACA | 480 |
| PRKAR2A | 771 |
| PLCG1 | 848 |
| NBEA | 1043 |
| PRKACB | 1167 |
| ITPR3 | 1758 |
| CAMK4 | 1835 |
| CALM1 | 2569 |
| GeneID | Gene Rank |
|---|---|
| PRKCD | -938 |
| CAMK2D | -628 |
| ADCY7 | -609 |
| PRKCE | -493 |
| CAMKK1 | -336 |
| PDE1B | -308 |
| CREB1 | -273 |
| PRKAR1A | -147 |
| ITPR2 | 190 |
| AHCYL1 | 266 |
| CAMKK2 | 293 |
| ADCY4 | 377 |
| PRKACA | 480 |
| PRKAR2A | 771 |
| PLCG1 | 848 |
| NBEA | 1043 |
| PRKACB | 1167 |
| ITPR3 | 1758 |
| CAMK4 | 1835 |
| CALM1 | 2569 |
| ADCY9 | 2727 |
| PRKCA | 3486 |
| KPNA2 | 3922 |
| CAMK2G | 6968 |
| PRKAR1B | 7076 |
| ITPR1 | 7110 |
Regulation of expression of SLITs and ROBOs
| 819 | |
|---|---|
| set | Regulation of expression of SLITs and ROBOs |
| setSize | 117 |
| pANOVA | 0.000473 |
| s.dist | 0.188 |
| p.adjustANOVA | 0.0449 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| NCBP1 | 8402 |
| RPS25 | 8288 |
| RPS27A | 8228 |
| PSMA3 | 8188 |
| RPS3 | 8185 |
| RPS6 | 8168 |
| RPS28 | 8167 |
| RPL4 | 8137 |
| RPSA | 8071 |
| RPS24 | 7985 |
| RPL34 | 7954 |
| RPL3 | 7916 |
| RPL15 | 7772 |
| RPL28 | 7634 |
| PSMB5 | 7598 |
| RPS20 | 7538 |
| RPL38 | 7481 |
| RPL9 | 7462 |
| UBB | 7418 |
| RPL41 | 7287 |
| GeneID | Gene Rank |
|---|---|
| NCBP1 | 8402 |
| RPS25 | 8288 |
| RPS27A | 8228 |
| PSMA3 | 8188 |
| RPS3 | 8185 |
| RPS6 | 8168 |
| RPS28 | 8167 |
| RPL4 | 8137 |
| RPSA | 8071 |
| RPS24 | 7985 |
| RPL34 | 7954 |
| RPL3 | 7916 |
| RPL15 | 7772 |
| RPL28 | 7634 |
| PSMB5 | 7598 |
| RPS20 | 7538 |
| RPL38 | 7481 |
| RPL9 | 7462 |
| UBB | 7418 |
| RPL41 | 7287 |
| PSMC1 | 7227 |
| RPL26 | 7225 |
| RPL26L1 | 7153 |
| PSMA5 | 7049 |
| PSMD12 | 7015 |
| RPL32 | 6861 |
| PSME2 | 6844 |
| PSMB10 | 6829 |
| NCBP2 | 6756 |
| PSMB7 | 6667 |
| RPL37A | 6591 |
| PSMB6 | 6558 |
| RPS23 | 6550 |
| PSMD11 | 6544 |
| USP33 | 6511 |
| RPL23 | 6505 |
| RPL37 | 6405 |
| RPS16 | 6351 |
| PSMC6 | 5996 |
| RPS10 | 5908 |
| UBC | 5810 |
| EIF4A3 | 5779 |
| RPS18 | 5632 |
| RPL27A | 5614 |
| PABPC1 | 5582 |
| RPS8 | 5562 |
| PSMB3 | 5497 |
| LDB1 | 5453 |
| UBA52 | 5448 |
| PSMD4 | 5325 |
| RPL29 | 5290 |
| RPS29 | 5166 |
| PSMD7 | 5075 |
| RPL22 | 5041 |
| PSMB1 | 4974 |
| PSMF1 | 4670 |
| PSMD1 | 4661 |
| RPS9 | 4648 |
| RPL6 | 4621 |
| RPL36 | 4617 |
| PSMD9 | 4605 |
| RPS3A | 4514 |
| RPL17 | 4433 |
| RPL11 | 4330 |
| RPS27L | 4151 |
| CUL2 | 4094 |
| PSME3 | 3994 |
| PSMD14 | 3709 |
| PSMD2 | 3621 |
| RPL31 | 3555 |
| RPLP1 | 3408 |
| RPS12 | 3328 |
| PSMA6 | 3273 |
| PSMC3 | 3247 |
| PSMB9 | 3199 |
| RPLP0 | 3049 |
| PSMD8 | 3011 |
| PSMA7 | 2927 |
| RPS26 | 2822 |
| CASC3 | 2750 |
| RPS19 | 2666 |
| PSMD13 | 2662 |
| PSMD3 | 2545 |
| UPF2 | 2503 |
| PSMC5 | 2470 |
| PSMD6 | 2403 |
| RPS7 | 2356 |
| RPL14 | 2209 |
| RPS11 | 2201 |
| RNPS1 | 2173 |
| UPF3A | 2172 |
| RPL18 | 2150 |
| RPL7 | 2139 |
| PSMC4 | 2130 |
| GSPT1 | 2009 |
| RPL35 | 1903 |
| EIF4G1 | 1882 |
| PSMA1 | 1855 |
| RPLP2 | 1447 |
| PSMA2 | 1432 |
| RPS5 | 1210 |
| RPS15 | 1135 |
| DAG1 | 1109 |
| RPL23A | 1098 |
| PSMB8 | 756 |
| RBX1 | 651 |
| RPL39L | 485 |
| RPL13 | 339 |
| FAU | 233 |
| PSME1 | 209 |
| PSME4 | 207 |
| RPS15A | 72 |
| ETF1 | -25 |
| RPL8 | -295 |
| RPL10A | -562 |
| SLIT1 | -672 |
| RPL36AL | -1188 |
Selenocysteine synthesis
| 882 | |
|---|---|
| set | Selenocysteine synthesis |
| setSize | 65 |
| pANOVA | 0.000477 |
| s.dist | 0.251 |
| p.adjustANOVA | 0.0449 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| RPS25 | 8288 |
| RPS27A | 8228 |
| RPS3 | 8185 |
| RPS6 | 8168 |
| RPS28 | 8167 |
| RPL4 | 8137 |
| RPSA | 8071 |
| RPS24 | 7985 |
| RPL34 | 7954 |
| RPL3 | 7916 |
| RPL15 | 7772 |
| RPL28 | 7634 |
| EEFSEC | 7576 |
| RPS20 | 7538 |
| RPL38 | 7481 |
| RPL9 | 7462 |
| RPL41 | 7287 |
| RPL26 | 7225 |
| RPL26L1 | 7153 |
| RPL32 | 6861 |
| GeneID | Gene Rank |
|---|---|
| RPS25 | 8288 |
| RPS27A | 8228 |
| RPS3 | 8185 |
| RPS6 | 8168 |
| RPS28 | 8167 |
| RPL4 | 8137 |
| RPSA | 8071 |
| RPS24 | 7985 |
| RPL34 | 7954 |
| RPL3 | 7916 |
| RPL15 | 7772 |
| RPL28 | 7634 |
| EEFSEC | 7576 |
| RPS20 | 7538 |
| RPL38 | 7481 |
| RPL9 | 7462 |
| RPL41 | 7287 |
| RPL26 | 7225 |
| RPL26L1 | 7153 |
| RPL32 | 6861 |
| RPL37A | 6591 |
| RPS23 | 6550 |
| RPL23 | 6505 |
| RPL37 | 6405 |
| RPS16 | 6351 |
| RPS10 | 5908 |
| RPS18 | 5632 |
| RPL27A | 5614 |
| RPS8 | 5562 |
| UBA52 | 5448 |
| RPL29 | 5290 |
| RPS29 | 5166 |
| RPL22 | 5041 |
| SEPHS2 | 4943 |
| RPS9 | 4648 |
| RPL6 | 4621 |
| RPL36 | 4617 |
| RPS3A | 4514 |
| RPL17 | 4433 |
| RPL11 | 4330 |
| RPS27L | 4151 |
| PSTK | 3968 |
| RPL31 | 3555 |
| RPLP1 | 3408 |
| RPS12 | 3328 |
| RPLP0 | 3049 |
| RPS26 | 2822 |
| RPS19 | 2666 |
| RPS7 | 2356 |
| RPL14 | 2209 |
| RPS11 | 2201 |
| RPL18 | 2150 |
| RPL7 | 2139 |
| RPL35 | 1903 |
| RPLP2 | 1447 |
| RPS5 | 1210 |
| RPS15 | 1135 |
| RPL23A | 1098 |
| RPL39L | 485 |
| RPL13 | 339 |
| FAU | 233 |
| RPS15A | 72 |
| RPL8 | -295 |
| RPL10A | -562 |
| RPL36AL | -1188 |
Signaling by GPCR
| 922 | |
|---|---|
| set | Signaling by GPCR |
| setSize | 195 |
| pANOVA | 0.000588 |
| s.dist | -0.144 |
| p.adjustANOVA | 0.0449 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| RGS3 | -1407 |
| FZD8 | -1349 |
| GNA15 | -1343 |
| NLN | -1321 |
| ADORA3 | -1302 |
| ADORA2A | -1279 |
| RGS1 | -1268 |
| GNG12 | -1213 |
| HRH2 | -1173 |
| CDC42 | -1172 |
| PRKCB | -1153 |
| AKT1 | -1052 |
| PLCB3 | -1010 |
| GNB1 | -1002 |
| PRKCD | -938 |
| DHH | -921 |
| LHB | -919 |
| APP | -913 |
| PLCB2 | -912 |
| CD55 | -891 |
| GeneID | Gene Rank |
|---|---|
| RGS3 | -1407 |
| FZD8 | -1349 |
| GNA15 | -1343 |
| NLN | -1321 |
| ADORA3 | -1302 |
| ADORA2A | -1279 |
| RGS1 | -1268 |
| GNG12 | -1213 |
| HRH2 | -1173 |
| CDC42 | -1172 |
| PRKCB | -1153 |
| AKT1 | -1052 |
| PLCB3 | -1010 |
| GNB1 | -1002 |
| PRKCD | -938 |
| DHH | -921 |
| LHB | -919 |
| APP | -913 |
| PLCB2 | -912 |
| CD55 | -891 |
| RGS19 | -788 |
| KRAS | -784 |
| OPRL1 | -767 |
| QRFP | -760 |
| DGKH | -747 |
| CAMK2D | -628 |
| RPS6KA1 | -627 |
| PPP2CB | -624 |
| DGKA | -610 |
| ADCY7 | -609 |
| PREX1 | -593 |
| PPP3CA | -532 |
| TRIO | -525 |
| GIPR | -497 |
| PRKCE | -493 |
| PPP3CC | -471 |
| LPAR5 | -429 |
| HCRT | -375 |
| GPR176 | -360 |
| CAMKK1 | -336 |
| PDE1B | -308 |
| CREB1 | -273 |
| GNAT1 | -243 |
| PDE2A | -173 |
| PRKAR1A | -147 |
| PPP3R1 | -141 |
| DRD3 | -92 |
| ARHGEF12 | -72 |
| SRC | -41 |
| ADM | -8 |
| NET1 | 5 |
| ARHGEF3 | 95 |
| ARHGEF19 | 110 |
| ITPR2 | 190 |
| PTGER4 | 218 |
| PDE4B | 256 |
| AHCYL1 | 266 |
| CAMKK2 | 293 |
| ADCY4 | 377 |
| PDPK1 | 444 |
| S1PR4 | 462 |
| PRKACA | 480 |
| RGS12 | 578 |
| NMB | 609 |
| ARHGEF2 | 630 |
| GRK6 | 674 |
| PRKAR2A | 771 |
| PIK3R2 | 866 |
| NBEA | 1043 |
| ARRB1 | 1072 |
| PDE7A | 1143 |
| HEBP1 | 1145 |
| FZD6 | 1146 |
| PRKACB | 1167 |
| ABHD6 | 1184 |
| ABR | 1302 |
| S1PR1 | 1379 |
| GNB4 | 1400 |
| PTCH1 | 1422 |
| GNRHR2 | 1442 |
| AKAP13 | 1475 |
| RASGRP1 | 1725 |
| ITPR3 | 1758 |
| CAMK4 | 1835 |
| OPN3 | 1925 |
| ARHGEF1 | 1999 |
| TIAM2 | 2047 |
| WNT3A | 2069 |
| DGKZ | 2151 |
| WNT1 | 2206 |
| PIK3R5 | 2231 |
| HRAS | 2241 |
| LPAR2 | 2278 |
| VIPR1 | 2293 |
| RASGRP2 | 2303 |
| CCR1 | 2327 |
| PRKCQ | 2375 |
| PIK3R1 | 2531 |
| CXCR4 | 2548 |
| CALM1 | 2569 |
| PSAP | 2609 |
| RHOA | 2719 |
| ADCY9 | 2727 |
| PDE8A | 2787 |
| GNB2 | 2806 |
| PPP2CA | 2847 |
| CDK5 | 2882 |
| GABBR1 | 2909 |
| PAK1 | 2913 |
| P2RY1 | 2965 |
| RPS6KA2 | 3010 |
| S1PR2 | 3017 |
| HBEGF | 3061 |
| DGKE | 3157 |
| MAPK1 | 3217 |
| GNA12 | 3221 |
| DGKD | 3364 |
| FZD7 | 3401 |
| PTGER2 | 3427 |
| GPSM3 | 3428 |
| GRB2 | 3473 |
| CXCL2 | 3477 |
| PRKCA | 3486 |
| RHOB | 3615 |
| DAGLB | 3624 |
| GNAI2 | 3664 |
| ARHGEF17 | 3784 |
| KPNA2 | 3922 |
| ECE1 | 4068 |
| GPR65 | 4124 |
| RGS2 | 4139 |
| PIK3R3 | 4166 |
| GPR68 | 4268 |
| ROCK1 | 4490 |
| FZD3 | 4702 |
| GNAL | 4827 |
| LPAR6 | 4851 |
| RGS16 | 4985 |
| FGD3 | 4989 |
| ADRB2 | 5003 |
| P2RY2 | 5020 |
| MAPK7 | 5187 |
| ECE2 | 5214 |
| ARRB2 | 5233 |
| PPP1CA | 5270 |
| PPP3CB | 5366 |
| GNAS | 5417 |
| AKT2 | 5440 |
| CCR7 | 5458 |
| PDE3B | 5481 |
| FZD5 | 5557 |
| CHRM3 | 5585 |
| TAS1R1 | 5619 |
| PRKCH | 5663 |
| PLEKHG2 | 5723 |
| CCR10 | 5933 |
| GNB5 | 6045 |
| ABHD12 | 6068 |
| VAV1 | 6303 |
| WNT2B | 6349 |
| PPP2R5D | 6390 |
| FZD2 | 6411 |
| C3AR1 | 6596 |
| GRK5 | 6616 |
| ITSN1 | 6622 |
| ARHGEF7 | 6761 |
| GNG4 | 6944 |
| RGS10 | 6949 |
| GPR132 | 6966 |
| CAMK2G | 6968 |
| RGS14 | 7041 |
| PRKAR1B | 7076 |
| ITPR1 | 7110 |
| GNAQ | 7124 |
| PIK3CA | 7235 |
| SOS2 | 7347 |
| OBSCN | 7381 |
| GNG5 | 7410 |
| GNA13 | 7515 |
| GPSM2 | 7557 |
| PDE4C | 7643 |
| DGKQ | 7702 |
| VAV2 | 7749 |
| GNAI3 | 7816 |
| PPP2R1B | 7877 |
| GNG2 | 7887 |
| LTB4R | 8014 |
| MAPK3 | 8081 |
| PIK3CG | 8093 |
| PROK2 | 8148 |
| LTB4R2 | 8255 |
| CNR2 | 8263 |
| NTSR1 | 8294 |
| CCL27 | 8403 |
| PTCH2 | 8406 |
Mitochondrial translation elongation
| 535 | |
|---|---|
| set | Mitochondrial translation elongation |
| setSize | 81 |
| pANOVA | 0.000664 |
| s.dist | 0.219 |
| p.adjustANOVA | 0.0449 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| MRPL47 | 8226 |
| AURKAIP1 | 8219 |
| OXA1L | 8131 |
| MRPS21 | 8122 |
| PTCD3 | 8109 |
| MRPL30 | 8047 |
| MRPL19 | 8025 |
| MRPS33 | 7992 |
| MRPS31 | 7966 |
| ERAL1 | 7911 |
| MRPS10 | 7836 |
| GADD45GIP1 | 7827 |
| MRPL42 | 7815 |
| MRPL27 | 7736 |
| MRPL10 | 7697 |
| MRPS11 | 7667 |
| DAP3 | 7632 |
| TUFM | 7516 |
| MRPL39 | 7494 |
| MRPS27 | 7438 |
| GeneID | Gene Rank |
|---|---|
| MRPL47 | 8226 |
| AURKAIP1 | 8219 |
| OXA1L | 8131 |
| MRPS21 | 8122 |
| PTCD3 | 8109 |
| MRPL30 | 8047 |
| MRPL19 | 8025 |
| MRPS33 | 7992 |
| MRPS31 | 7966 |
| ERAL1 | 7911 |
| MRPS10 | 7836 |
| GADD45GIP1 | 7827 |
| MRPL42 | 7815 |
| MRPL27 | 7736 |
| MRPL10 | 7697 |
| MRPS11 | 7667 |
| DAP3 | 7632 |
| TUFM | 7516 |
| MRPL39 | 7494 |
| MRPS27 | 7438 |
| MRPL37 | 7358 |
| MRPL55 | 7303 |
| CHCHD1 | 7269 |
| MRPL13 | 7092 |
| MRPS16 | 7028 |
| MRPL1 | 7006 |
| MRPL35 | 6889 |
| MRPL2 | 6617 |
| MRPL46 | 6439 |
| TSFM | 6415 |
| MRPS30 | 6402 |
| MRPL54 | 6395 |
| MRPS36 | 6353 |
| MRPL20 | 6209 |
| MRPS26 | 6194 |
| MRPS23 | 5857 |
| MRPL12 | 5591 |
| MRPS12 | 5286 |
| MRPL22 | 5218 |
| MRPL24 | 5181 |
| MRPL52 | 5168 |
| MRPS17 | 5154 |
| MRPL48 | 5073 |
| MRPL45 | 4727 |
| MRPL44 | 4705 |
| MRPS18B | 4629 |
| MRPS28 | 4382 |
| MRPL32 | 4062 |
| MRPL49 | 4037 |
| MRPS18A | 3867 |
| MRPL34 | 3831 |
| MRPS18C | 3802 |
| MRPS9 | 3510 |
| MRPS2 | 2764 |
| MRPS5 | 2651 |
| MRPL33 | 2630 |
| MRPL18 | 2600 |
| MRPS15 | 2580 |
| MRPL15 | 2411 |
| MRPS22 | 2055 |
| MRPS34 | 1675 |
| GFM1 | 1669 |
| MRPL51 | 1507 |
| MRPL23 | 1446 |
| MRPS14 | 1431 |
| MRPS25 | 1033 |
| MRPL14 | 990 |
| MRPS35 | 902 |
| MRPL4 | 787 |
| MRPS6 | 774 |
| MRPL53 | 726 |
| MRPS7 | 442 |
| MRPL11 | 147 |
| MRPL41 | -27 |
| MRPS24 | -87 |
| MRPL21 | -102 |
| MRPL38 | -142 |
| MRPL36 | -314 |
| MRPL50 | -611 |
| MRPL43 | -1040 |
| MRPL16 | -1346 |
Integrin cell surface interactions
| 426 | |
|---|---|
| set | Integrin cell surface interactions |
| setSize | 23 |
| pANOVA | 0.000716 |
| s.dist | -0.408 |
| p.adjustANOVA | 0.0449 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| CD47 | -1421 |
| BSG | -1060 |
| AGRN | -920 |
| ITGA6 | -618 |
| ITGA2 | -602 |
| ITGB2 | -332 |
| ITGA5 | -224 |
| ITGB8 | -130 |
| JAM2 | 126 |
| COL23A1 | 225 |
| ITGB7 | 716 |
| COL9A2 | 965 |
| CD44 | 1077 |
| ITGAE | 1222 |
| ICAM1 | 1618 |
| ITGA1 | 1650 |
| F11R | 1739 |
| ICAM3 | 1824 |
| ICAM5 | 3744 |
| ITGAV | 5171 |
| GeneID | Gene Rank |
|---|---|
| CD47 | -1421 |
| BSG | -1060 |
| AGRN | -920 |
| ITGA6 | -618 |
| ITGA2 | -602 |
| ITGB2 | -332 |
| ITGA5 | -224 |
| ITGB8 | -130 |
| JAM2 | 126 |
| COL23A1 | 225 |
| ITGB7 | 716 |
| COL9A2 | 965 |
| CD44 | 1077 |
| ITGAE | 1222 |
| ICAM1 | 1618 |
| ITGA1 | 1650 |
| F11R | 1739 |
| ICAM3 | 1824 |
| ICAM5 | 3744 |
| ITGAV | 5171 |
| ICAM2 | 6266 |
| ITGA4 | 6534 |
| ITGAL | 6648 |
Peptide chain elongation
| 649 | |
|---|---|
| set | Peptide chain elongation |
| setSize | 64 |
| pANOVA | 0.00075 |
| s.dist | 0.244 |
| p.adjustANOVA | 0.0449 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| RPS25 | 8288 |
| RPS27A | 8228 |
| RPS3 | 8185 |
| RPS6 | 8168 |
| RPS28 | 8167 |
| RPL4 | 8137 |
| RPSA | 8071 |
| RPS24 | 7985 |
| RPL34 | 7954 |
| RPL3 | 7916 |
| RPL15 | 7772 |
| RPL28 | 7634 |
| RPS20 | 7538 |
| RPL38 | 7481 |
| RPL9 | 7462 |
| RPL41 | 7287 |
| RPL26 | 7225 |
| RPL26L1 | 7153 |
| RPL32 | 6861 |
| RPL37A | 6591 |
| GeneID | Gene Rank |
|---|---|
| RPS25 | 8288 |
| RPS27A | 8228 |
| RPS3 | 8185 |
| RPS6 | 8168 |
| RPS28 | 8167 |
| RPL4 | 8137 |
| RPSA | 8071 |
| RPS24 | 7985 |
| RPL34 | 7954 |
| RPL3 | 7916 |
| RPL15 | 7772 |
| RPL28 | 7634 |
| RPS20 | 7538 |
| RPL38 | 7481 |
| RPL9 | 7462 |
| RPL41 | 7287 |
| RPL26 | 7225 |
| RPL26L1 | 7153 |
| RPL32 | 6861 |
| RPL37A | 6591 |
| RPS23 | 6550 |
| RPL23 | 6505 |
| RPL37 | 6405 |
| RPS16 | 6351 |
| EEF2 | 5988 |
| RPS10 | 5908 |
| RPS18 | 5632 |
| RPL27A | 5614 |
| RPS8 | 5562 |
| UBA52 | 5448 |
| RPL29 | 5290 |
| RPS29 | 5166 |
| RPL22 | 5041 |
| RPS9 | 4648 |
| RPL6 | 4621 |
| RPL36 | 4617 |
| RPS3A | 4514 |
| RPL17 | 4433 |
| RPL11 | 4330 |
| RPS27L | 4151 |
| EEF1A1 | 3605 |
| RPL31 | 3555 |
| RPLP1 | 3408 |
| RPS12 | 3328 |
| RPLP0 | 3049 |
| RPS26 | 2822 |
| RPS19 | 2666 |
| RPS7 | 2356 |
| RPL14 | 2209 |
| RPS11 | 2201 |
| RPL18 | 2150 |
| RPL7 | 2139 |
| RPL35 | 1903 |
| RPLP2 | 1447 |
| RPS5 | 1210 |
| RPS15 | 1135 |
| RPL23A | 1098 |
| RPL39L | 485 |
| RPL13 | 339 |
| FAU | 233 |
| RPS15A | 72 |
| RPL8 | -295 |
| RPL10A | -562 |
| RPL36AL | -1188 |
rRNA processing
| 1134 | |
|---|---|
| set | rRNA processing |
| setSize | 149 |
| pANOVA | 0.000796 |
| s.dist | 0.16 |
| p.adjustANOVA | 0.0449 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| PES1 | 8341 |
| RPS25 | 8288 |
| DDX47 | 8287 |
| RPS27A | 8228 |
| RCL1 | 8222 |
| RPS3 | 8185 |
| RPS6 | 8168 |
| RPS28 | 8167 |
| RPL4 | 8137 |
| RPSA | 8071 |
| RPS24 | 7985 |
| CSNK1E | 7983 |
| RPL34 | 7954 |
| RPL3 | 7916 |
| WBSCR22 | 7872 |
| FBL | 7793 |
| RPL15 | 7772 |
| RIOK2 | 7755 |
| UTP20 | 7701 |
| GAR1 | 7687 |
| GeneID | Gene Rank |
|---|---|
| PES1 | 8341 |
| RPS25 | 8288 |
| DDX47 | 8287 |
| RPS27A | 8228 |
| RCL1 | 8222 |
| RPS3 | 8185 |
| RPS6 | 8168 |
| RPS28 | 8167 |
| RPL4 | 8137 |
| RPSA | 8071 |
| RPS24 | 7985 |
| CSNK1E | 7983 |
| RPL34 | 7954 |
| RPL3 | 7916 |
| WBSCR22 | 7872 |
| FBL | 7793 |
| RPL15 | 7772 |
| RIOK2 | 7755 |
| UTP20 | 7701 |
| GAR1 | 7687 |
| RPL28 | 7634 |
| RPP30 | 7603 |
| C1D | 7585 |
| BYSL | 7563 |
| WDR75 | 7541 |
| RPS20 | 7538 |
| ELAC2 | 7506 |
| RPL38 | 7481 |
| WDR18 | 7463 |
| RPL9 | 7462 |
| UTP6 | 7403 |
| DDX52 | 7367 |
| RPL41 | 7287 |
| RPL26 | 7225 |
| THUMPD1 | 7215 |
| RPL26L1 | 7153 |
| EXOSC10 | 7129 |
| RPP14 | 7012 |
| RPL32 | 6861 |
| DCAF13 | 6595 |
| RPL37A | 6591 |
| RPS23 | 6550 |
| RPL23 | 6505 |
| FCF1 | 6479 |
| RPL37 | 6405 |
| LTV1 | 6380 |
| RPS16 | 6351 |
| MPHOSPH6 | 6246 |
| EXOSC6 | 6042 |
| RRP7A | 5962 |
| RPS10 | 5908 |
| IMP4 | 5827 |
| TBL3 | 5814 |
| RPS18 | 5632 |
| RPL27A | 5614 |
| RPS8 | 5562 |
| NOP10 | 5553 |
| UBA52 | 5448 |
| WDR12 | 5442 |
| RPL29 | 5290 |
| RPS29 | 5166 |
| PNO1 | 5053 |
| WDR43 | 5052 |
| RPL22 | 5041 |
| UTP15 | 4993 |
| NOL6 | 4802 |
| SENP3 | 4693 |
| EXOSC7 | 4662 |
| RPS9 | 4648 |
| RPL6 | 4621 |
| RPL36 | 4617 |
| RPS3A | 4514 |
| RPL17 | 4433 |
| NOB1 | 4405 |
| IMP3 | 4395 |
| RPL11 | 4330 |
| PELP1 | 4290 |
| PDCD11 | 4218 |
| UTP3 | 4201 |
| RPS27L | 4151 |
| FTSJ3 | 4146 |
| NOL12 | 4088 |
| HEATR1 | 3939 |
| BMS1 | 3878 |
| EBNA1BP2 | 3873 |
| NSUN4 | 3736 |
| MRM1 | 3590 |
| RPL31 | 3555 |
| EXOSC2 | 3525 |
| DDX21 | 3469 |
| EXOSC8 | 3443 |
| RPLP1 | 3408 |
| RPS12 | 3328 |
| NOL11 | 3213 |
| RPLP0 | 3049 |
| RBM28 | 3026 |
| DIS3 | 2928 |
| XRN2 | 2897 |
| TFB1M | 2841 |
| RPS26 | 2822 |
| RPS19 | 2666 |
| NOP14 | 2648 |
| RIOK1 | 2384 |
| RPS7 | 2356 |
| RPL14 | 2209 |
| RPS11 | 2201 |
| RPL18 | 2150 |
| RPL7 | 2139 |
| WDR36 | 2073 |
| RPL35 | 1903 |
| RPP21 | 1823 |
| NOP56 | 1724 |
| RPLP2 | 1447 |
| WDR3 | 1443 |
| TSR1 | 1421 |
| NOP58 | 1322 |
| EXOSC4 | 1277 |
| RRP1 | 1248 |
| RPS5 | 1210 |
| RIOK3 | 1192 |
| TEX10 | 1160 |
| RPS15 | 1135 |
| CSNK1D | 1107 |
| RPL23A | 1098 |
| MPHOSPH10 | 1092 |
| RRP9 | 1022 |
| ISG20L2 | 997 |
| RPP25 | 991 |
| NOP2 | 904 |
| NCL | 872 |
| RPP38 | 823 |
| NIP7 | 820 |
| DHX37 | 689 |
| NOC4L | 665 |
| PWP2 | 608 |
| EXOSC3 | 501 |
| RPL39L | 485 |
| RPL13 | 339 |
| NHP2 | 301 |
| FAU | 233 |
| GNL3 | 216 |
| RPS15A | 72 |
| RPL8 | -295 |
| DDX49 | -412 |
| RPP40 | -457 |
| EXOSC5 | -485 |
| RPL10A | -562 |
| ERI1 | -851 |
| RPL36AL | -1188 |
L13a-mediated translational silencing of Ceruloplasmin expression
| 467 | |
|---|---|
| set | L13a-mediated translational silencing of Ceruloplasmin expression |
| setSize | 82 |
| pANOVA | 0.000839 |
| s.dist | 0.214 |
| p.adjustANOVA | 0.0449 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| EIF4H | 8386 |
| RPS25 | 8288 |
| RPS27A | 8228 |
| RPS3 | 8185 |
| RPS6 | 8168 |
| RPS28 | 8167 |
| RPL4 | 8137 |
| RPSA | 8071 |
| EIF4A2 | 8016 |
| RPS24 | 7985 |
| EIF3K | 7962 |
| RPL34 | 7954 |
| RPL3 | 7916 |
| RPL15 | 7772 |
| RPL28 | 7634 |
| RPS20 | 7538 |
| RPL38 | 7481 |
| RPL9 | 7462 |
| RPL41 | 7287 |
| RPL26 | 7225 |
| GeneID | Gene Rank |
|---|---|
| EIF4H | 8386 |
| RPS25 | 8288 |
| RPS27A | 8228 |
| RPS3 | 8185 |
| RPS6 | 8168 |
| RPS28 | 8167 |
| RPL4 | 8137 |
| RPSA | 8071 |
| EIF4A2 | 8016 |
| RPS24 | 7985 |
| EIF3K | 7962 |
| RPL34 | 7954 |
| RPL3 | 7916 |
| RPL15 | 7772 |
| RPL28 | 7634 |
| RPS20 | 7538 |
| RPL38 | 7481 |
| RPL9 | 7462 |
| RPL41 | 7287 |
| RPL26 | 7225 |
| RPL26L1 | 7153 |
| EIF2S1 | 6910 |
| RPL32 | 6861 |
| RPL37A | 6591 |
| RPS23 | 6550 |
| RPL23 | 6505 |
| EIF3A | 6467 |
| RPL37 | 6405 |
| RPS16 | 6351 |
| EIF3E | 6310 |
| EIF3B | 6240 |
| EIF4A1 | 5915 |
| RPS10 | 5908 |
| RPS18 | 5632 |
| RPL27A | 5614 |
| PABPC1 | 5582 |
| RPS8 | 5562 |
| UBA52 | 5448 |
| RPL29 | 5290 |
| RPS29 | 5166 |
| EIF3H | 5136 |
| RPL22 | 5041 |
| EIF3F | 4913 |
| RPS9 | 4648 |
| RPL6 | 4621 |
| RPL36 | 4617 |
| RPS3A | 4514 |
| RPL17 | 4433 |
| RPL11 | 4330 |
| EIF2S2 | 4264 |
| RPS27L | 4151 |
| RPL31 | 3555 |
| RPLP1 | 3408 |
| RPS12 | 3328 |
| RPLP0 | 3049 |
| RPS26 | 2822 |
| EIF4B | 2671 |
| RPS19 | 2666 |
| RPS7 | 2356 |
| RPL14 | 2209 |
| RPS11 | 2201 |
| RPL18 | 2150 |
| RPL7 | 2139 |
| RPL35 | 1903 |
| EIF4G1 | 1882 |
| RPLP2 | 1447 |
| EIF3J | 1279 |
| RPS5 | 1210 |
| RPS15 | 1135 |
| RPL23A | 1098 |
| EIF3L | 880 |
| RPL39L | 485 |
| RPL13 | 339 |
| FAU | 233 |
| RPS15A | 72 |
| EIF3M | -129 |
| EIF3G | -171 |
| EIF3I | -201 |
| RPL8 | -295 |
| RPL10A | -562 |
| EIF4E | -590 |
| RPL36AL | -1188 |
GTP hydrolysis and joining of the 60S ribosomal subunit
| 337 | |
|---|---|
| set | GTP hydrolysis and joining of the 60S ribosomal subunit |
| setSize | 83 |
| pANOVA | 0.000939 |
| s.dist | 0.211 |
| p.adjustANOVA | 0.0449 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| EIF4H | 8386 |
| RPS25 | 8288 |
| RPS27A | 8228 |
| RPS3 | 8185 |
| RPS6 | 8168 |
| RPS28 | 8167 |
| RPL4 | 8137 |
| RPSA | 8071 |
| EIF4A2 | 8016 |
| RPS24 | 7985 |
| EIF3K | 7962 |
| RPL34 | 7954 |
| RPL3 | 7916 |
| RPL15 | 7772 |
| RPL28 | 7634 |
| RPS20 | 7538 |
| RPL38 | 7481 |
| RPL9 | 7462 |
| RPL41 | 7287 |
| RPL26 | 7225 |
| GeneID | Gene Rank |
|---|---|
| EIF4H | 8386 |
| RPS25 | 8288 |
| RPS27A | 8228 |
| RPS3 | 8185 |
| RPS6 | 8168 |
| RPS28 | 8167 |
| RPL4 | 8137 |
| RPSA | 8071 |
| EIF4A2 | 8016 |
| RPS24 | 7985 |
| EIF3K | 7962 |
| RPL34 | 7954 |
| RPL3 | 7916 |
| RPL15 | 7772 |
| RPL28 | 7634 |
| RPS20 | 7538 |
| RPL38 | 7481 |
| RPL9 | 7462 |
| RPL41 | 7287 |
| RPL26 | 7225 |
| RPL26L1 | 7153 |
| EIF2S1 | 6910 |
| RPL32 | 6861 |
| RPL37A | 6591 |
| RPS23 | 6550 |
| RPL23 | 6505 |
| EIF3A | 6467 |
| RPL37 | 6405 |
| RPS16 | 6351 |
| EIF3E | 6310 |
| EIF3B | 6240 |
| EIF5B | 5991 |
| EIF4A1 | 5915 |
| RPS10 | 5908 |
| RPS18 | 5632 |
| RPL27A | 5614 |
| RPS8 | 5562 |
| UBA52 | 5448 |
| RPL29 | 5290 |
| RPS29 | 5166 |
| EIF3H | 5136 |
| RPL22 | 5041 |
| EIF3F | 4913 |
| RPS9 | 4648 |
| RPL6 | 4621 |
| RPL36 | 4617 |
| RPS3A | 4514 |
| RPL17 | 4433 |
| RPL11 | 4330 |
| EIF2S2 | 4264 |
| RPS27L | 4151 |
| RPL31 | 3555 |
| RPLP1 | 3408 |
| RPS12 | 3328 |
| RPLP0 | 3049 |
| RPS26 | 2822 |
| EIF5 | 2798 |
| EIF4B | 2671 |
| RPS19 | 2666 |
| RPS7 | 2356 |
| RPL14 | 2209 |
| RPS11 | 2201 |
| RPL18 | 2150 |
| RPL7 | 2139 |
| RPL35 | 1903 |
| EIF4G1 | 1882 |
| RPLP2 | 1447 |
| EIF3J | 1279 |
| RPS5 | 1210 |
| RPS15 | 1135 |
| RPL23A | 1098 |
| EIF3L | 880 |
| RPL39L | 485 |
| RPL13 | 339 |
| FAU | 233 |
| RPS15A | 72 |
| EIF3M | -129 |
| EIF3G | -171 |
| EIF3I | -201 |
| RPL8 | -295 |
| RPL10A | -562 |
| EIF4E | -590 |
| RPL36AL | -1188 |
NOTCH2 Activation and Transmission of Signal to the Nucleus
| 563 | |
|---|---|
| set | NOTCH2 Activation and Transmission of Signal to the Nucleus |
| setSize | 12 |
| pANOVA | 0.000967 |
| s.dist | 0.55 |
| p.adjustANOVA | 0.0449 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| NCSTN | 8369 |
| RPS27A | 8228 |
| UBB | 7418 |
| APH1A | 6905 |
| PSEN1 | 6541 |
| APH1B | 6499 |
| PSENEN | 6061 |
| UBC | 5810 |
| MIB1 | 5480 |
| UBA52 | 5448 |
| ADAM10 | 5018 |
| PSEN2 | 2706 |
| GeneID | Gene Rank |
|---|---|
| NCSTN | 8369 |
| RPS27A | 8228 |
| UBB | 7418 |
| APH1A | 6905 |
| PSEN1 | 6541 |
| APH1B | 6499 |
| PSENEN | 6061 |
| UBC | 5810 |
| MIB1 | 5480 |
| UBA52 | 5448 |
| ADAM10 | 5018 |
| PSEN2 | 2706 |
Signaling by ROBO receptors
| 951 | |
|---|---|
| set | Signaling by ROBO receptors |
| setSize | 146 |
| pANOVA | 0.000979 |
| s.dist | 0.159 |
| p.adjustANOVA | 0.0449 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| NCBP1 | 8402 |
| RPS25 | 8288 |
| PFN2 | 8238 |
| ABL2 | 8234 |
| RPS27A | 8228 |
| PSMA3 | 8188 |
| RPS3 | 8185 |
| RPS6 | 8168 |
| RPS28 | 8167 |
| RPL4 | 8137 |
| RPSA | 8071 |
| RPS24 | 7985 |
| RPL34 | 7954 |
| RPL3 | 7916 |
| RPL15 | 7772 |
| PAK4 | 7768 |
| RPL28 | 7634 |
| PSMB5 | 7598 |
| RPS20 | 7538 |
| RPL38 | 7481 |
| GeneID | Gene Rank |
|---|---|
| NCBP1 | 8402 |
| RPS25 | 8288 |
| PFN2 | 8238 |
| ABL2 | 8234 |
| RPS27A | 8228 |
| PSMA3 | 8188 |
| RPS3 | 8185 |
| RPS6 | 8168 |
| RPS28 | 8167 |
| RPL4 | 8137 |
| RPSA | 8071 |
| RPS24 | 7985 |
| RPL34 | 7954 |
| RPL3 | 7916 |
| RPL15 | 7772 |
| PAK4 | 7768 |
| RPL28 | 7634 |
| PSMB5 | 7598 |
| RPS20 | 7538 |
| RPL38 | 7481 |
| RPL9 | 7462 |
| UBB | 7418 |
| SOS2 | 7347 |
| RPL41 | 7287 |
| PSMC1 | 7227 |
| RPL26 | 7225 |
| RPL26L1 | 7153 |
| PSMA5 | 7049 |
| PSMD12 | 7015 |
| RPL32 | 6861 |
| PSME2 | 6844 |
| PSMB10 | 6829 |
| NCBP2 | 6756 |
| PSMB7 | 6667 |
| RPL37A | 6591 |
| PSMB6 | 6558 |
| RPS23 | 6550 |
| PSMD11 | 6544 |
| USP33 | 6511 |
| RPL23 | 6505 |
| RPL37 | 6405 |
| CLASP2 | 6396 |
| RPS16 | 6351 |
| CAP1 | 6176 |
| PSMC6 | 5996 |
| RPS10 | 5908 |
| ABL1 | 5899 |
| UBC | 5810 |
| EIF4A3 | 5779 |
| NTN1 | 5763 |
| RPS18 | 5632 |
| RPL27A | 5614 |
| PABPC1 | 5582 |
| RPS8 | 5562 |
| PSMB3 | 5497 |
| LDB1 | 5453 |
| UBA52 | 5448 |
| PPP3CB | 5366 |
| PSMD4 | 5325 |
| RPL29 | 5290 |
| CLASP1 | 5253 |
| PAK2 | 5230 |
| RPS29 | 5166 |
| PSMD7 | 5075 |
| RPL22 | 5041 |
| PSMB1 | 4974 |
| EVL | 4872 |
| PSMF1 | 4670 |
| PSMD1 | 4661 |
| RPS9 | 4648 |
| RPL6 | 4621 |
| RPL36 | 4617 |
| PSMD9 | 4605 |
| RPS3A | 4514 |
| RPL17 | 4433 |
| RPL11 | 4330 |
| RPS27L | 4151 |
| CUL2 | 4094 |
| PSME3 | 3994 |
| NCK1 | 3798 |
| PSMD14 | 3709 |
| PSMD2 | 3621 |
| RPL31 | 3555 |
| PRKCA | 3486 |
| SRGAP1 | 3456 |
| RPLP1 | 3408 |
| RPS12 | 3328 |
| PSMA6 | 3273 |
| PSMC3 | 3247 |
| PSMB9 | 3199 |
| VASP | 3146 |
| RPLP0 | 3049 |
| PSMD8 | 3011 |
| PSMA7 | 2927 |
| PAK1 | 2913 |
| RPS26 | 2822 |
| CASC3 | 2750 |
| RHOA | 2719 |
| RPS19 | 2666 |
| PSMD13 | 2662 |
| RAC1 | 2583 |
| CXCR4 | 2548 |
| PSMD3 | 2545 |
| UPF2 | 2503 |
| PSMC5 | 2470 |
| PSMD6 | 2403 |
| RPS7 | 2356 |
| RPL14 | 2209 |
| RPS11 | 2201 |
| RNPS1 | 2173 |
| UPF3A | 2172 |
| RPL18 | 2150 |
| RPL7 | 2139 |
| PSMC4 | 2130 |
| GSPT1 | 2009 |
| RPL35 | 1903 |
| EIF4G1 | 1882 |
| PSMA1 | 1855 |
| PFN1 | 1516 |
| RPLP2 | 1447 |
| PSMA2 | 1432 |
| NCK2 | 1297 |
| RPS5 | 1210 |
| PRKACB | 1167 |
| RPS15 | 1135 |
| MYO9B | 1112 |
| DAG1 | 1109 |
| RPL23A | 1098 |
| PRKAR2A | 771 |
| PSMB8 | 756 |
| RBX1 | 651 |
| SRGAP3 | 586 |
| RPL39L | 485 |
| PRKACA | 480 |
| RPL13 | 339 |
| FAU | 233 |
| PSME1 | 209 |
| PSME4 | 207 |
| RPS15A | 72 |
| ETF1 | -25 |
| SRC | -41 |
| RPL8 | -295 |
| RPL10A | -562 |
| SLIT1 | -672 |
| CDC42 | -1172 |
| RPL36AL | -1188 |
Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC)
| 601 | |
|---|---|
| set | Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) |
| setSize | 69 |
| pANOVA | 0.000992 |
| s.dist | 0.23 |
| p.adjustANOVA | 0.0449 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| NCBP1 | 8402 |
| RPS25 | 8288 |
| RPS27A | 8228 |
| RPS3 | 8185 |
| RPS6 | 8168 |
| RPS28 | 8167 |
| RPL4 | 8137 |
| RPSA | 8071 |
| RPS24 | 7985 |
| RPL34 | 7954 |
| RPL3 | 7916 |
| RPL15 | 7772 |
| RPL28 | 7634 |
| RPS20 | 7538 |
| RPL38 | 7481 |
| RPL9 | 7462 |
| RPL41 | 7287 |
| RPL26 | 7225 |
| RPL26L1 | 7153 |
| RPL32 | 6861 |
| GeneID | Gene Rank |
|---|---|
| NCBP1 | 8402 |
| RPS25 | 8288 |
| RPS27A | 8228 |
| RPS3 | 8185 |
| RPS6 | 8168 |
| RPS28 | 8167 |
| RPL4 | 8137 |
| RPSA | 8071 |
| RPS24 | 7985 |
| RPL34 | 7954 |
| RPL3 | 7916 |
| RPL15 | 7772 |
| RPL28 | 7634 |
| RPS20 | 7538 |
| RPL38 | 7481 |
| RPL9 | 7462 |
| RPL41 | 7287 |
| RPL26 | 7225 |
| RPL26L1 | 7153 |
| RPL32 | 6861 |
| NCBP2 | 6756 |
| RPL37A | 6591 |
| RPS23 | 6550 |
| RPL23 | 6505 |
| RPL37 | 6405 |
| RPS16 | 6351 |
| RPS10 | 5908 |
| RPS18 | 5632 |
| RPL27A | 5614 |
| PABPC1 | 5582 |
| RPS8 | 5562 |
| UBA52 | 5448 |
| RPL29 | 5290 |
| RPS29 | 5166 |
| RPL22 | 5041 |
| RPS9 | 4648 |
| RPL6 | 4621 |
| RPL36 | 4617 |
| RPS3A | 4514 |
| RPL17 | 4433 |
| RPL11 | 4330 |
| RPS27L | 4151 |
| RPL31 | 3555 |
| UPF1 | 3538 |
| RPLP1 | 3408 |
| RPS12 | 3328 |
| RPLP0 | 3049 |
| RPS26 | 2822 |
| RPS19 | 2666 |
| RPS7 | 2356 |
| RPL14 | 2209 |
| RPS11 | 2201 |
| RPL18 | 2150 |
| RPL7 | 2139 |
| GSPT1 | 2009 |
| RPL35 | 1903 |
| EIF4G1 | 1882 |
| RPLP2 | 1447 |
| RPS5 | 1210 |
| RPS15 | 1135 |
| RPL23A | 1098 |
| RPL39L | 485 |
| RPL13 | 339 |
| FAU | 233 |
| RPS15A | 72 |
| ETF1 | -25 |
| RPL8 | -295 |
| RPL10A | -562 |
| RPL36AL | -1188 |
rRNA processing in the nucleus and cytosol
| 1135 | |
|---|---|
| set | rRNA processing in the nucleus and cytosol |
| setSize | 145 |
| pANOVA | 0.000999 |
| s.dist | 0.159 |
| p.adjustANOVA | 0.0449 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| PES1 | 8341 |
| RPS25 | 8288 |
| DDX47 | 8287 |
| RPS27A | 8228 |
| RCL1 | 8222 |
| RPS3 | 8185 |
| RPS6 | 8168 |
| RPS28 | 8167 |
| RPL4 | 8137 |
| RPSA | 8071 |
| RPS24 | 7985 |
| CSNK1E | 7983 |
| RPL34 | 7954 |
| RPL3 | 7916 |
| WBSCR22 | 7872 |
| FBL | 7793 |
| RPL15 | 7772 |
| RIOK2 | 7755 |
| UTP20 | 7701 |
| GAR1 | 7687 |
| GeneID | Gene Rank |
|---|---|
| PES1 | 8341 |
| RPS25 | 8288 |
| DDX47 | 8287 |
| RPS27A | 8228 |
| RCL1 | 8222 |
| RPS3 | 8185 |
| RPS6 | 8168 |
| RPS28 | 8167 |
| RPL4 | 8137 |
| RPSA | 8071 |
| RPS24 | 7985 |
| CSNK1E | 7983 |
| RPL34 | 7954 |
| RPL3 | 7916 |
| WBSCR22 | 7872 |
| FBL | 7793 |
| RPL15 | 7772 |
| RIOK2 | 7755 |
| UTP20 | 7701 |
| GAR1 | 7687 |
| RPL28 | 7634 |
| RPP30 | 7603 |
| C1D | 7585 |
| BYSL | 7563 |
| WDR75 | 7541 |
| RPS20 | 7538 |
| RPL38 | 7481 |
| WDR18 | 7463 |
| RPL9 | 7462 |
| UTP6 | 7403 |
| DDX52 | 7367 |
| RPL41 | 7287 |
| RPL26 | 7225 |
| THUMPD1 | 7215 |
| RPL26L1 | 7153 |
| EXOSC10 | 7129 |
| RPP14 | 7012 |
| RPL32 | 6861 |
| DCAF13 | 6595 |
| RPL37A | 6591 |
| RPS23 | 6550 |
| RPL23 | 6505 |
| FCF1 | 6479 |
| RPL37 | 6405 |
| LTV1 | 6380 |
| RPS16 | 6351 |
| MPHOSPH6 | 6246 |
| EXOSC6 | 6042 |
| RRP7A | 5962 |
| RPS10 | 5908 |
| IMP4 | 5827 |
| TBL3 | 5814 |
| RPS18 | 5632 |
| RPL27A | 5614 |
| RPS8 | 5562 |
| NOP10 | 5553 |
| UBA52 | 5448 |
| WDR12 | 5442 |
| RPL29 | 5290 |
| RPS29 | 5166 |
| PNO1 | 5053 |
| WDR43 | 5052 |
| RPL22 | 5041 |
| UTP15 | 4993 |
| NOL6 | 4802 |
| SENP3 | 4693 |
| EXOSC7 | 4662 |
| RPS9 | 4648 |
| RPL6 | 4621 |
| RPL36 | 4617 |
| RPS3A | 4514 |
| RPL17 | 4433 |
| NOB1 | 4405 |
| IMP3 | 4395 |
| RPL11 | 4330 |
| PELP1 | 4290 |
| PDCD11 | 4218 |
| UTP3 | 4201 |
| RPS27L | 4151 |
| FTSJ3 | 4146 |
| NOL12 | 4088 |
| HEATR1 | 3939 |
| BMS1 | 3878 |
| EBNA1BP2 | 3873 |
| RPL31 | 3555 |
| EXOSC2 | 3525 |
| DDX21 | 3469 |
| EXOSC8 | 3443 |
| RPLP1 | 3408 |
| RPS12 | 3328 |
| NOL11 | 3213 |
| RPLP0 | 3049 |
| RBM28 | 3026 |
| DIS3 | 2928 |
| XRN2 | 2897 |
| RPS26 | 2822 |
| RPS19 | 2666 |
| NOP14 | 2648 |
| RIOK1 | 2384 |
| RPS7 | 2356 |
| RPL14 | 2209 |
| RPS11 | 2201 |
| RPL18 | 2150 |
| RPL7 | 2139 |
| WDR36 | 2073 |
| RPL35 | 1903 |
| RPP21 | 1823 |
| NOP56 | 1724 |
| RPLP2 | 1447 |
| WDR3 | 1443 |
| TSR1 | 1421 |
| NOP58 | 1322 |
| EXOSC4 | 1277 |
| RRP1 | 1248 |
| RPS5 | 1210 |
| RIOK3 | 1192 |
| TEX10 | 1160 |
| RPS15 | 1135 |
| CSNK1D | 1107 |
| RPL23A | 1098 |
| MPHOSPH10 | 1092 |
| RRP9 | 1022 |
| ISG20L2 | 997 |
| RPP25 | 991 |
| NOP2 | 904 |
| NCL | 872 |
| RPP38 | 823 |
| NIP7 | 820 |
| DHX37 | 689 |
| NOC4L | 665 |
| PWP2 | 608 |
| EXOSC3 | 501 |
| RPL39L | 485 |
| RPL13 | 339 |
| NHP2 | 301 |
| FAU | 233 |
| GNL3 | 216 |
| RPS15A | 72 |
| RPL8 | -295 |
| DDX49 | -412 |
| RPP40 | -457 |
| EXOSC5 | -485 |
| RPL10A | -562 |
| ERI1 | -851 |
| RPL36AL | -1188 |
Here is the session info with all the versions of packages used.
sessionInfo()
## R version 4.1.0 (2021-05-18)
## Platform: x86_64-pc-linux-gnu (64-bit)
## Running under: Ubuntu 20.04.2 LTS
##
## Matrix products: default
## BLAS: /usr/lib/x86_64-linux-gnu/openblas-pthread/libblas.so.3
## LAPACK: /usr/lib/x86_64-linux-gnu/openblas-pthread/liblapack.so.3
##
## locale:
## [1] LC_CTYPE=en_AU.UTF-8 LC_NUMERIC=C
## [3] LC_TIME=en_AU.UTF-8 LC_COLLATE=en_AU.UTF-8
## [5] LC_MONETARY=en_AU.UTF-8 LC_MESSAGES=en_AU.UTF-8
## [7] LC_PAPER=en_AU.UTF-8 LC_NAME=C
## [9] LC_ADDRESS=C LC_TELEPHONE=C
## [11] LC_MEASUREMENT=en_AU.UTF-8 LC_IDENTIFICATION=C
##
## attached base packages:
## [1] grid stats4 parallel stats graphics grDevices utils
## [8] datasets methods base
##
## other attached packages:
## [1] pkgload_1.2.1
## [2] GGally_2.1.1
## [3] ggplot2_3.3.3
## [4] gtools_3.8.2
## [5] tibble_3.1.2
## [6] dplyr_1.0.6
## [7] echarts4r_0.4.0
## [8] ENmix_1.25.1
## [9] doParallel_1.0.16
## [10] qqman_0.1.8
## [11] RCircos_1.2.1
## [12] DMRcatedata_2.6.0
## [13] ExperimentHub_1.14.2
## [14] AnnotationHub_2.20.2
## [15] BiocFileCache_1.12.1
## [16] dbplyr_2.1.1
## [17] beeswarm_0.3.1
## [18] reshape2_1.4.4
## [19] gplots_3.1.1
## [20] eulerr_6.1.0
## [21] R.utils_2.10.1
## [22] R.oo_1.24.0
## [23] R.methodsS3_1.8.1
## [24] plyr_1.8.6
## [25] RColorBrewer_1.1-2
## [26] forestplot_1.10.1
## [27] checkmate_2.0.0
## [28] magrittr_2.0.1
## [29] kableExtra_1.3.4
## [30] mitch_1.0.10
## [31] DMRcate_2.2.3
## [32] IlluminaHumanMethylation450kmanifest_0.4.0
## [33] topconfects_1.4.0
## [34] limma_3.44.3
## [35] GEOquery_2.56.0
## [36] missMethyl_1.22.0
## [37] IlluminaHumanMethylationEPICanno.ilm10b4.hg19_0.6.0
## [38] IlluminaHumanMethylation450kanno.ilmn12.hg19_0.6.0
## [39] minfi_1.34.0
## [40] bumphunter_1.30.0
## [41] locfit_1.5-9.4
## [42] iterators_1.0.13
## [43] foreach_1.5.1
## [44] Biostrings_2.56.0
## [45] XVector_0.28.0
## [46] SummarizedExperiment_1.18.2
## [47] DelayedArray_0.14.1
## [48] matrixStats_0.58.0
## [49] Biobase_2.48.0
## [50] GenomicRanges_1.40.0
## [51] GenomeInfoDb_1.24.2
## [52] IRanges_2.22.2
## [53] S4Vectors_0.26.1
## [54] BiocGenerics_0.34.0
##
## loaded via a namespace (and not attached):
## [1] rappdirs_0.3.3 rtracklayer_1.48.0
## [3] tidyr_1.1.3 bit64_4.0.5
## [5] knitr_1.33 data.table_1.14.0
## [7] rpart_4.1-15 RCurl_1.98-1.3
## [9] AnnotationFilter_1.12.0 generics_0.1.0
## [11] GenomicFeatures_1.40.1 preprocessCore_1.50.0
## [13] RSQLite_2.2.7 bit_4.0.4
## [15] webshot_0.5.2 xml2_1.3.2
## [17] httpuv_1.6.1 assertthat_0.2.1
## [19] xfun_0.23 hms_1.1.0
## [21] jquerylib_0.1.4 evaluate_0.14
## [23] promises_1.2.0.1 fansi_0.4.2
## [25] scrime_1.3.5 progress_1.2.2
## [27] caTools_1.18.2 readxl_1.3.1
## [29] DBI_1.1.1 geneplotter_1.66.0
## [31] htmlwidgets_1.5.3 reshape_0.8.8
## [33] purrr_0.3.4 ellipsis_0.3.2
## [35] backports_1.2.1 permute_0.9-5
## [37] calibrate_1.7.7 annotate_1.66.0
## [39] biomaRt_2.44.4 vctrs_0.3.8
## [41] ensembldb_2.12.1 withr_2.4.2
## [43] cachem_1.0.5 Gviz_1.32.0
## [45] BSgenome_1.56.0 GenomicAlignments_1.24.0
## [47] prettyunits_1.1.1 mclust_5.4.7
## [49] svglite_2.0.0 cluster_2.1.2
## [51] RPMM_1.25 lazyeval_0.2.2
## [53] crayon_1.4.1 genefilter_1.70.0
## [55] labeling_0.4.2 edgeR_3.30.3
## [57] pkgconfig_2.0.3 nlme_3.1-152
## [59] ProtGenerics_1.20.0 nnet_7.3-16
## [61] rlang_0.4.11 lifecycle_1.0.0
## [63] dichromat_2.0-0 rprojroot_2.0.2
## [65] cellranger_1.1.0 rngtools_1.5
## [67] base64_2.0 Matrix_1.3-3
## [69] Rhdf5lib_1.10.1 base64enc_0.1-3
## [71] png_0.1-7 viridisLite_0.4.0
## [73] bitops_1.0-7 KernSmooth_2.23-20
## [75] blob_1.2.1 DelayedMatrixStats_1.10.1
## [77] doRNG_1.8.2 stringr_1.4.0
## [79] nor1mix_1.3-0 readr_1.4.0
## [81] jpeg_0.1-8.1 scales_1.1.1
## [83] lpSolve_5.6.15 memoise_2.0.0
## [85] zlibbioc_1.34.0 compiler_4.1.0
## [87] illuminaio_0.30.0 Rsamtools_2.4.0
## [89] DSS_2.36.0 htmlTable_2.2.1
## [91] Formula_1.2-4 MASS_7.3-54
## [93] tidyselect_1.1.1 stringi_1.6.2
## [95] highr_0.9 yaml_2.2.1
## [97] askpass_1.1 latticeExtra_0.6-29
## [99] sass_0.4.0 VariantAnnotation_1.34.0
## [101] tools_4.1.0 rstudioapi_0.13
## [103] foreign_0.8-81 bsseq_1.24.4
## [105] gridExtra_2.3 farver_2.1.0
## [107] digest_0.6.27 BiocManager_1.30.15
## [109] shiny_1.6.0 quadprog_1.5-8
## [111] Rcpp_1.0.6 siggenes_1.62.0
## [113] BiocVersion_3.11.1 later_1.2.0
## [115] org.Hs.eg.db_3.11.4 httr_1.4.2
## [117] AnnotationDbi_1.50.3 biovizBase_1.36.0
## [119] colorspace_2.0-1 rvest_1.0.0
## [121] XML_3.99-0.6 splines_4.1.0
## [123] statmod_1.4.36 multtest_2.44.0
## [125] irr_0.84.1 systemfonts_1.0.2
## [127] xtable_1.8-4 jsonlite_1.7.2
## [129] dynamicTreeCut_1.63-1 testthat_3.0.2
## [131] R6_2.5.0 Hmisc_4.5-0
## [133] pillar_1.6.1 htmltools_0.5.1.1
## [135] mime_0.10 glue_1.4.2
## [137] fastmap_1.1.0 BiocParallel_1.22.0
## [139] interactiveDisplayBase_1.26.3 beanplot_1.2
## [141] codetools_0.2-18 utf8_1.2.1
## [143] lattice_0.20-44 bslib_0.2.5.1
## [145] curl_4.3.1 openssl_1.4.4
## [147] survival_3.2-11 rmarkdown_2.8
## [149] desc_1.3.0 munsell_0.5.0
## [151] rhdf5_2.32.4 GenomeInfoDbData_1.2.3
## [153] HDF5Array_1.16.1 impute_1.62.0
## [155] gtable_0.3.0
END of report